Gene list
Applied filters:
COG category: Carbohydrate transport and metabolism
Organism: Xanthomonas campestris pv. vesicatoria, 85-10
Gene type: CDS
Number of genes found: 251
 | ||||||
| Show UniProt / TrEMBL protein name | |
View in Fasta format (DNA) | |
View as list | |
|
| ||||||
# Xanthomonas campestris pv. vesicatoria, 85-10 >XCV2765 putative glycosyltransferase MRIDLIAPPYSGHLHPILAIAQQLTAQHEVCVISTPAARAHIEACGLAAA SVLDAHADRLLLSIANPPHAVGHNPVRLRRQLHNALRLMAQLGEALQQRW RARRPDLVIVDFTLPSAGLAAQTMGIAWWTSMPSPCVIETTDGPPAYFGG LLPATTPLQRVWHAAARRLTRGFKRTLHLCYRRQMRACGLPAIYRRDRSE AVYSPQCILALGVPSFELAQRWPTAVRFVGPQLCTPPSSVPAPTFVDGRR HVLVTLGTHLQWVKQRMDGVLRALAPQFPEVVFHFSDGDTGASPQPGQGN YQRLPYVDYAQHLHRYALVIHHGGAGILYACLAAGLPAIVYPLDYDQFDH AARLQVAGAAWWLRDLDGLPALLRQALGAGEVPHGVRRLQAALQLIQSQA RIAQLVEGFARTGAVPPV >XCV0030 putative secreted protein MCPRKRLRRPPDARAQVLSLLFATTAPVQARAGAAGNRHHTSLFHPVASA LSTGLSIAAIGHFSWSFRGKIEAAYACNLGGTSMRHGVMDMTSCH >XCV2947 putative membrane protein MSAQSSVQPELAVRQWRTPLELGFLGVVWGCSFLFMRVAAPKFGTVVLVE IRLALGALVLLPFLWLARERFPLHRWPMLAAIGVLNSALPFLLFAWGAQH APAAVGAICNAMTVLFTALIAFLFFGERIGTRRALALLVGFIGVLVLATG KSAGLSVGPAALAGATASLLYGIGYNLVKRHMGDLPPAASAASTLGCSAL LLAPLAWWQWPTTPVPAVAWACATALGVVCTGLAFLMYYRLIQRIGPARA STVTYLVPVFGALLAWSLLGEPLTWTMLVAAVLILGSVAFSQRAR >XCV1808 putative xylose isomerase MSNTVYIGAKEYFPGIGKIGFEGRDSDNPLAFKVYDANKTIGDKTMAEHL RFAVAYWHSFCGNGADPFGPGTRAYPWDAGTTALNRAEAKADAAFEFFTK LGVPYYCFHDIDLAPDADDIGEYEKNLKHMVGIAKQRQADTGIKLLWGTA NLFSHPRYMNGASTNPDFNVVARAAVQVKAAIDATVELGGENYVFWGGRE GYACLHNTQMKREQDNMARFLTLARDYGRAIGFKGNFLIEPKPMEPMKHQ YDFDSATVIGFLRQHGLDQDFKLNIEANHATLSGHSFEHDLQVASDAGLL GSIDANRGNPQNGWDTDQFPTDLYDTVGAMLVVLRQGGLAPGGLNFDAKV RRESSDPQDLFLAHIGGMDAFARGLEVANALLTASPLEQWRAERYASFDS GAGADFAAGKTTLADLAKHAASNAPQQLSGRQEAYENLINQYLTR >XCV1795 conserved hypothetical protein MVSTPEHTAVLAVDSRCTHGEGVLWCEQRQALYWVDISEKRLWRHHPASA QSRYWTLPDRPGCIGLMHDGRVLVALAKAIGIVDPDTVEEDALPFEKLAD VEADNPLTRSNDGRVDRHGNLVFGTMDEHDSKAARGAFYQFSLKHGLRAL PLPGVSIPNSICFGLDGRTMYYCDSVRPQILCCDYDPQTAQTTNTRVFTT LDRDDAEPDGSIIDSEGHLWNAQWRASRVVRYRPDGSVERIVQLPIKHPT CSAFGGAALDRLHVISSRLDHSADELARMPEAGSLFVCDLAIAGLPESRV ASA >XCV1807 putative xylulose kinase MSLYVGLDVGTQSVKLVAYDPQDRAVVATIAAPMELISRDDGTREQQAQW WIDGIVHCFAQLDGEQRARVRGISVSGQQHGFVPVATDGSVTAPVKLWCD TSTALECDEIMDAVGGAAGSVAAAGNPIMAGYTASKLPWTRKHRPEAYAA MTTVMLPHDYINFWLTGERFAEVGDASGTGWLDVRTRQWSERMLSAVDAQ RDLRDALPPLVDTGAVYALSDAAAQALNLPAGVRVTTGGGDNMMAAIGTG NVVPGRLTMSLGTSGTLFAYADHPVVDDEARWAAFCSSSGGWLPLICTMN CTVATEAVMRMFSITRDQTEAMIADTAPGADGLVLLPFFNGERTPDLPAA RGCLFGMDMHNTTAAHFYRAAMEGATYSLRNGFDAFVAAGLQFDTILLTG GGSKSAQWRQMVADIFNLQVVVPTQPEGAAFGAALQALWACERADGGDAA LADVVLEHLQVDDGLAAQPNPQRVAQYQQHYQTFLKHLHVVSPLYAG >XCV0543 major facilitator superfamily protein MQTEPTSHPPLPRRLVLLMAAATGLAVASNYYAQPLLETLAQAFGIQVRS AGAVVTAAQLAYAAGLLLLVPLGDRLERRGLIVGLFVLSALGLLVSASSH SFAMLLVGTIVTGASSVAAQILVPFAATLAAPHERGRVIGTVMSGLLLGI LLARTAAGVLAGVGGWHTVYWIASVALLLTAGLLWRGLPRHPGNAQLAYP QLVGSVLALLRDDAVLRSRAVLGGLIFAGFSMFWTTLAFLLSGPSYGYGT AVIGLFGLIGAAGALAANRSGHWSDHGHGDRVSWGGLAMLLLSWGLLAFA PQSIGLLIVGVLLLDIAVQGVHIANQSVIYQRNPAARNRITSAYITCYFI GGAVGSTLGTAAYAQAGWMGVVIGGAVLAAAALGWVGLSVARRQWK >XCV0136 hypothetical protein MAATVLTEEGHAGATYFLTGPETLDMQAATSRLSKIIGRKVRYLDLPTPV FRVLMRATGNSPWMAKGLTVQFADVVAGHHDIDPTFEIERLTGKRPHTFD DFVRDHRQAFVG >XCV0922 putative secreted protein MTVVAHLRYLPLALLLSSSLASAADTPFVARDLIGDGAFTHNAEGPATGP DGALYAVNLGKDGTIARIALQADGGARAEVFVTLPEGSTGNGIRFRDGTM YVADYTGHKILQVNMQTRAVSTFAALPEADGPNDLALAPDGSFYASDPNW KDNGGRLWHIGRDGAVRLLEAGMTTPNGLDVSPDGKQLYVNESMSRKVWA YDRGSDGSLRNKRLLISFPDFGMDGMRCDADGNLYIARYDAGQIAVVSPQ GKLLRTVALKGRKASNVAFGGADGKQVFVTLQDRGAVETFRSDRRGRETG H >XCV2350 putative major facilitator superfamily protein MICSSLNLLRFISVRLLRVGLYSKSVTFQGSTSPAIAAEFGTSPQEAGSI ATVSQLGYALGIVLVVPLGDRNEPRSLVRYLLAGVALALFAASFSPSLGV LATLSFVICMGTCVPQIVLPLAAGLTRPERRGRVIAAVQTGLVLGILFSR MLAGIGANSLRWRNVYLIASILMVISAVILPVILPRRRSAIKPIPYLSLI SSLLHLFGRERDLRLSCLLGAVVFAAFSAFWTTISFKLAQAPFNFDLAET GLFALWGGIGGLASLLAGGLIDRFGYDRVNAFSIALTAFSFIIVLALRDS YIALVVGANLVSFSLSTGQIANQARILGFGEQRNRKCT >XCV1360 putative galactosidase precursor MRSPRRLWTPALLALAISTFAHAAPAPATLYLGADLSYVNEMEECGVQYR ENGVVKDPFELFHAHGANLVRVRLWNDARWTRYSDLADVKKTIARARAQG MQVLLDLHYSDDWADGEKQLIPKAWASIADTDELARTLYGFTYDTLSALD RAGLMPELVQVGNESNSDLMDSTPWDKKRPINWQRNAKLFNAGIKAVRDM SVRSAIKPRVMLHIAQPENVEPWFADATKAGVTDFDLIGISYYRKWSTQS MAELGKTIRRLRGRYDADVVVVETAYPWTLDSGDTSHNLLGEDSLIAGYP ATPQGQARYMVDLTQLVIDTGGAGVVYWEPAWTSSHCKTRWGTGSSWENA SFFDFKHGNEVLPAIDFMRHPYTGVPASRASDAGKHDASAPESSVDAGKR TQP >XCV1738 putative major facilitator superfamily protein (fragment) MISAQGTGAGVTKSLAYSFAISLAYPLAPLLLLRFAQRWENKWQITASAL GAVLFGGLFELQHQAVGMVLCGAMVAFCNAWMSFAYHGYQAELFPTGLRA RAVGFCYSFSRLSTAVSSVLIGWLLTQVGSHGVLAFIALSMSIVASVIAA FGPRTRNRALEEIAG >XCV4394 drug:H+ antiporter-1 family protein MGASDDSPPQPHHSIHRYTRRFAQLRRAMSLSPDSAPVPGRRRAALIFIF ITVLIDVLSFGVIIPVLPDLVRHFTGGDYVVAAGWIGWFGFLFAAIQFVC SPLQGALSDRFGRRPVILLSCLGLGLDFILMAIAHSLPMLLLARVISGVC SASFSTANAYIADVTPPDKRAGAFGMLGAAFGIGFVAGPLIGGWLGSIGL RWPFWFAAGLALLNVLYGWFVLPESLPAERRTARLDWSHANPLGALKLLR RYPQVFGLASVVFLANLAHYVYPSIFVLFAGYQYHWGPREVSWVLAGVGV CSIIVNALLVGRLVRRLGERRALLLGLGCGVIGFIIYGLADSGTAFLIGV PISALWAIAAPSAQALITREVGADAQGRVQGALTGLVSLAGIAGPLLFAN VFAWFIGSGAPLHLPGAPWLLAAVLLAAGWAMAWKRAARGAGTSPAAQP >XCV0358 putative cellulase MSDHPSPRRAPAASSHSTTPPVAGGISRRRVLQGAAGAAVVATTGWAGHA AAQSASLPFAGLNLSGLASNSYVENAEIGTHYRAITAQHVAAAGSCPLFR LPTTAARFTRGQGAPLNESYCRQVQDALDNIAARGKRAIVELHDYMRLPQ RVAAKSGYRRDASGAVVDARGNRVGDLAAAGLWADTYPLRNFNYVGYLDS RDQLLKLYEYRVIGTPGCTLYNDAGLPDLWARLVNRFKQHPAVFGWGVMN EPYQGAERNADGSVLSMAAHWQKTATACSKAIIDRDRNHFVFVCGNGYAS ARRWQDDSMGLFDIPDPYDCIVYEAHNYLDSDGSGGGNWIGPGGRNEVIK PDTGIDMVSPFIEALQQAGKRGYLGEHGYPAGNRSAEIATTRMLAHLQAY NIPSTQWCFGPGWPDDDVLGMSRDVGADIQTKANLAAVQAFFDVRLSSYV PPR >XCV4467 putative sugar hydrolase precursor MLSVVPPNRSTARAARTSFWRRAAVGLCLLGVAMSGPLAAQDPAQVNTFI GSKDDGNTYPGASAPFGLIQVSPIGAHYAGWRYDDPSIRGFGHSFLSGAG CWEQGGQVSILPVTGRIGPGGDFDTNDAKAFDQKRYAARYTHDGEVGQAG YYKVRLTDYGSIDAEASALTRAATERYTFAPGADTGHVLVNVAQANDRHV VIGSQVQIVGDRVVEGKLTTQSFCGGHEYTTWFRLEFDRPFTAHGVWGEE GGVPGARHGMGGELKPNGAWLSFPLGKDKRARAVTVVSAISHVDAQGARS NLRADGMQGGKLLSLEQMRQRAQQAWRNALASMQVEGASNDERSVAYTAL YHALLQPLTGSDADGRYRGYDDAIHRADGWTYYEYFSLWDTYRSQNQLLA LLQPTRARDIGRSLLAIQQQGGWLPRWGYANYDTNIMTGDPVTPFLVDLW RFGALQGNEAQAYAALRQNAFGQPPINSRHAGRSGNANYLANGFVQYDRA FPSKGMDVDPHHGGSATLEYALADCALAQMAQALGHGDDSAQLRKRGGNW HNVWDADVRDTETGFAGFPRPRLEDGSWYAPSDDRYSPRSEHGFHEGTAW QYQWLVQQDIPGMLQAMHGREHTGKRLDAFFAYDDLLKDPLTAARTHWVV GPYSYYNQYRYNPNNEPDLHAPWMYTLIGQPWKTATVVRAAQQLFTNAPN GVTGNDDLGTMSAWYLFSALGLYPAVPGSGQFLLHAPRFKRVTLNLGNGK RLRIDAPGANGRALQYVDSVRWNGKPQPQVFLDWAQLQQGGTLSFALTPQ APTQGWGTQADALPTSFCATPQAQ >XCV2799 putative secreted protein MARPCRAPQRVQRGRKADGASCLAASMLKMICMAATLGVAASSPALADEL EFQGRRAQAQALDDGSFVLRWPQGERRIAAQPMRTHTASPLFDALFALAQ QEMADDRVEAIRDPAFNDGKPVPCACFETGERWPYVWTRDVSFAADLALA QLEPERTRNALRFKLSAARDGRTPGLFVAQDTGSGGSWPISSDRVVWFLA ARGLLDDKPFAEEVSQALQATITQDRDAVFDAQIGLYRGETSFLDWREQT YPDWTREDVRFIAESFALSTNVLHYQALRLAEQLARQQGDARAVQYAQWA DALRQAIDRRFWDARSSQYVSYLGSAAHPVRYAKVDLLGLSLGVLADVFP PQRARLALRNYPMVAGGSPVVWPQEAAQPIYHNRAIWPFVSAYALRAART LDDAPRIALELQSLMRGSALAGSNMENYEMQRLAVHVEEGARSGPVVNSP RQLWSVAGYLSAVQEGVFGLSADGKLQPKLPRSLLPLLFGDAKQIVLEQG ARRYVLQRPANDAGELLVAGRSERQGQTTLVQLVGRNADLTPPPRPKQVF APQMPPAPVAQQIGNTYRIGIPEGTTLYLDGRALDASAHWDLPDDGLLHV LSLTRRRDGLESLHSPSLTLGPLQQLPGSQHWSWRPAHAGVHRVSLRYRN ANGPINTGITAAVKHLVLECPGKPAQSQVIVMPHSVGEQLSTQGTFDAVA GQACTFRLENGFNMSALAHFAQYNGGRGGRDGVVNAAQVSALLVGPAARV EAAP >XCVd0157 hypothetical protein MMPAHGQSCTVQLGVPVGAAAEAKDLASAVWAHAAPAFGGQTSVREALER LRADPMRTRDIGFALRLADEVAPSPAAAHTAPLVLRNLVAELAGLTTVEE HKQLAASWQ >XCV0155 putative secreted protein MRLLLFALLLLFACIAHAAPQRIFIAGDSTAAQYGAERAPQAGWGQLLQD WFDPAQWQVRNHAKGGRSTRSFIAEGRLDAIAKELQRGDVLLIQFGHNDA KREDPTRYTDPTTDYVQFLRRYVATARDKGATPILITPAARLLYDFGALL DTHGRYTLAMQQLAAQEHVGLIDLNASSSDWIRALGEQAAKPYFLFVPEQ GKADGTHFSRAGATAIACLVVHGWVQLQPALKPQLRRDADCGAAPNTSAQ RAAQAHPSLVVHERDLAREQPGPHGGAGPTTAYPFFADAPALKFVLRKRV LHKGAGIGLHLHDKDEIYYIVSGRGLYALDGKQYDVAAGDALLTRPGSTH ALQQTGEEPLVLLLAYTASK >XCV4364 xylosidase MSDELQAANLQALARTAISAPLVTHLYTADPSAHVFDGALYIYPSHDLDA GVAFSDDGSHFDMADYHVLRMAHPGAAVEDLGQVLHVRDVPWAQRQMWAP DAAQRNGKTYLYFPAKRADGIFQIGVAVGDRPEGPFVAEPQPIAGTYSID PAVLAADDGAHYLYFGGIWGGQLQHYRDNVYAQTHQEPVGEAPALGPRVA RLHAHMTELAEPSREVVILDEHGAPLRADDHARRFFEGPWVHQHAGRYYL SYSTGDTHQICYATSDSPYGPFNYQGVLLAPVVGWTTHHSICLFQEQWYL FYHDSVLSGGQTHLRSIKMAPLEHAADGTIATIYPYGEDAVSPW >XCV2507 ABC transporter sugar permease MMKRNSVAGWVFAAPSIMVLGMFFGVPVFAALVLSVTDFDLYALADSSHL RFVGLGNYIDLLQTPLFWKSLWNTTYFVLLGVPMSIGVSLGAALLLNAKA SRFKALFRTALFAPVVTTLVAVAVIWRYLFHIKYGLVNFGLSHLGIAPID WLGDPRWAMPTIMLFAVWKNFGYNMVIFLAGLQAIPQDLYEAARIDGASR WKQFLHITLPMLGPVLMVVGVITISGYFQLFAEPYVMTRGDPLQSTVSVL YFMFEEGFKWWNLGRASAVAFLLFLIILAVTTVMLRFGRKKDLI >XCV1418 putative arabinose efflux porter MRGNCDGVGAGAESPLVSRFPVVLHCTIIDRPATLESGMTDTDLSSPRVS RRDYVLILLALAMGGFAIGISEFSTMGLMTQIAQGLQITEPQVGHVISAY ALGVVVGAPLLAILGARWPRRTLLLLLMVFYALGNVASALAPSYHAMLLC RFIAGLPHGAYFGVASLVAASISPPNQRATAVGRVLLGLSVALLVGNPLA TWLGQIVSWRWAYASVSVIALGTVAAVAVLLPPQPEELRQQPLRELRAFN QPQVWLALAIGAVGFSGMFCVFSYLAPTLTAVTGVTAARIPLAMVAFGVG GVLGSILGGWLFDRMQFRAVPVLLLWSVVVMLTFPLAAQSGVWVFVSIVA VGTMGALAPALQTRLMDVAAEAQTLAAASNHAAFNTANALGPWLGGMAIT AGWGWTSTGYVGAATALGGLLVYAAAVWQERHRQRAVLTNC >XCV2491 putative sugar epimerase MISWRDRLTKALPQIAVVVHDLLMVWVCWQLLHAGRYSMLRDAPDLPLWD WRTAVVLVAQGLVFWKMGLYRGLWRFASVPDLWNIFKSSFLGLVAIVLAL AYDRLDGVPLSVLVVYPFALSAMLGTPRLLYRAWKDYQIAHSGDAGQRVL ILGAGRAAEGLVRDLRRTGAFVPIGYLDDASNLHGAKIQGLNVLGNLDQA AAIAKETAAKLLVIAIPSLDASGMQRVVAICESTGLPFRMVPKLINVLEG RSLPGELKEVAIEDLLNRKPVTPDWRLIRDWLTNKTVMVTGAGGSIGSEV CRQCARHGARRIVLLEIDELALLTIDSDLRRLFPDIEVVRVLGDCGDPAV VAHALNTATPDAVFHAAAYKQVPLLEEQLREAVRNNVLATENVARACQRA RIETFVFISTDKAVEPVNVLGASKRYAEMICQSLDARDAPTRFITVRFGN VLDSAGSVVPLFREQIRQGGPVTVTHPDVTRYFMTIPEACQLVIQAAASA SHGAIYTLDMGEPVPIRLLAEQMIRLAGKQPGKDVAILYTGLRPGEKLHE TLFYSDEDYRPTAHPKILEAGVREFSHEQVLQLVTRLREAVNRYDINAME TVLGSLMPDFAAARRKVDARSDTVVPFPAREVRRL >XCV4094 drug/metabolite transporter superfamily protein MGFGMCSRIEGSAALPGTVPMSSSHDAAAPARSGLVVLALLLVYVVWGST YLAIRFALEGGAQPLTMVSGARFIVAGSVLYSVLRWRGVAAPTRAQWKNV ALMGAALLLLGNGMVVLAERSVSSGLAATAVASVPLWMALFGALRGQHAS GGEWLGIVIGFVGVVWLNAGSSLTATPVGLVLLLIAPIGWAFGSVWSRGR DLPSPFMTAAGQMVCGGVLLVSTGLLIGERPQVWPSPQGLLAVAYLCVFG SIVAFTAYVWLLHHVRPALAGSYAYVNPVIAVSLGAWLGHERFSAQDIGA MAVILAGVLVVTFAKARR >XCV1601 conserved hypothetical protein MSRLPATPAPDFRSADVLRQHIADTMAFYHPRAIDPAGGFFQYFRDDGSI YDAGHRHLVSSTRFVFNYAMAYREFGDAAYLQAVRHGLDYLRNVHRNPQT GGYAWTLRDGVVEDDMNHCYGVAFVLLAYACGLKAGVDEARAWMDETWQL LEKYFWDAEFGLYRDEADAQFNFTSYRGQNANMHMCEAMIAAYEASGEQR YLDRALVLAENMTRRQAAKADGLVWEHYDLQWNIDWDYNRDNPKHLFRPW GFQPGHQTEWAKLLMLLDRYAPADWLLPTAQHLFDVAVERSWDTQRGGLY YGFDPDGNVCDDDKYFWVQAESLAAAALLAQRSGDDRYWQWYDKLWAYSW AHMIDHQYGAWYRILDADNRKYSDEKSPAGKTDYHTMGACYEVLNVLRPA A >XCV4034 putative glucosyltransferase MPESSADPLRQRPVVIATLGTHGDVRPIIALALGLQRRGYPARVLTSSNF ESLIRAHGLEFFPLSGDLQQLLHDHPDVAEMRGAPGILRKKLLEWARDWP AQGRAACADAGLILGVGSASFLVHSLGEAYGVPVAFAQLQPLTESRHLPL MLMPNLRLPGRVNVALHRLMRFVGWQLMRPAFNDIVRPALGLPGYPWSGP DRSALRVIYGYSAHVCPRPPDWPESAQVCGFWQLPPSQWQPPAALQAFLQ AGPPPLYIGFGSMTSSAVAQLTATVKAAVRLTGQRALLASGWGGLGAGDA VADDAERFFHLEQAPHDWLFPRVAVAVHHGGAGTSGAALAAGIPSVVLPF GYDQLFWAHCLAQRGVAPPALARAGLQPEALAAAIRQAGTPAMRAAARAL GQRIGQEDGVRNAVDQLEAWQLLEPAAVTPAAAARTEQHAIA >XCV1645 putative 3-hydroxyanthranilate 3,4-dioxygenase MLIPPINLHAWIEEHRHLLKPPVGNKCIQQDGFIIMVVGGPNARTDYHYD EGPEWFFQLEGEMVLKVQDEGVARDIPIRAGEVFLLPPKVPHSPQRAAGS IGLVIERERLPNEQDGLQWYCPQCNHKLYEAMFPLKNIETDFPPVFDRFY RSLALRTCSQCGHLHPAPERYATVED >XCV2889 conserved hypothetical protein MSDTAPDRPAGDFQLDPRLAADSVFVADGPLSQVRLMDDTRFPWLVLVPR VADVSEWIDLDGGQQRLLLAEINQLSQLLRAEPGVGKLNIGALGNIVRQL HVHLVGRHPGDAAWPGPVWGSGSAQRFAAEALQQHVAAWAQRLR >XCV0139 putative alpha-amylase family protein MRICVLNDALKDPTGLEQRCVAAREAGCDYVVMAAPFERDAEGRLIEPAA GAPTQMQRLQESVQAARRAGVKLLIDVRLDEVGGASAVVRDNPQWFRARS TAVPDPRQPRATPEVAEARFAYAQEGAALVEWWIARLLEWVGQGVGGFRL LQPQQVPVQRWRELIARVHAQAPEVVFAAWTPGLGLEALQELAGAGFDVA FSSLAWWDGRGSWFFDEDSALRALAAQVVAVLDAPDGKRAAAPEQHWQLA LALGGAWLLDDAHLAALPSSIRITNGLPTSNAGMRLRPLLREATGLTAVA IEPLGGLPSLLLINGDTRHVVPVPASDLLRLLGDAEALVAEDGRTLSGAT LEALEPGEVRVYRSVPARHVLAVPRMRPRAQTAGTWPRVCIESVTPSVDN GRFPVKRTVGDRICVEADAFCDGHDRIAVAVLWRPADAKTWASAPMRALG NDRWRAEFPLERIGTYEFRVEAWRDVFATLHADLEKKRAASTVLPVDVQE AIAVVQAAQARSDGALAERLQAVLARIGAQSEPLQQLAIVLEPDTAQAMA QADDKPFRSEYPVTFRVESERRAAHFASWYELFPRSQSGDASRHGTFDDV IKRLPHIRAMNFDVLYMPPIHPIGLNNRKGRNNSVTAVEGEPGSPYAIGA TDGGHTEVHAELGGLEGFRRLIQAARAQGLEVALDFAIQCAPDHPWLKEH KDWFTWRADGSIPYAENPPKKYQDIVNVDFYASGAVPDLWNTLRDAVLFW VNEGVTLFRVDNPHTKPFPFWEWLIADVRGRRPDVVFLSEAFTRPKMMYR LAKCGFSQSYTYFTWRNHKHELQAYVEELNEGVPRECFRPHFFVNTPDIN PLFLQTSGRNGHLIRAALATTLSGLWGMYQGFELCEATPLAPGKEEYLDS EKFQLRAWPERAPGDIVEEITRFNQLRRMHPELQSHLGTRFYQAHNDQVL YYGKFLDAGYLSRSRSMVLVAINLDPHAGQDADIEIPLWELGLPDHASVA VDDLWDGHRFAWHGKYQHIRLEATRPFALWRIRAGEVA >XCV1886 class II aldolase and adducin family protein MNATTAPLPYSTTRLHELAHLLIANIRELAHAGWTPATSSNFSHRLDEQH AAITVSGRDKGRLVEENIMVVDFDGLAVGRPLRPSAETLLHTQLYRRFPE IGCVLHTHSPVQTIASRLYAGSGVIRLEGYELLKAFDGNTTHETAVEVPV FANTQDMQVLAAQVDALLDKQSMWGYLIEGHGLYAWGRNMAEARRHLEAF EFLLHCELELLKLRGTR >XCV1325 putative xylosidase MRGDDTASKPFGMARRLAAPRGAAWRRAHDMSAMLQRSGSARSTHPATRV EACHHAGLASQNVMPRRPACCHAGVVLALRQGMARGDLLKRLAWVAGLLA ALICQLAHAGTALITQIDYQGDDGGPAPTAAQYRNPVVAGFHPDPSAVRV GDDFYLVNSSFGYFPGLPVFKSSDLVHWNQIGNAIDRPTQINYGNDELTR GLFAASISYHAGTFYIANTCFYCDGGNFLITATDPAGPWSDPIWLDVKGI DPSLFFDDDGSAWLVNNDVPAGKLRYDGHRAIWLQRLDLASMKLVGTRQV IVDSGFKPATNPEHIEGPHLFRRDGYYYLTAAEGGTGEQHAQMIYRSRQI TGPYETWSGNPVLTQRDLDPLRNAPITSAGHAQFVELKDGTWWAVFLATR PYRGNHYNLGRETFLLPVQWRDGWPVVLPHGAAVPVVAARPPLPAGTQPL PTTGPMQWSERFGDARVPMQWMTIHPPIRPWYQPGAQGLRVTPANIALGD IGRGQPAYLGHRLQHHHATLVASVDGSALAPGEQAGLAIVAKESNFLAAM LVREDSGAAVVLYRRAGPQQPGTGTELARAPLPDATQPVKLRFALDAARV RVDYAVGQGQWQTLLEQGDASVLSTESAGGFLGATFGPYAYAR >XCV0849 putative alpha-amylase (fragment) MRNYRICGGGSDPGLPDLVGNDWVVQQQRAYLQALKSIGVTGFRVDAAKH MTFDHLNRVFDAGIRSGVYVFGEVITGGGTGNGDYDQFLAPYLQSTPHAA YDFPLFNAVRNAFAIGASMQQLVDPAASGQALPGNRAVTFAVTHDIPNNA GFRYAILDPVDETLAYAYLIGRNGGMPMIYTDNNESGDNRWVNAYLREDL RRMIGFHNGVQGTDMQVLSSSSCHILFRRGSLGIVGINKCGNPVTTTVGM NNSVLYWNADYVDALGSGNVVRISSSSYTFTLPARGARMWRR >XCV4340 putative membrane protein MKTLLLVASALLYVAALCLPALHGGAEHVSGVVLLLFGWIQVLDGQCVAW LGNLLFFSAWLCYLFKSDRTALGLLLSACLIGMDTFRATRYLKNEAGHEV MIDRIGAAFYVWELSFLVLVIVVLMRLSETRGVTRPNTV >XCV4337 beta-glucosidase precursor MPSHPPAPFRSLAHGVLLALACTAGAAHAATPPPYLDTQRSFEQRAADLV SRMTLEEKAAQMQNAAPAIPRLGVPAYDWWNEALHGVARAGGATVFPQAI GMAATFDLPLMHEVATAISDEARAKHHQFLRQNQHARYQGLTFWSPNINI FRDPRWGRGQETYGEDPFLTARMGVTFVQGLRGEGADAPKNAQGEPYRKL DATAKHFAVHSGPEADRHHFDARPSQRDLYETYLPAFEALVKDGKVDAVM GAYNRVYGESASASKFLLQDVLRQQWGFKGYVVSDCWAIVDIWKHHKIVA TREQAAALAVKHGTELECGEEYSTLPAAVRQGLIDEAQIDTALTTLMTAR MRLGMFDPPGQLPWSTIPASVNQSPAHDALARRTARESLVLLKNDGLLPL SRAKLKRIAVIGPTADDTMALLGNYYGTPAAPVTVLQGIRAAAPNAQVLY ARGADLVEGRDDPAATPLIEPQYLRPSANSPERGLRGEYFRNRDLSGTPA LVRVDAQIGFKWDRGSPTDNLLARGEAGPSEAVPADNFSIRWSGQLVPPT TGTYHLEAAADDGVRLYLDGKPVIDRWSTSDRLHADGVDVQLQAGRAYQV RLEYFEGERDAGVRLAWRQPGAKPPLQEALDVASSADVVVFVGGLTGDVE GEEMKVNYPGFAGGDRTDLRLPKPQRDLLEALQATGKPVVAVLTTGSALA IDWAQQHLPAILLAWYPGQRGGTAVADTLFGDANPGGRLPVTFYKESETL PAFDDYAMRGRTYRYFGGTPLYPFGHGLSYTQFAYSGLRLDRTTIAADGS LTATVTVKNTGQRAGDEVVQLYLHPLTPQRERAGKELHGFQRITLQAGEQ RALHFILDAKNALRIYDAQRKAYAVDPGAYEVQIGASSADIRARQRFTVT DK >XCV2339 putative major facilitator superfamily protein MFAPMLLVYAKVLSGTAIAVVFAAYWLGLFPSLLFGARLSDRWGRRNLMR AVILVSIVGSGVLLFAGSSFGLLALGRVIVGLAAGAAFGPGTVWLSELND RSGSRRSAPILTAVALTSGFALGPLVSGGLAQWLILPAALPYLVHIGLML CVAPIVWSAPETAPRTSAKNRPTIGAALRNPLFLRLVLPTAPWVFGSIAA AIVVLPQTADLGEAGIAATGAVAALTLLSGVLVQPVASRLALRQGLGTAF VGGLVLLCLGMIAGAGMEFTRYTPLLFPAAVLLGCAYGFLLTAGLRAIPL IARIEDRSLLTGIFYVLAYSGFFWPILVNVLAPAIPKTAMFALSAAVGLA TVGSVAKIGGSQR >XCV0307 putative polysaccharide deacetylase MNAARDLLGYGATPPAAQWPGGARIAVQFVINYEEGAENCVLNGDAGSEA FLSEMVGAHAHPGARAMAMESLYEYGSRAGFWRLHRLFTARNVPMTVFGV AQALASNPDAVAAMQAAQWEIASHGLRWIDYQHVDEATERAHIAQAIAVH TRVTGSRPLGWYQGRTSPNTARLIAEEGGFVYDADSYADDVPYYDHRHGR AQLIVPYTLDANDMKFVAYNGFADGEPFFRYLRDSFEQLRSEGGRMLSIG LHGRIVGKPARAAALARFVDHVLASGDAWIARRIDIARHWLQVHPA >XCV2970 putative membrane protein MPTTDLRKAQLQIHFCVLLWGITAILGKLITLQALPLVWWRMLIVVVALA LWPRVWRGLRGLSGRVVLGYCGIGALVALHWLTFYGAIKLANASVAATCI ALAPVFTAVIEPLVTHRPFRPRELLFGLAVLPGVALVVGGVPDGMRAGVV VGAISAVFVGLFGSLNKRMVAHADALTVTALELGAGTLTLTLLAPAMPLL LPALHGDLLVVPSLHDGVLLLALSLACTLLPFALALVALRHLSAYSVQLV TNLEPVYAIVLAIALLGEQRELTLQFYLGVAIILGAVFLHPVLERRRTVA HPELLGTAEAKNIVD >XCV3211 beta-glucosidase precursor MSLSVFPCRLAAALSVSLALPLIAAPAVAAKNTDATPEQRAAALVAQMSR EEKVAQAMNDAPAIPRLGIPAYEWWSEGLHGIARNGYATVFPQSIGLAAS WNTRLMQQVGTVVSTEARAKFNQAGGPGKDHKRYAGLTIWSPNINIFRDP RWGRGMETYGEDPFLTGQMAVGFIRGLQGEDLNHPRTIATPKHIAVHSGP EPGRHGFDVDVSPRDVEATYTPAFRAAIVEGQAGSVMCAYNSLHGTPACA ADWLLNGRVRGDWGFKGFVVSDCDAVDDMTQFHYFRPDNAGSSAAALKAG HDLNCGHAYRELGTAIARGEVDEALLDQSLVRLFAARYRLGELEAPRKDP YARLGAKDVDNAAHRALALQAAAESIVLLKNDANTLPLKAGTRLAVIGPN ADALAALEANYQGTSSAPVTPLLGLRQRFGAQQVSYAQGAPLAAGVPGMI PETALRSDGKPGLRGEYFDNVDMSGAARVVRQDRTVSFNWDQVAPAKGVP ADRYAVRWSGELLPPSAGDSTLAVRVARCFDCSGHDPVRLYIDDKLVVAG NAEDKHVPAGMHNADGRSVETVLHFDDTRPRKIRLEMEHRGQDQGVRLEW LAPAAAQLAEAEQAVAQADAVVAFVGLSPDVEGEELRIDVPGFDGGDRND IALPAPQQALLERAKASGKPLVVVLMSGSAVALNWAKTHADAIVAAWYPG QSGGTAIARMLAGDDNPGGRLPVTFYRSTKDLPAYVSYDMKGRTYRYFKG EPLFAFGYGLSYTRFAYDAPQLSTTTLQAGSSLQVTTTVRNTGARAGDEV AQVYLQYPDRPQSPLRSLVGFQRVHLAAGEQRTLTFNLDARALSDVDRSG QRAVEAGNYTLFVGGGQPGTGAAGNTAPFSIQGRSPLPK >XCV1357 conserved hypothetical protein MAGSSLRGVDNLWTSRKSVPVKIRPLRSMLMTKLGRCWHADAVVWSLLVV VGQPLFVLFAELASRTQDAAMRAPTTQRAARPSVVKRRLLDLLGTLFGAR RANACVCAAHCTHRLLFWDSSPSEKLRSKLVQSRKSPMIDRRTFLATGVV AAASFGASAARIAQTPRASGPAPWGAVPSPRQLRWHRWEQYAFVHFAMNT FTDKEWGYGDEDPRKFDPSDFSADQIVAAAKAGNLKGLIFTAKHHDGFCL WPTRLTEHCIRNSPYKDGKGDIVGEMAAACRRAGLAFGIYLSPWDRNHAE YGRPGYLDYFRKQIVELCTGYGDLFEFWFDGANGGDGYYGGARESRKIDA PAYYNWPRMIELVHRHQPMACTFDPLGADIRWGGNEDGIAGDPSWPTMPN APYTQENGNSGVRGGALWWPAETNTSIRPGWFYHADEDGKVRSPENLVRY FDTSVARGTNMNLNLPPDRRGRIPDHDVAVLQSFGDAIRASFAIDLAKGA KASASASRGAGFEPARVLDRQPDSYWSTPDEVTTPTLTLELSSAHSFDLI RLREYLPLGVRVTRFAVEAEVDGQWRRLAEAQCIGAQRIVRLERPIAARR VRLVVLEAPVCPAISELALFRAVAPVPVARPMATAPDVLSTAGWRIVEAS APGAETLLDDDASTIWITPAPTPGHPMQVTIDLGGSRQVAGFSLTPSRAV MTGAAPPKGYRAETSEDGQHWQPAGAGELSNIAYALSTQRLNFPGVRQIR YLRLSFAETAVPAERLAIAGIGAFSRLR >XCV0850 putative alpha-amylase (fragment) MRNTPAHAPPSLIQRGARLLLTALALLLTTANAQADVILHAFNWPYATVE ARAKQIADAGYRKVLVAPAYRSEGSAWWARYQPQDIRLIDNPLGDTAAFK KMVQALANNGVETYADIVFNHMANEAATRSDLNYPGSVVLSQYAADPGRY DRCACSARCSQTSSAPAISARRNASATTTTPTKCVITAFAAAAAIQACRI SWATTGWCSNSAPICRRSRALA >XCV1219 conserved hypothetical protein MQIAQLTLTDAFKVLFSVRQVQAAEMAIAPGQGEGGPDNRHRGADQWLYV VDGTGEAVIEGQTHALQAGSLIAIERGETHEIRNTGSTPLKTVNFYHPPA YDAQGEPLPAGEGA >XCV3289 putative major facilitator superfamily protein MLRLTALLLGVALLLTGSGLLGTLLAVRGDQAGFDARALGLIMSGYFAGF FLGTFFAPPLIRRIGHIRAFAFYAALAAIAVLLHPIWLNAWGWGVLRLVT GAALVGLYTVIESWLNAEPDARRRSRVFSVYMAINLSALALGQVLLTIGD AGAPAMFTLTAILFCAAVMPVMTTRLIPPEVPHVSRLRLVTLYALAPVAT IGAGLSGLAMGAFWGLLPVYANRIGLNSDGVAMFMLTAIVGGAVLQWPIG RISDGHDRRIGLVTVSVLAAGIAIAAALPMVQTQTTVLFVLFFVYGGLAF SLYPFAVAHMLDYLPREDLLSGSSSLLLVHGVGAAIGPALAGGAMQKFGP AALPVYFAVMLLALAGFTLSRLLRFTRRRPHPIAFRPMLRTTPSALELMP ETQQTDTPLRTK >XCV3616 glycoside-pentoside-hexuronide:cation symporter family protein MSSTVPKLSFARILALNAGFFGVQYSFGLQQSNMSPIYNYLGADHANLPY LWLAGPITGLVLQPFVGAWSDRSVTRWGRRMPYMVLGALVCSLCLLAMPF STALWMAVCLLWVLDAANNVAMEPYRALVSDVLAPPQRPLGYLTQSAFTG LAQTLAYLTPPLLVWMGMNQDAANAHHIPYVTIAAFVIGAGFSAGSILLT ARSVREPAIAPAEIARIRQRGAGLGATVREIGSALREMPPTMRQLAPVML FQWYAIFCYWQYIVLSLSTTLFGTTDPTSHGFREAGLVNGQIGGFYNFVA FLAAFAMVPVVRRFGPKYTHAACLVAAGIGMWLLPGIENRWLMLLPMIGI GLAWASMMGNPYLMLADSIPSERTGVYMGLFNLFIVLPMLIQIVTLPLYY EHVLHGDPRNVVRLAGALMLAAAAAMLCVRGRKQGTSPAGA >XCV1336 putative aldose 1-epimerase MQRVFGQLPDGVEIHALTLRSQAGLQAEVLTYGGILHTLQLTTAQGVVPL VLNLPDLAAYAADGDSLNILVGRFGNRIAGARYTLEGVTHVLAANEGRNQ LHGGLRGFGRRVWSVLEQAPDQVLLGYDSPDGEEGYPGNLHVRAHLQLHG LSLQLNFQAHCDAATALNLTHHPYFNLSGDPQLRAAAQVLRVPADRYLPV DAESIPTGEIASVTGTPFDFRQPAALADNIQPAHPQIILGKGYDQCLVLA ADADCVAELYSPHSGVALRISSDAPAVQVYEGQHLDAHHPGLGRGVCLEP QDYPDAPNHPNFPSTILRPGQTYRRSISYRFAKAGPDQPWDAVRAALDA >XCV3790 putative membrane protein MPTTRSPLPAIAWMVAAVACFSLMDAGMKLLSAHYPPLQVTLLRGAASLP FVLVWVFATAGPRAIVPVRWGLHLLRGVLGMVMIGCFVFGIKRMPLSTAY TLYFVAPLLVAALSVPLLGEHVGPRRWTAIGIGLVGVIVVLRPGVDGLIS LPGLMVLLAATAYAVAAITASLLTRTDTPQAMVVWFLLFMAIGAGLLAIP GWVPLQAGHAGLIAGMGLAGALGQVALTQAFMRGEASMIAPLEYTGLVWV IGWDWVLWQTLPGSWTWTGAGIIVASGLYLLRRERIRQADRPLPLERP >XCV1739 putative major facilitator superfamily protein (fragment) MSPSVLAPPEQPSPSAQIAARIDRLPASATLWRLVGLLALGGFFELYDLF QTAYISPGLIGDGIFASGADGAFGMSDQAAFAAATFLGLFVGAALLSPFA DGFGRRPVFTFALIWYTAATVAMGLQSTASSVIVLRCVVGIGLGIELVTI DTYLSELVPRHMRSAAFAFAFFVQFLAVPTVALTAWMLVPFAPLGMSGWR WVVLLSGAFALAIWWLRSRLPESARWLAAHGRHAEADAVVTELEARCCGV RRIAGASGCWWSSMCFRRSASSVSATGCLR >XCV3309 putative major facilitator superfamily protein MRRILGPVLAAHYLAAFTALGMPLFLPQVLAELAPSAAVGWSGVLYVLPT LCTALTASSWGRWADRHGRKRSLLRAQLGLALGFAIAGFAPSLTWLVIGL VVQGTCGGSLAAANAYLASQPQAGPLARALDWTQYSARLAMVSAPALLGM ALALGPAQSLYRALALLPLIAFALTWRLPADRPAARGHTAGKAATSSRHA APSPASPRPHAAPLWPALLLAQFLFCFAMVVTFPYFIPYALARGAGHDAL AGLLYSLPHLVYLVVLPWWRRGDSEAWLVPGLALFAVACVWQALLHDAVT LAAARLLFGFGMLFGLRGLNRSLAHIASGHGAGRLFGRFDACGKWAGVFA GAAAGALAQASGPATPFLAAALAATVAALTVLVRFPSRRTADVAAHDA >XCV0453 alpha-amylase family protein MNQRNAITPSWGAWPAGEGQVRFALWAPAAKSVDVVFDDSARCALQAGQD GFFSAVIDCAANARYRYSVDGAEPVPDPASRWQPEGVHGPSAVQPTDGYA WQNAQWQGRPWDEAVIYEVHVGTCGGYAGVQAQLPQLAAMGITTIELMPL SAFPGAHNWGYDGVLPYAPVEAYGTPDELKALIDAAHGHGLMVLLDVVYN HFGPDGNYLHSYAAPFFNEDKPTPWGAAIDFRKPPVQRYFLDNALMWLHE YGFDGLRLDAVHAISPNAFLDTLRETVEASLPAGRHVHLVLENEANQASQ LQRGYTAQWDDDFHNALHVLLTGEEEGYYAAFADKPTEHLARVLGEGFAY QGEPDPRGHVRGEPSGALPPHKFVVFAQNHDQIGNRARGERLSVLVSPQR LRAALALTALTPMIPLFFMGEPWGAKQPFLFFTDFGPPLDDAVREGRRKE FAHFAAFADEAQRATIPDPNSHTTFAASRAPIADAAHGDGAQWASWFTAL LDVRRRWLVPGLAQARAVRASVLADGAVAATWELPGGLWHIAFNVGTQPV PLPPLRGRVAHVENVAADARELPVDGFIAWHEAQA >XCV3219 putative neuraminidase MHPPRLLSRLVASLAASLGVVAAQAQSPASPPSPIVLSEFIADRAPTPQA HASTLLETRDGRLLAAWFGGEHEGAADVGIWLAQRGPQQWQTPRRIADGA HAGVDGVAVPAWNPVLFQSTTGPVQLYYKLGPNPRQWWGLRLLSTDDGAH WSPPQRLPDGILGPIKNKPVQLPNGRILAPSSSEDRGWRAHLEWSDDDGA HWQRGMPLNDAKAIGAIQPSLLLYPDGRLQALGRSQQNKLFSTFSLDGGL HWQPMHLLDVENPNSGTDAVMLRDGRALLVYNPAIAGKDWWDGRGTLAVA VSNDGVHWQRVLTLEDSAHDEFSYPAVIQTRDGLVHVSYTWKRRRIKHVV LDPTRFGACSTCQAPAPATLSERCTTACGHAADPSS >XCV4408 metabolite:H+ symporter family protein MSAPPSSPIAAGSGTAAGSLRRSVSNTLKGSAGNLVEWYDVYVYSVFATY FESQFFSKEDKNATMFVWAIFAMTFLMRPIGAWYFGRFADRYGRRLALTI SVSVMALCSFVIAITPTVATIGIAAPIILLVARLLQGFATGGEYGTSATY MSEAAIPGRRGFLSSFHYVTLVGGHVLAQTTLLIMLHFFDASQVSEWGWR VAFGLGGIGALVVFWLRRTMDESLSSESIADSRTGKAKASGSMRELFVNQ WRPLLLCFLITAGGTIAFYTYSVTGPKMIQTAFAGGDVMAGTIINLVALT VLMLMQPVGGWLSDIVGRKTLLVFFGIGGVLYTWFLVMELPKQTDWLTAF AILTVGFVILTGYTSINAVVKAELFPTHVRALGVGLGYALANSAFGGTAP LLYQASLKTNHVTEFVIYATAVIAVSLVVYMFFLTNKGSNWLDDEAAMHQ RKR >XCV0412 hypothetical protein MTLESHNQQTANTAFFIGLSACLGLPGELAQRLGEGETILGPAGMLCRVH TQG >XCV0716 putative carbohydrate kinase MACGCGPDRPQPLPFAPRRTRRPAAMPGNWRVFPTQRPDSMSALICGSLA YDTIMVFPDQFKNHILPDKVHILNVSFLVPRMRREFGGCAGNIAYNLHLL GGAPIPMGTVGQDFGPYREHFETLGIDLSRVKIIDDLFTPQAFITTDHDN NQITAFHPGAMMRSYENHVKDVPGVTLGLVGPDGREGMIQNAEEFAAGGI PFIFDPGQAMPLFNGPELRQFIEQAQYVVVNDYESNLLQERTGWDEKDIV SRVQAYITTQGPKGALVHTPEKTYDIPPAHERRVVDPTGCGDAFRAGLIY GIQGGYDWLTIGRMGNLMGALKVEHPGTQNQRFDFAEFNDQFKQQFGYAL >XCV0652 drug/metabolite transporter superfamily protein MLKGVLLGFACYAAYSISDAFVKLLEGTLPVYEVLFLGALLMLLAVPFLK KPNDQLRELVMAKQPALWLLRALTGAIGNLTSVIAFTTLPMAEAFALIFL MPIFVTVLSVIFLKEEVHWRRWSAVIVGFIGVLIVLRPGFRHLTHGHVAA IVCGLVGAISVIALRMAGHSEKRLTLYGAGVIGPLVMGGIMMLPSFVWPT LSQWGLLAGYGLLAGLAAICMMYATRMAPVSLVAPTQYSQMLWAIAFGYL LFHDHLDWPMAVGIALILGAGLFTLVREEQVSRWWRRTKIV >XCV0235 putative major facilitator superfamily protein MPVTKDRPRGTRALEALHFSVADVQDGLGPFLSVFLQSKGWSVAAIGTVM SVGGIAGMLATTPAGALVDATRRKRAVVVIGCLAILLATALIWLQPTSSG VVAAQIASALAAAGIGPALTGITLGLVHAHGFDHQLARNQVANHAGNVLA AVLAGWLGWRYGFAAVFLLTAFFGALALVAVLAIPAAAIDHRAARGLASN NGGDALSGWRVLLTCRPLALLAATLGLFHLGNAAMLPLYGMAIVAAHAGD PSALTATTIVVAQATMVVVALLAMRWIRVHGHWWVLLVAFMALPLRALVA ASVIHGWGVFPVQILDGLGAGLQSVVVPALVARLLQGTGRVNVGQGAVMT VQGVGAALSPAFGGWLAHAFGYRIAFLTLGAIALLAVALWAGCRGMLQAA ASMQAETVL >XCV1201 conserved hypothetical protein MAAARLRMLTAAALRAMPLPSPGGDKEQRGRVLVVGGSMRVPGAALLAGE AALRAGAGKLQIATAASVAPAMALAVPEALVLGLGQNGQGEITRGHRALD AALAACDAAVIGPGMASTTTATALVKLAAAKAVCPLVLDAGALSRSLRAP PGRPFVLTPHAGEMATLAGDDKAAVEAAPGEYALAFAQKMRSVVIVKGAD SFIAGPDGALWVHRGGVPGLGTSGSGDTLAGLIAGFAARGSDALTAALWG VFVHAAAGKQLAKRIGTVGFLAREIPPEVPGILDRLSRR >XCV4395 putative transglycosylase precursor MTLARRALPFVLGLLPLAASADPAFDRCLAGLQPQAAAKGVDAASFQRFT AGLAPDPSVLPLLDAQPEFTTPIWDYLASLVDSQRVSDGQAMLVTHRELL ARLSEQTGVDPATIVAVWGVESDYGRVTGKRPLLVSLATLSCAGRRQPFF RGEFLALLSLLQQGDLSAEGLTGSWAGAFGQTQFMPSTYARIAVDGDGDG RRDLVTSIPDALASTANYLVKAGWERARPWGMEVTLPRGFDASKAGRTRR QPLQAWQRAGLLGTDGTPLAPAGLPAETPAALLLPAGASGPAFLVFGNYD AIYAYNAAESYALSIALLADRLRGGPGLIAAWPTDDPGLGRPERRELQQL LLARGYQIGEADGMVGSATRRAIQVEQTRLGLQPADGRPGQRILTALRAA PPVTGAAAMRATAFKLPAAYPAFAQSPSVHKASPMSDTTGLTTGDFHGFP SLLIDTPFSTAAISLFGGQLLSFVPKGGQDVMWLSPSAKQPPTPIRGGAP VCWPYFGRQDQTGDVPAHGFVRTVAWQLTESRREDDGTVVLTLTPPRFDD LALRLRMTLRIGRTLEQRLITENTSAAPVRFTQALHNYFRVGDALKVSVQ GLDGLDYLDKYENYATAHRQQGDWSLRDPRDPGRSDRIYTNAGGRYTLTD PVLGRRVVIATEGSRSLVAWNPGEEAGRQMADVGEGWRDYVCLEAANAGP DVIELAPGASHTLTQTISVE >XCV1804 putative secreted protein MSMHSPVARAMSHSSARRCLRPLLLSALTLALAGCQSGDKGDAGKPAATN AAASTAAATPDNAQAPAAQTPMPQFVSKDGKHALMVDGAPFLILGAQVNN SSNYPGIMDKVWPAMQVLGPNTVQVPIAWEQVEPEEGRFDFSFVDTLLGQ AREHKVRLVLLWFATWKNNGPQYAPHWVKTDNQRFPRVVTREGKSIGSLS PHAQATLDADRKAFVAFMQHLKKVDPQHTVIMIQPENEAGTYGSVRDFSP MAQKLFDGAVPDELIKRMHKQPGTWAQVFGADADEIFHAWSIGRYIDQVA EAGKAEYPLPMYVNAALRGPFNPGQPGQYASGGPTDNVLDVWKAAGPHID LLAPDIYMPEYRMYTTVLERYARPDNALFVAETGNRPEYARYLYPTLGHD GIGWSAFGIDYTRYSNYPLGAKHVNEETLAPFALGFQAVSMGMRPFAKAA SEGKLHGTAEEPGQAVQELKLNDRWSATITYGVPQFWFKGDPPGNPEPIG AALIAELSPDEFLVTGYHARVTLHPASDATANMIYDRVEEGVYEGNDWKF QRNWNGDQTDYGVNFSSVPQLLKIKLATYK >XCV0362 aromatic acid:H+ symporter family protein MPQHTASFGHFVLERMTPFQWRAVAVCVLLTMLDGFDVMAMAFTAPHVSA DWQLSGKLLGMLFSAGLIGMALGALGLAPLADRIGRRALTLACLAILTVG MGMSAVASTAWQLGALRLLTGLGIGGMLACVAVTAGEFSSPRWRNTAIVL QVTGYPVGATLGGMIAELLMQQWSWPAVFVLGAVASLLCVPLVLAFLPES LEFLIMRRPPDAVARFNAVLARMGMPPHDALPPLPPQSATQAQGYRALFD AAMRRHTLLIALGFFSLMFAFYFVISWTPKLLVTAGASATDGVTGGVLLN LGGIGGGLLFSGLASCVRLARLTIGSLLLMGLAMLASGLCSTQLSWAFAV ALLTGAAMFAAVGGMYAIVPIVFNAAVRSTALGWAIGVGRLGAILSPFCA GVLLDAGWSPAMLYLACSVPLLLAIFAVLAMRLPNR >XCV4169 putative glycosyl hydrolase MSVRIEDHAMLGNCHSAALVDHRGTIDWLCLPRFDSDAVFAALLGEEQHG QWALSPAADFRSERAYQDDSLVLCTRMITDNGTVELIDFMVASENGEVHQ HLVRIVRCVQGSVPMHMRLTFRFNYGRTVPWVTRIVDGIRAIAGPDQLAL RSPQTLRGQDMGTETDFTLREGESTWFLLSHGASHQATPPLIDAEQALQR TTAFWHGWARRCTDVGPWTEQVRRSLVVLKGLSYLPTGGIVAAPTASLPE HLGGMRNWDYRYCWLRDSVFTLIALLQAGYRDEAAAFRDWVQRTIAGSPD QLQALYGIAGERRLQEWEAHWLPGYEHSGPVRIGNGAVDQFQLDVYGELI GAFHYAREKGVGLPSDDDGSSASLLEKILETLETLWREPDEGIWEIRDER RHFVHSKVMAWLAFDCGARDGITNADAEKRAHWGRIAEEIRADVLEKGVH PEGHFVQSYGSDRLDASLLLIPIVGFLPPDDPRIAATADAIARDLTIDGL VERYRADDSADGLPAGEGTFLACSFWLVENYALLGRTDQARALLERLLGL CNDVGLLAEEYDPRSKRMLGNFPQGYSHVALVNAALRLHGRMGEKETHP >XCV3150 major facilitator superfamily protein MPTERPITAAVLSIQTQPTSILAAPYRAATLGMVALVSLNAFESLAVAAA MPTVARELNGLPLYALAFGGALATSVIGMTAAGRWSDRAGPGGALAAGLL CFVVGLLVAGLAPSMPILIAGRLLQGLGAGAYSVALYVIVGRLYPEVLRP RVFAAFSAGWVVPSLIGPGISGLIVQHLGWRWVFLSVPLLAIPAGLLLWP ALRGQAWTRDRSDAPTASMGWAIGAAMGVLGVYLGGQLHGMLAPGAMLPA VLLTAYCAWRLLPAGTLRLARGLPSVIALRGIAAAAFFGFEAFLPLLLSR ERGLSPLLAGVALSVGALGWFGGSWYQGHSRAGWSRPRLLKSGALLMTLG IAISAGAVWPPIPVPLAIAGWALTGLGMGLLYPSLSAVMLSLSPPAQQGA NSSALQLSEAIAVAAMLALAGAVFAALLTSATRAAYLSVFALAWLLAVAS FLVARRV >XCV2505 putative secreted protein MKPVFLRLCAMAAFVTSAGAAQAQERVLDGFNDIGAWRLVVSNQVSGSLR PVATPSGGHALCLDYNFNGVSGYVGIRRNLPITYPDNYRMSFAVRGESPS NDLQLKLIDASGDNVWWVNRPGFNFPKNWTTFNYRKRNIEKAWGPGQDKQ LRSSADVEFTIYNKVGGKGTVCFDRLTLTPLPPEDTSPLQAKAITDTAPA LEQRLADGKPDTFWLSGAVKQQTVTLDLGRVREFGGAVVQWVPGLQASQY VVRSSSDGRSWRDLRTVTAGAGGTDWLALPDTEARYLRFDLKDGPNWRYG IKEVQLQPLAFAATPNDFIKSLAAQLPRGSYPRGFSGEQPYWTILGLDGG TEQGLIGEDGAVEVGKGGFSIEPFVVTGGKVLHWSDVSSEQSLQDDYLPI PSVDWHHDLMNLRVTAFVQGTPDQAQLVARYQLHNTGKDAREFTLALAVR PFQVNPPAQFLNTLGGVSRIDQLAVDGGQVSVNGKPRVFAAQRPDAGFAS AFDSGMDVSHLTAATPPTVTQVKDETGLASGVLLYRWKLEPGQRREVALV IPQTGAAQLPAGFDADKAQQQVAQQWRSKLDRVRISVPAEGKPVVDTLRT ALAHMLISRIGPRLQPGTRSYSRSWIRDGAMISEGLLRLGREDVVRDYVD WFAPYQFADGMVPCCVDDRGSDPVPENDSHGELIYNIAEYYRYTGDKAFL EKMWPHVTGAYDYMERLRASERTEENFMRNPAFYGMMPVSISHEGYSAKP VHSYWDNFWALRGYKDAAMLAGALDKPEEAARFSAARDEFSGDLVASLGA AVRQHNLDFLPGSAELGDFDATSTTIALTPGGEQQRLPQDLLTKTFERYW KEFSDRRDGKREWKDYTPYEWRNVAAFVRLGWRDRAWDATAFFFKDRAPQ PWNQWAEVVSRTPRTPFFVGDLPHAWVASDFVRSVLDMFAYGRESDASLV IAAGTPTRWFEGKGIGIAELRTPYGRLNYTLQRTDKQLVLQLQPGLILPP GGVVLPWPYQGTPGKATINGESAEWQNGELRIQQLPANVQIDVPSAVRRA ERATQ >XCV2506 ABC transporter sugar permease MSRDVGESRWNAVLINGGLLALAVISLAPLLWMLSVSFMPTGEASRFPPP MLPSAFTTANYHELFARTGMARNFANSLLVSGLITLGSLLVNTMAGYAFA KLQFVGRERIFKILMAALVIPAQVAMLPLFLLMKQLHLVNNIGGVVVPAL ATVFGIFLVRQYARSIPDELIEAARIDGASEMRIFFQIVLPMLKPVLVTL TIFTFMGSWNDFMWPLIVLTDQEQYTLPVALAALSREHIMDVELMMAGAV VTVIPVLLLFLALQRYYIQGLLLGSVKG >XCV4135 putative membrane protein MSRPPPLPQAAPQRPRAADLWNRHWKWAVPGIGIALSVLLALLIGGVLYV ITAALKSSDVYLDALQIAKTDAQVVQRLGMPINEDVLINGSIR >XCV2334 putative major facilitator superfamily protein MTDNGTASIGGASDELPEKVQSGNIWRLSIAQALAGANSTVLYATGAIVG DMLAPVPVLATLPISIFVVGMAACILPAGAIARRHGRRTAFLVGTGAGVL TGLLGMLAVIIGSFWLFCLATFLGGGYAAVVLTFRFAAADGVAPDRRARA LSLVMAGGVAAGVVGPQLVNYTMNMWPPYMFAATFLAQGAVAAVSALILL GVRLPMPTAAEVAGGRPLAVIARQPRFVAAAITGAVTYMLMNFLMTAAPL AMHMCGHSQESANQGIQWHVIAMYGPSFFTGSLIKRFGAGRVATVGLLLT GLSAAVGLAGIDVAHFWATLILLGLGWNFGFLGASAMVLECHRPEEKTRV QSLNDFIVFGLMAVGSFLSGGLLSTYGWTTVLWVSFIPLALAVLSLAVAL RRKPVSLAG >XCV0906 putative membrane protein MTSRSHDTLILSLLAVLMAATRINHFAPVPDASWAMFFIGGFHLAARTKL AFPLLMLLAVAVDWLVITGQGLSFWQHYCVSPAYWCLIPAYFALWAGGMW LRRHYHGAQWSALARLVPALLIAVALCQLIAQGSFYWISASVADPTVAGW FKNYTDWLGPYLRSAALYVAAAAVIQVAAERLSAPRRQPYAG >XCV2728 putative xylosidase precursor MTRTFSRSLVLTCGLLLASAPACAMQPPQGTRLHAPGNPILADGSEYSAD PAPLVADGKLYIIAGRDTAAPNLNAFVMPGWQLFVSSDPASGDWIHYRDL LRPKQVFAWTDKRYAYASQIVQGPDGRYYLYAPVQQRDSPNADPFAIGVA VADSPLGPWTDAHPQGPVVSQSVPGRNDIQNIDPTVLVDDDGRVYLYWGT FGALYGVELQRDMVTFKGTPVLVDTLDGYFEAPWLFKHKGTYYLAYAANN AGRLSPCTPTLYHACIAYASAPTPLGPWTYRGIVLPPVSSTTSHPGIVEF QRQWYLVYHTADATGGGHFRRSVAIDRLEWDESTQPASIRTVVPTRRPTP PAPPMRNQASSAYATASNGPDIPVQYWIAALNDGVVKANPLPPEMWASWT DNNPPQQWLQYSWAQPITVDRTRIVFWADHPAGADVGVAPPARWHLEYRN AGRWQPVQPRDGYGTRPDHEEAVSFAPVTTRCVRVVMDASGNAASYAALA VQEWEVLAPQPQRLPSATAADSQRCDAP >XCV0137 conserved hypothetical protein MILVSGATGGIGGELCKLLQDVATPFRAMCRKQEQVDNLQQKGMDAVLGD FDTPETLQGAMQGCHTLFLITPPTPEQVAQETAAIDAAKRAGIGRIVKVS ASDCNVRSPVPWAKSHALIDHHLRASGIAWTILKPTAYMQNFLWFKDPIA KGVFPMAAGRGSVS >XCV4361 Anion:cation symporter family protein MSEVPAAAPGAATARLGRVRWRVCALLLAATTINYVDRQVLGVLAPFLQT QIGWNEIQYGYIVTAFQAAYALGLLCSGAVIDRFGTRLGYALAIGLWSLA AMGHALATSVVGFAIARFFLGLGESGNFPAALKTVAEWFPRRERALATGI FNSGSNIGAIVAPLLVPLIATAWGWQAAFLFTGVLSATWLAVWWFSYHPP EQQPRLSAAELAHIRSDAHEPVQRRLSWLQVLRHRQAWAFVLGKFITDPI WWFFLFWLPKFLHAEYGLSLLQLGVPLIVIFVLADIGSIAGGWVAGRFIA RGWSVNRARKTAMLICAISVVPIVFAARADNLWLAVALIGLATAAHQGWS ANLFTLPSDMFPRHAVATVVGIGGFAGAVGGMLIATFIGFLLQATGSYVP VFLMAGSAYLLALAVVHTLVPRLEPAQLPADPAPTSS >XCV1831 metabolite:H+ symporter family protein MTTHAPPTQLTRSDYKTLGLSALGGALEFYDFIIFIFFAKVLGELFFPPG IPEWTRQLQTFGIFAAGYLIRPLGGIVMAHFGDLLGRKRMFALSIGLMAL PTLAIGVLPTYAQIGLAAPLLLLTMRLLQGAAIGGEVPSAWVFVAEHVPA RRTGLACGTLTAGLAAGVLLGSLSAGALNRAFSPEEIAEYAWRLPFLAGG IFGLLSVYLRRWLHETPVFAELVAMRALARETPLKVVLRDHPRSLAMSLW LTWVIAAAVLVVSLMTPTLLQSAYGYPAPVALQANLLAVLLQAIGSVVAG ALSDRWGNGRVLLAGSVLLGISAWLFYRFAGDPRLLFPLYALLGTALGVL GAIPRVMVEAFPPVVRLSGVSFAYNLGYAVFGGLTPLLVVMLLKQHPMGP AYYVILLASIGAMVGARLSQRERIGRG >XCV0697 major facilitator superfamily protein MRDKYVQRDWQPHERPTLPGSASTPLHPIRRRIQYGLVGAVVALTGGLSN ALVTANLPYLQGTLGAYATEMAWLPAAYVMTNMSANLLLVKFRQQFGLRR FTEIFLALYALIAFAHLFVHSLSSAITVRAAHGLVGAALSSLGLYYVIQA FPSKYRLKAVVLGLGMTQLALPLARVFSTDLLEFGEWQGLYLFECGLAVF ALACVLALKLPPSDRYRVFEPLDFLTFSLFAAGAAGLAAVLSLGRLLWWT STPWLGVVLAASIVLLCTAAWIEHNRRNPMINTRWLASADMLRLGLAILL IRLVLSEQSTGAIGFFQTLGLANTQLQTLFALMLLGAVVGVAASAWLINP ARVAEHLIIAVAAICVGCFMDADATSLTRPEQMYVSQFLLAFGSTFFIGP AMVAGIGRVIAQPGNLISFIVLFGMAQNMGGLLGSALLGTVQVVREKYHS SQLVEHLALTDPQVAARVQAYASLYGRSIGDPALRQAQGVRTLGTVATRE ANVLAYNDVFLLIGCIAIATGVWILSVLLWRRYLRPSVSPPPPPAPTARP >XCV1973 conserved hypothetical protein MSLSPDALKVLNDFGNEPGVTKPHVDQLRQLLTESPELTRQLNEAVDQKL VTSFKPLTDPHAGGSFDPIGHSIQLPLTKLVGPNGLAPASAGDLTFVLGH ELQHSTFSPDAEAARQQFMTEARTIARTTHDYTSAAEKVIASNREDESRA EIAGWNATLSRVKGSTPQPTLEDIYRAAPGRMRDFIDTAAGSQGLVYTLK PNLSLNQDLTMSATPANIEAMGVNYFDKPAQDTQIGYGGLSDYHNHYGPW VIGTAAIFERHYNKAQQGTPEQPMIFNLQRLGLKEDALERNGIDLGSNTR PMPYLDSSTQPPTPGLFQHSKNTHLHVSPISAQELEQELRARESPSQGTS LHLLPSDPGHADHPLYQQIKDGVQKLDSAHGRQWDASSERMTASLLALAK EEGLSRVDHVVLNNPTAQLAGGEKVFVVQGALNDPAHQRAHMSTMDAVQT PETQSFDRLQAINQTQAQAREQQQALEQSQQAVSQAGPSMTR >XCV2662 metabolite:H+ symporter family protein MTAAAPLAAPNNSHGRVLFASLIGTTIEFFDFYIYATAAVLVFPTLFFPA GDGSAAMLQSLATFAVAFVARPVGSAVFGHFGDRVGRKATLVAALLTMGL STVAIGLLPSYAQIGVFAPALLALCRFGQGLGLGGEWGGAVLLATENAPP GKRVWYGMFPQLGAPLGFLLSTGTFLGMGAVLDDAQFMRWGWRVPFLASA LLVLTGLWVRLSITETPDFQKTLDRKTRVRLPLGTVVAQHWPALIVGTLG AFATFVLFYLMTVFALGYGTKTLGYDKEQFLLLQMAGIVFFALGIPLSAK FGDRHGAPLAMMLASIAIVAFGLAFAPLFQASHPLQVLAFLSLGFFFMGL TYGPCGTLLAELYPTEVRYTGASLSFNLASILGAAPAPYVATQLAASYGV QSVGYYLGGAAVLSLMALVVARRWRR >XCV1203 glycosyl hydrolase MSRPCAEFQRDATGTLPIAAYAAIGDGRSVALCGADGSIDWWCVPKMDSP PLFDRLLDAGEGGYFALTPQQLQQVQRRYRDGSNILETTFSTATGSARLT ESLNSGEAGRLPWSELARRIEGLEGRVVFDLIYRPGTRAGEATPWQSETP NGRVHHVGPLMTMLRYDTEAAQLVHCDDRGVHATLAIRAGDTQVVALLAA EEDALPVPALEDIGGRIERSDQEWREWSGNLSYANSYHDAVVRSALALKF LWFSPTGAIAAAVTTSLPEQIGANGNWDYRYAWVRDAAYTTKAFLRVGAL ADAKAAFSWLMRTIRQHRPGVRPCYTLDGALVPDEREIDIPGYCNTRPVR VGNTANNQLQLCLYGDIFEMAARFLDAGHILDQETARQLFELGNECANTW MRKDAGFWELETAEHYTMSKVECWLALRRASELAKAGHLSTAMLPRWERE QARILEWIDMHCWSYAKQAYTFYAGTDDLDASLLLASRFGLGGPRRERMI ATRDAIASELGSDALLHRYSGMQQREGAFIACSFWLVEAYGLLGERAEAR HLFEQLLERLGNDVALMPQMLDTSTGAALGNVPQGLSHLALIHAALAVDG E >XCV3625 Polysaccharide deacetylase MASLGMTTPETLYRTPSRPYRWVGLLALSQAAVALLWWHLGWAWGLPALL LSHALFVVPVFLPRARLYAPVLARLPGRAPHVWLTIDDGPSDDTPAILDL LDAYDAKATFFLVGARAEQRPELVRDMVRRGHGIGNHSHTHPQAWFWALG PRRMAQEIGQAQRVLACITGQAPRLYRSVVGMTNPFVASPLRAHGLTRVA WSARGFDGVQCEPDTTIARIVRDLQPGAIVLLHEGAAHGHNLTILRGVLE AMQARGLVGRRPD >XCV3430 putative O-glycosyl hydrolase MLMVRKAFRRGALWVLCACMGWTAVEAAPADDPPGPYDVRVLAGGVALTK KLAAQTPWLSADADWSVVGWVRPSRSITGPALIAGVGDPQGAGRYFAIDG GTLGFAQGADNVLRSTQTLRAGSWTQVAAVAQGERLTLYANGRKVASGRV QQTAIAPTLVFGPRQQPAAYTQHFGGDIAGFTAQAGALDAQAIARLAANA PDPALQRFEDASPGWRLQVKQMAGQLAPQPAATLPRSSAAFSAPVAQPVP DAPALQSLDATSWRVDAWQLAAAPELGAATGATLSRRDDTTGNASWHVAT VPGTVLTTLVDRGVYPDPDIGLNNMAIPEALSRQDWWYRSSFDLPAAAQG KRLELLFNGINYAGEIWVNGVQVGRTRGAFARGRFDVSRQLKPGRNVIAV RVSPPPHPGIAHEQSMRAGVGENGGMQALDGPTFIASEGWDWIPAVRDRN AGLWQDVQLHASGPLALGDIQVLTARLAPDHQRAELEINVPLRNDTPAAV QGNVQLAFGDVTIQRQVTVPAGGSTLKFTAADTPQLRLVNPRLWWPNGYG EPALYTLQVGVDVEGARSDAQQLRFGIREVTYELSLFDDEGALRRVLVDL NQARQRGERIVDVRHAAIRPVPGGNAQSLYPGALGSPAVQQLDDSTLAPH LVIRINGVRIAVKGGNWGMDDWRKRVSRERLEPYFRLQRDAHFNVVRNWV GQNTEASFFELADEYGMLVLNDFWQSTQNYNMEPADAALFLDNAAEVIKR FRNHPSIVLWFGRNEGVPAPILNEGLDKLVAELDGTRWYTGSSNEINLQG SGPYNYREPVAYFNKLAQGFSVEVGTPSFSTLESFKASVPAVGDQWPISD AWAYHDWHQSGNGDTNSFMRTLTDKLGAPTSLEDFERKAQLLNYETHRAI FEGFNAQLWSKNSGRLLWMSHPAWPSNMWQVYSHDYDTHAAYYGVRTAAE TLHVQMNLPGYEVVVVNNAATPERGLRVRAQVYAHDGKLLQQREQPLDAA AVAVSAPVLQLAPLLKDTNGLGFVRLQLLGRDAVVRSRNFYWVARDAVAM RGLDALAKVPLQLTTQLQQGNEAVLCATVRNRSQQVALNTKLTLVDAQGQ RILPAYYSDNYLSLVPGEERVVEIRGPSAATLRNATLQLRGWNAEPSTGV ANGVP >XCV1845 putative membrane protein MTEVKNELSNQATSSLRVGTTLFNVILSAFFALIFFGSPVVLNEAESRAV FDYLLYIGPAVSAIIAGFGLYVSKGKRIFGIGVDGLFFCVSASFLFLCVV AYAFSKGYLATMLSQSLGVFLLLPLLWILSSLIGKKISIGIVSFLVVFIF AVVFAFAWIYVVSEYKLERPGLIMEAVIKFLFSH >XCV3987 putative secreted protein MSVRRLLALACSATLFTAGTAVAAPAAAPAASIPKAQWPFQATTVADFDE PWAMTFLPDGSLLVSEKRGALMRLDLKTKRKSAITGIPAVAYGGQGGFGD VLAHPRFAKNGLVYVSYAEPGEGDTRGAAVARAKLTLDATGGGTLSDLKV IWRQDPKVTGNGHFGHRLAFGPDGKLWISSSERQKFTPAQDMKANLGKLI RLNDDGSVPTDNPFVAQGGVAAQVWSLGHRNILGLAFDSRGRLWEHEMGP LGGDELNLIQRGANYGYPIVSNGDNYDGTPIPDHYTRPEFAAPKISWTPV ISPAGFVIYSGKQFPAWRGNGFIGGLSSMALVQVSLGDQPREVARYDMGA RIREVEQGPDGALWLLEDEASGSTGRLLKLTPKSKAAVENDA >XCV1842 putative major facilitator superfamily protein MALIGLLVSVRENGGEPARHLDQRRAPVVRSTMSHRQGWIVLSSIMVAIS LLGLVLSVVAGSLPLIALSCIAAAFGGATLDASVDAFRIEQEAVHQQPAK LLTAYQFGYRIALLLSDGLVFLLAARLSWQVAYAILLPLMLVPICGTLFL RSAPDSALTPDRASAKKQGSTLISLRPSTLQGWIAVIVFIGCYRLPDILL GPMINPFFYALGIGKSVVGSLHIWLGIPAAFLGILAAGTSLKRMSLSTTI LVGAALQALALLVLALLSSNERSAELLWASVIFQNLASSYTGIALVAYMS KLVTLGRDLPPLSRTS >XCV2857 putative membrane protein MTSLGTVPLYTPAATRNDSRALPFIVAAAIFFIAQLIIDARDFTGDAGAY WALSSAIINGTFPQTIRGYAYPLLLTPFRLVFDQSQPAGLLSLKIGQSIG YAYTFSILLPNLYRSIFGEKLSTARRLIPPTLIASVFPGLISYPLSDAPS LGLMALSVYITVNSIRSKSLYGLFAAGLICYLTYNIRTIYLFSFIALAIV SATFFAKDIQHRAFALATFLAGSLIGALPQIAINHTHHATMSPLVVTDVR GASLFARQLTWGMVVDRYETYIDPGTAKATPTFYANQRGAALLEKNGGFV KNQSFTRMLAIMAKHPITFFQIYLRHTASALDARDGEVYTKQPSAEKNRR SILFLIIVTFGITQLGKAIFFAPSQQTVSARALYTLTLLAPCIAIIPGAI ETRFFLPLYCLAYCALAFQEISRRAFFIQLGLAAILTASIYSFVADSVKS PIHSRPESYIPGEPG >XCV1600 putative fructokinase MSATKHQVVCFGEALIDMLALPQDGPDQARTFAQYAGGAPANVAVAVARL GGAAHFVGMLGRDMFGDFLLQSLQQSGVATDGIVRTDQAKTALAFVALDD AGERSFSFYRPPAADLLFRPEHFAADGFTQAAVLHVCSNSMTEPEIAQCT LDGMRRARADGAIVSLDLNLRPMLWPQDVDPAALLWEALALADVVKLSRE ELEYLAGTLDGDASAVTQKLWQGKASCLLVTDGGGPVHWQTRTDAGQVPA FQVQVRDSTAAGDAFVGGLLYQLATRAASLEQLCGDSAAINEVIRFAAAV GALAVTRKGAFAAMPSIDDVHSLIQEQS >XCV0051 putative transcriptional regulator, ROK family MGAGRGMQQAHGTISTSVAPTQGRGRIKLSCLIKAIMTTTNVSPCMPSLF ANAAIRSHYRRRSDGQAAGSSERLLLDLIRRAGQFERADLPRASGLSVPG IKGIVDPLVAHGLLQLRPSLRRGRGQPNAQVSLVPGYAYSVGVSVMVDGF AVVLIDFAGQVRGMRQLTAFPLTLAVVRAQLPALVEALLTAAGVDRQHVF GVGLSMTGPRIGDGTRVNPPLSLAAEWMQVELDRFVADCLQLPVWMDNDA HCAALAEAVYGIGRQSPDLVYLSISDGFAAGVIAAGNVRRGAHGNGGELG RISAITGMARPTLESLRQALAADGHALPDLHTMLQHYDAAWPQIDAWLDA VEPTVTLAVAAIIALIDPRVIVFGARLPTDLAQRLIARIAFEPAPRRGVA LPYPTLQVGQVTAHATVLGAAMLPFKETLF >XCV3164 major facilitator superfamily protein MQRSPGQAPMSQPVPTLRAYATIKPLLWLVSLAIFMQMLDATIVNTALPS MARSLRESPLQMQSVVFSYALAVAMFIPASGWIADRFGTRRTFLAAIIVF TLGSLLCAAAQHLPQLVAARVVQGIGGAMLLPVGRLAVLKTVARADFLRA MSFIAIPALIGPLIGPTLGGWLVEVASWHWVFLINLPIGVLGFIAALKIM PDHYGDARRRFDLVGYLMLAFGMVALSLALDGISELGLRHAFVMLLAIGG LAALAGYWLHAGNTANALFPLALFKVASYRIGILGNLFARVGSGSMPFLI PLLLQVGLGMSPMNAGLMMVPVALAGMAAKRAAVKLVGRFGYRRVLMLNT VLVGVAMASFALIDIGQPLWLRLVQLACFGAVNSLQFTVMNTVTLRDLDR DQASPGNSLLSMVMMLATGFGAAAAGSLLAAFNTHLGDTHGATAALHATF LCVGGITLSSTLIFWQLAETRPHPKEVEAVAE >XCV2798 glycoside-pentoside-hexuronide:cation symporter family protein MTAKPRLNFWQIWNMCFGFLGIQFGFALQNANASRIFQTLGAQVDDVPGL WIAAPLTGLIVQPVIGYLSDRTWTPWGRRRPYFMVGAVFTTLALLVMPNA PMLWVAAGTLWVLDASINISMEPFRALVGDQLPPSQRPTGYAMQSFFIGI GAIVASFLPWLLTHWGIANTAPPGQLPDSVRYTFYLGAAVLFLSITWTVL RTREYSPEQLAGFDDAHPPLAQVASTGMAPTPMASVLWCGLGVLLATAIA WQHGDRMLYVLAGLCLAYGVLLALARMLPATSMLVAIVQDVRSMPMTMRR LAWVQFFSWFALFAMWIYTTAAVTQVHFGANDTASAAYNDGANWVGVLFG AYNGFAALAAVVIPLLVRAIGLRWGHLCNLWLGAAGLLSMLVIRDPQWLL LSMVGVGFAWASILSLPYALLSDSVPAPKMGVYMGIFNFFIVIPQLVAAS ALGFVLRVWLGGQPIYALAIGGLSLLIAGVCVVRVPVASGGQ >XCV4473 Anion:cation symporter family protein MTQATRPLPPSDDMGPTYRKILWRLIPFLFVCYLFNYLDRVNVGFAKLQM LGDLGMSETVYGLGAGIFFIGYLACGVPSNLILQRIGARRWVAIMMVSWG LLSTCLLFVRTPAGFYTLRLLTGAAEAGFFPGIVLYLTRWFPRARHGRVM TVFMSAIPISGVLGGPLSGWILDHFSAGQGGLAGWQWMFLLQGLPTVLLG IGVWFLLSDGVQQASWLNPQEKQALARVLAEDEAGKPAGASTSLGAVLRN PAVWLLGTVYFCIQSGVYAINFWLPSIIQGSGVTDPIRIGLMSAIPYLAA AVFMVLMGRSADRRGERRWHLVIPLLMGAAGLCIAASVTDNLGLAVFGMT LATMGAVSGLPLFWPLTNGFLTAAAAAGGLALINSTGQVAGFLSPYLVGW IKDTTHSTEVALYVLAGAMALGAALVLRVPARAVNR >XCV3314 putative alpha-ribazole-5'-phosphate phosphatase MSAQITLLRHGDTGQRSYRGQLDDPLTELGWQQLRAATADGTWDAVVAST LQRCALFATELAHARAIPLQLDRRLREYHFGRWQGVPVANIDRDEGQALG RFWADPVRHPPPQAEPFTDFCARLSAALDAIVARYPAQRVLVVTHGGAIR ALRCIVEARPFGNMTDIAVPHASLHPLAWPPAVATPIAVSMASSSG >XCV1247 major facilitator superfamily protein MTSAVPSTRRMALLLAGLAMFGPFSIDTIFPAFSQLGRSLAVDQVAIQQT ISVYLLAYGLMSIAHGPLSDAWGRKRVILGGLALFVAGSIGCALSQDLPT LLAFRALQGLSAGVGMIVGRAVIRDLFHGPDAQRLMSQVSMIFGIAPAIA PIIGGWILLSGGGWPLIFWFLVVFGLVLLIATLTWLPETHPVEARTPLQF KRLLQDYVRIGFNPRFQRLAAAGSFNFAGIFLYIASAPVLIMQHLKLGEG DFAWLFIPTIGGMTLGSFLSGRMAGRMQPVRQIRIGFICCGVAALANLAY TFAVAQIALPWAVLPIFLAGVGMALIFPILALAVLDMYPQQRGLASSLQA FTQLMTNTVVAGVLSPLLSEHPRHLAIGMTGFFLLGWLFWRWERRSGRRL RHRQATEAVPLEPADHL >XCV4484 Polysaccharide deacetylase precursor MTTSPLHRLLLCASCVGVLALAGCGTQDASDAAGAAKPAAATSAGTQADK TGNATGALIAQLREQLDRHRRIIVLLADEDKQTPRDRATSSSVGQQLFHE NLEQRERIAASLDTILASKDARRFATISAVLDEVESASDLFDADRLAFAE VLRDLHARIGRDSALPAVKLHQRIGEDLEALDEIERSYNKELTQIFSRFD RSRAIVPKREKWGDYVAQLRTLYTRENILRDHGVVEPYPFAARDSDSEVF GRDLPPKTVVLTFDDGPHKAYTEEIVAILKRYDVPGVFFEVGRNLGSLDA NGKPQLAPLSKISHSLMEEGYAVGNHSLTHAQLSKTTGDALRRQVLDTDT LLRAVDDKRAPLFRFPYGARNAEGLQLLGEAGLKSIMWNIDSLDWADPVP ESIVQRVLDQVNKDQRGIVLFHDIHDRAVKALPQILDRLIADGYQFAGWN GREFSVARAPGAAADATVTTGYAKSWAIVIGIDDYAHWPKLDYAANDAQA IASTLTGPLGFPSSQVIVLKDGQATRNNILAAFHDRLGEGRAQTNDRVFV FFAGHGATRRLASGRDLGYIIPVDSDPQHLASDAIAMSDLQNIAESLQAK HVLFVMDACYSGLGLTRGGPTSSAYLRENARRIARQMLTAGGADQQVADS GPNGHSVFTWVLLQALAGKGDLNGDGLITGTELAAYVAPAVSAVSAQTPA FGSLPGSQGGEFVFQVPSGEEFLTAQTAQLSADAIALNSRVDAARPVPAA AGVAVAAVPVTVKTLQGGQATLVLPTAAKSSDRQRAQLANERGLQLYKEK RYADAAEQFAEALKLRPDFALAANNLGFVYYRQGRFAESARWLENTLKID PSRAVAYLNLGDAYAKAGDRDKARKAYATYLELQPQGSGAEQARAQLQSL >XCV3305 HpcH/HpaI aldolase family protein MAVAVGILNALPSVQLCELLGRIGYSFVVLDLEHVLHAPDTLEHAIRACE LSGCEAWVRVPEVDEKLIGRVLDAGARGIVVPRTESAAQIGDAIAAARFP PLGRRGITGGRVTGFGNVDLPTYIAHANANTRIVPMIESAAGVAALPEIL AIPGVALVMEGALDLALDLGLGPQPTHPQVWELLLQLHAQCLAANVPFCP NPRTDAQRAHWLQQPELRWLLAGEDRALIQRALRGHLASLAVPQSPPACR STP >XCV4349 putative L-fuculose-phosphate aldolase MFALEQRQRVVALCIELSRRGYLAGTGGNVALRIDAECFAVTPSAIDYLS MQAEDICIVRTKDLHQLDGTRTPSVETGLHAQVMRRRPDVGCSIHTHQPV ASACTLLGAPLEVTQPALRRLLGARIPIAGYMPSGTGLLARLLARQLQPT VNAYLLRNHGVVCCGTNLEAAVTVVEALELAARSHLQTQIQARAAREPDL AAGLLRVLTALDSSRHTSGASSLSQT >XCV1826 putative endo-1,4-beta-mannosidase MLSFAQRTLFVVAGLALSSAAHAGLTVSGTQLRESNGNALVLRGVNLPHA WYAGRTDAALAAIAATGANSVRVVLSSGYRWTRTPEADVVRIIARCKSLG LIAVLEVHDTTGYGEDTAAANLVNATNYWVGIRKALIGNEDHVVINIANE PFGNSLTASEWVNGHATAIATLRKNGLTHALMVDAPNWGQDWQFYMRDNA AVLLARDSRRNLMFSVHMYEVFGSDATINNYLRAFNDKKLALVIGEFGGD HRGAHVDEAAIMRRARDYNVGYMGWSWSGNDSSTKSLDIAIGWNAAQLST WGRNLILGADGITATSRRASVFGPL >XCV1057 putative phosphoglycerate mutase MRSRFRCGERAPPPRNSQRMRILLARHGETPWNAEGRYQGQIDIPLSPVG EGQARALGERLHTLQIDRAVASPLSRAQATAKAALGASRQALLQTDADLQ EIAHGEWEGLLASEINDKDPARLRAWREEPDTVLMPGGESLRQVLDRSWR GLVRATDGLGAHDTLLVVAHDAVNRVILCKILGLPLSKLWSFRQAPTTLN LLEGDDVEHLEVVRLNDCAHHTPFFGEAKHRAL >XCV0843 putative secreted protein MQLPCNTRVIAVCVFALAASTQVSAAQVRIAQEADGYRLLVDGAPFVIKG AGLGNGSMETLAARGGNALRTWRVDPDPQRQRALLDRAQGNGLKVAVGIE VGNQRHGFDYDDATAVKQQLQRILAQVRQSAAHPAVLMWVVGNELNLDYT NPKVWNAVGEIAEAIHAIDPDHPVTTTLAGFDKQLIDQLKTRAPALDLIA VQLYGDIAALPQKLHESGWRGPYVVTEWGPTGHWESPTTSWGAPIEDDST RKALLLEQRYRSDIASDTRQGLGSFVFLWGDKQERTPTWYGLFLSSGEAT PSVDTLQLLWTGQWPATRAPTVAALTLAGQRATDSVSLRPGQAVTARIRA SGASVLRYDWHVRSESTARSIGGDPETLPPLVDAAIAPNRVPGGRNGARA TGEEVRLIAPPPGNYRLFVEVRDDAGRAGYANLPFRVLPPSPALRQGASE PSQPDMHSSR >XCV1803 putative sialate O-acetylesterase MTASFVRRGCLLGLVLVSPAAWAVPTLPLLFADGAVLQRDQPMPVWGWSS PNAAITVSFDGKRATAKADATGQWKVRLPAHAAGGPYVLRVQGDGGELQV REVLVGDVWLASGQSNMEWPLAQASDGPQAVAAANDAQLRHFKVPKSWSV QPQARLTGGEWKAATPANAGEFTAVGYFFAKELRASTGVPIGIVNSTWGG SAIEAWMDATSLGLSADQNKGAIEAIKQRDAAAQAATGKRIARWPKVEGE MPQWREAAFDDSDWDSIPVTKQWESSGYDGMDGIAWYRTTMTLSAAEAKA GITLGVGQIDDSDTTYVNGQQVGSTEKQWNLPRVYQVPAAALKAGVNHIA VRVEDLSGGGGMHGPDEQRFVQTSAGAKRALGGWKFRPAAVRVSLTDNKN QLPTLLYNQMIHPLQPFPVKGVIWYQGETNATDTGAVKYREQFAAMIRQW RAERGDKTLPFLWVQLANFKAGGDTGELSPWALLRESQSKTLALPATGQA VIIDIGNPTDIHPTNKRDVGHRLALAARHVAYGQTLVYSAPVFKRARFDG GKAVLSFDLQGSALQVRGGGAVQGFRIAGADQRFHPASAQIEGDRVIVRS DAVATPVAVRYGWSENPDDANLINRDALPVSPFRTDTW >XCV0458 conserved hypothetical protein MDVLLAGATGLVGRHVLQQLLGDTRCTGVVAMTRRPLAQIHPKLRNQVID FERLEHWTAPRMEAAICALGSTMKQAGSRDAFYRIDHDYPLAIARAACAQ GTSVFVLNSPAGANAQSRIFYSRVKGELERDLRQIGFPSLTFVRPGLIGG EREERRTGEHIGSVVLGALGPLLPRRFRINPAERIAAAMVSAALAPARGE HSIEAAELAG >XCV2053 putative cinnamoyl-CoA reductase MKQTVLVTGGSGYVACRLVKQLLEAGDTVHATVRSLHDSPKLRPLRQLQA DHPDQLRLFEADLLVPGSFVGAMQGCSVVHHVASPFLMPEKIKNGRTQLL EPALQGVRNVLTTVNATSSVERVVLTSTIGAIFGDYRDVLDMPGQTLSEA FFNTTSSLDHNPYHYSKVVAEQEAWAMYRAQQRWDLVCINPGLVLGPSPA AGSDSGSLFLLDELMRGLFFYGVPDLSFATVDVREVANAHIAAAKRPSAH GRYIVASAQMISFLEIARFLRKVHRRPYLLPRLQIPGLALRLLGPFFGLS PKYIRNHLGIRFGLDNRRSRQELGVDYRPVEQTLHEHYASWDRQRRA >XCV2666 major facilitator superfamily protein MTQGSTVATASGADAGLLSKERIIARPGFNRWLVPPAALAIHLCIGMAYG FSVFWLPLSKALGITESIACPADMGLFARMVATTCDWKISELQWMYTLFF VLLGCSAAIWGGWLERAGPRKAGVVSALCWCGGLVISAVGIHFHQIWMLW LGSGVIGGIGLGLGYISPVSTLIKWFPDRRGMATGMAIMGFGGGAMIGSP LADALMRHFATPTSVGVMETFLVMAALYFVFMMAGAFGYRVPPSGWTPAG WTAPVASSNAMITANHVHVKKVWGIPQFWLLWGVLCLNVSAGIGVIGMSS PMLQEVFGGRLIGVDVGFASLDPTQLASIAAIAAGFTGLLSLFNIGGRFF WASMSDKLGRKNTYTLFFVLGICLYAAAPSAGGIGGIALFAGIFCIILSM YGGGFATIPAYLADLFGTQMVGAIHGRLLTAWATAGILGPVVVGYMREYQ LAHGSPPSQVYNTTMYILAGMLVLGLICNLLVRPVAARHFMTPDELAREK QLAHEKVDRTGHGTIPPEQMARIGHGGNPALVAFAWLAVGIPMLFGIWVT LQKAFVLFH >XCV1502 major facilitator superfamily protein MSSQASTAPGGPAAPAPAAGFRPASVALCTVGLAMASFMQVLDTTIANVS LPTIAGNLGASSQQATWVITSFAVSTAIALPLTGWLSRRFGETKLFVWST LAFTIASLLCGLAQSMGMLVVARALQGFVAGPMYPITQSLLVSIYPREKR GQALALLAMITVVAPIAGPILGGWITDNYSWEWIFLINVPLGVIASSIVG SQLRHRPEQLEKPRMDYIGLILLVVGVGALQLVLDLGNDEDWFSSDKIVL LACIAAVALVVFVIWELTDKDPIVDLKLFRHRNFRAGTLAMVVAYAAFFS VSLLIPQWLQRDMGYTAIWAGLATAPIGILPVLMTPFVGKYALRFDLRML ATIAFIFMSFTSFFRSNFNLQVDFGHVATIQLVMGVGVALFFMPVLQILL SDLDGREIAAGSGLATFLRTLGGSFAASLTTYLWARRTQVHHAHITEHIS VYTPGMQEQVTAMGQGDLQRGAASLNNMINHQASQMGFNDIFYLLGWTFL AIIFFLWLAKPPFGAGAGSAAAAGGH >XCV2193 major facilitator superfamily protein MTVSAAPAEGGAWAPLREPVFRALWLAILGSNVGTWINDVAASWVMAEQT GSPLMVAAVQSATTLPVVLLALVAGTLADIVDRRRYLLLTQAWMLLVGGM LALLAHLQLLTPWVLVALTFAMGVGAAMAMPAQAAIVSELVPRPMLASAV ALNSIGMNIARSIGPAVGGLIVAQFGPPWAFLLNGLTFGVMLYVLWRWRR DVRASALPPESFGAGLRAGLRYAARAGRLQAVLIKAAGFFVFASALTALL PLVVRRDMQLGAGSYGILLGCIGMGAISGALLLPRLRARYDRDLLVFVAT LVCAASLLGLALSRLLGVLCVVMVVNGLAWITVLSSLQIAAQTAVPAWVR ARALSLYIVVFSAGMASGSLLWGALAQRTSIATALQLAAAGAVIAALLVK RARIAGTEQLDLAPGGHWPAPAQTDRVEHDRGPVLVTVEYRIAAEARVAF LQLMTQLGNARRRDGAVVWGIAEDAATPGVQLEYFIVASWLEHLRQHERV TGDDRQLQEQIRALHHGERAPVVRHFVGGGGAALPPHAHSDI >XCV2508 ABC transporter sugar-binding protein MRLLKLLMLAVALCAGATGCERSDPGKTTVRFWAMGKEAEVVAELVADFE KQNPTIHVDVQNIPMTAAHEKLLTAFAADGLPDVCQLGNTWLPEFALLDT LEPMQPYVARSSVVDPADYFPGVWDTNLVDGTLYGVPWYVDTRLLFYRKD LLREAGYSEMPKTWAEMEQVMAAIKRKVGPDRYAILMPLNEFEQQLSFAL QQDDRLLRDHDNYGNFRGAGFRKALGFYDNMYQQGWAPKVSETQVSNVWY EFFNGYYAFYLSGPWNVREFKLRQPPGMEGKWGTAPLPGPNGLGAGIAGG SSLVIFKSSQHKDASWKLIEYLSQPQVQARFHAIIGDLPPRRSTWKLPSL ANDELAHAFGDQLERVKATPKVLEWERIVQEMRLVTERVVRGGQSHEAAV QELDQRVDEILAKRRWIFEQEGGHVGPAGDTAPPAVKPAAAGTTAPAAAA DQGAAR >XCV4014 peptide-acetyl-coenzyme A transporter family protein MTTSAPGYKGWRGIQRAFATPSAATMALLGFGSGLPFLLIASQTLSTRLR DVGLDLGSIGLISLASFFYLLKFLWAPLIDRYAFPLTAFLGRRRSWLLVA QIGVTIGLFALAFSRPDLSVTGLVGWVLFASFWGATQDSVVDAYRIEIAP DAAQAALAATYTLGYRIGLILGGAGALYMAQYLGWTWAYVGMAALMLVPI VTTLLCREPDRPEATVVRRVDVAGAFWQPISSFFSSNGLALGIVLLLFVG LYKFPDQVIGVMAGPFYLDSGFTKADIATVSKLFGVWMGIVGAFAGGAAI AAFGFRRMLLVAALGVALSNLAFLLMAHNPGKLWAFYAALSADNLFQGFA ATVLVAFMSSLTDRNFTATQYALLVSLANLPGKFAGGVSGFVVQATSYST FFILSALTVIPTLMLLAWLWPRLLAHDRRPD >XCV2736 putative secreted protein MMRLSARFKPQRRSRVAGLLWSLALLAGNAPLLAAAEELPRFVTKDGRHA LFVDGAPYTILAAQLHNSSAWPAVLPKALDDVVALHANTVEAPVYWEQFE PAQGRFDTTNVDALIAGARKRGLRVALLWFGSWKNGQMHYVPEWIKRDEA TYPRMRDANGEPVDVLSPHVAANMQADAWAFTALMQHLRKVDGDRHTVIL VQVENEPGAIGTVRDHGPAGEAAFAQPVPAAIARALGKPQGSWQQLFGAE AAEAFNAYATAAYIEQVAAAGKRVYPLPFYVNTWLRYKGKRYPGMDYPSG GATVNVFALWRAATPSIDFIGTDIYTSDYTEYTKVVGQYARPDNPAWVSE TGFEAATAPYLFHVLGQGGVGFSVFGMDGNPDSEANRAAVAAHAANFTLL APMQRILAQAAFDGRLQAVAEQPGAPQRTLRFGEWEAKVSFGAPMWGDAP PIGNDDHAGRLLVAQLGPEEFLVTGMAARIGFFRDAADTRHGQLLRVEQG RYVDGRWQMERQLNGDQTDYGLNFGRVDATGNVPVVLRVRVGTY >XCV1359 putative beta-galactosidase precursor MSGINRRELLRGMLASGVSAALPMGAAGTLASPGATAAPAAKNTVSTAAL GDAALAPRERLLFDFGWRFHLGHASDAPRDFEFGTFQRTFAKAGKDTATA AQLAFDDSAWQQVDLPHDWAVGLPFRQEPISAFMTEEDPAAAHGYKPLGT SFPENSVGWYRRTLQIPASDLGKRISLVLDGVFRECIVFCNGHIVGRHAS GYCGFEVDLSEVLDYGKPNIIAIRVDATLGEGWFYEGAGIYRHVWLQKTD PLHIPQDGVFVRGSVQDGNATAQLSTEVRNDGTAPRQCVVQARIAAPDGR TVAQAASAAITVAPGQVQVVEQTLPLGQAALWSIDTPQLYSLTTSVHSDG TALDALVTPFGVRSIAFDAQRGFLLNGAPLKLHGTNNPQDHAGVGTAIPD ALHAWRLRQLKSMGCNAYRSSHNPATPELLALCDRLGMLVIEETRRMSTD PEAMGELETMVRRGRNHPSVILWSLGNEEPQQVTERGARIVTRMQQRVRQ LDPTRPTTFAMDKGFGDGVGQVVDVVGFNYRTSQMDGFHAQYPHIPIYGS ETGSTVSVRGNYQRDDQRGHTRAYDLDHPWWASTAEAWWSYVAQRPYIAG GFIWTGFDYRGEPTPYNRWPNVASQFGVLDSCGFPKDNYWHYRAQWTSEP VLHLFPHWNWDGLLQPDDNGRIAVWCHSNLEAVELLVNGISQGLQQVPAY GHVQWRVVYAPGMIEARGYRGGKLVLSERRQTTGKPAAIRLSCDRNALRA DAEDVAVVKVEIVDAQGRLVPTADNLVQFALRGPARPIGVGNGDPSSHED DKAPRRKAFNGLCAALLQTTRSSGDIVLQATAPGLTASTLRLPAEPTRSR ASVA >XCV1205 conserved hypothetical protein MQLCYGPALHPPGAICMSPRLIAPRRARWLAVLAAVVAVFGNAAPRTPAT AFDAVDPFIGTGGEGHTYPGATVPFGMVQLSPDTQIKPRKDAYGWAAGYR HSDTTIVGFSHTHFSGSGHSDLGDILLMPQAGAIKLERGDASKPGSGYTA QFDHTSEQAQPGYYAVTLKDRNIRAELTASARVGVHRYQFPKSTPAHVLV DLRTSLYDYPGKVQWSRLRVRSDGTVTGFRETRGWAPGRQLYFAMRFSRP LTATQLHDTEQDIPYKGFPPPGEKNPAQRAQIEGRQLVGVFDVANDGTPL VVKVALSPVSEAGAIANLDAEMPGFDFDRVRADARAQWTQALSAIDAQGT TQQRTQLYTALYHTLLGPTLFMDSDGRYRGPDNAVHQATGWTNYSTFSLW DTYRALHPLLTLVQPAQRSSDVVNSLLASRRQSAYGILPVWAFHGLETWC MIGYHAVPVIADAYMKGIGGFDAEEALQAMVASANYGPYDGIAQYRELGY VPIDEEGEAASKTLEYAFDDWTIARMADKLGKPAIAAEFSQRAGNWKHAF DPATGYMRARTRAGTFREPFDPSASGYGSDYTEGNAWQYSWYVPQDVAGL AAAHGGDDTLLARLDAVFDAKVDPKIFEHMEDITGLIGWYAHGNEPSHHV AYLYAYAGQPWRTQARLTQIMRSQYHAGPEGLAGNDDLGQMSAWYVFTTL GFYPVAPGSNQYIIGRPFLPRATLNLPNGKRFAVIAESLSDARSYIGSAT LNGKPLTRAYVTHEEIQAGGELRFRMQATPNQQ >XCV1386 putative beta glucosaminidase MRDLTLPRASATMPRCATVAPGPGVPNMLLIGVAGTELSAQERDWLQHDA VAGVVLFKRNFASRTQVAELSAAIRAAAPRPVLVCVDQEGGRVQRFREGF SALAPLQSFGAQYAHDPESALAAARAHAQLMASEVRASGVDLSFAPVVDL GRGNRAIGDRAFSDDPQIVATFTRAYVQALHGAGMAATLKHFPGHGTVLE DTHVDHASDPRPLEVLQAEDLVPFVAGIEAGADAVMMAHVVYPQVAPEPA GYSQRWIEQILRGQMGFCGVVFSDDIGMAASFSAGGVAGRVHAHLDAGCD VVLVCHPELVAESLQAVQGRSLNTAALIGLIGRGALGWDGLLAGTDASFT TPPSAHFGTTA >XCV2652 major facilitator superfamily protein MSAAAATGPRAGGSAQREKAEPGAWLAVLAGTIGSFMATLDISIVNAALP TIQGEVGASGTEGTWISTAYLVAEIIMIPLTGWFVRTLGLRNFLLICAVM FTAFSVVCGLSTSLSMMIIGRVGQGLAGGALIPTALTIVATRLPPSQQTM GTALFGMTVIMGPVIGPLLGGWLTENVSWHYAFFINVPICVGLVALLLLG LKHEKGDWAGLLDADWLGIYGLTAGLGGLTVVLEEGQRERWFESSEINTL SLLALSGFIALVISQFRRRPPVIRLSLLLQRSFGAVFIMVMAVGMILFGV MYMIPQFLAVISGYNTEQAGYVLLLSGLPTVLLMPMMPKLLETVDVRILV IAGLICFAAACFVNLSLTADTVGTHFVAGQLLQGCGLALAMMSLNQAAIS SVPPELAGDASGLFNAGRNLGGSVGLALISTFQERRMTFHTETIGSSITA NASRAQEALAGLTAQMQGSAGGEAAARSIAQFARVVQQQALVMTYSDLFW IFGVIVVCTIPLAFLLKPLPKGAHLAMH >XCV1794 putative 2-oxo-3-deoxygalactonate kinase MIAIDWGTSSLRGYLLDADGKVVAQRRGSDGILACQGRFDAVLAGLVDGW DGPLLLSGMIGSRNGWVEQPYLPCPADTAALAQAMRCYDALLPGRALWFV PGVSTGEQAGVPDVMRGEETQLVGLIAALGDGAHVACLPGTHSKWAQIAN GQLTGFATVMTGELYAVLRQHSILGKLMDDDHAALDADAFLQGVDRSNDP GGLSHHLFGTRTLGLFERLSSAALPSYLSGVLIGHELRAHRGAHAIVHLV GSPALAQRYALALQHLGVESRLHPEDLAAAGLFALARQRGLA >XCV2555 major facilitator superfamily protein MSTPAPSPADSLRTLLAHPGFGLVLLYRVAAMLSYQIVAVTVGWHIYEMT GNPLSLGLIGLAEILPFFCIAPFAGYLVDHLPRRRLGMVAVLGLVATALL LLAITQGWLPVKGVWPIYAAISLTGAARSFLSPVYNALFARALPRDAFAR GASIGSVTFQAGMVIGPALGGVLVGWGGKGLAYGVAASVAMLAILALALL RVSEPVSAGPRAPIFRSIAEGAQFVLSNQIMLAAMALDMFSVLLGGAVSM LPAFIHDILHYGPEGLGILRGAPALGSIVVGVWLARHPLQRNAGRVLLLS VAGFGLCTIAFGLSRHFWLSAAILLVYGMCDGVSVVVRQTILQLATPDAM RGRVSSINGIFIGSSNELGAFYDGVMARLVGLVPAVVIGGCVTLGVVATT AWKAPRLRRLDLRDLQ >XCV2729 putative secreted protein MRELRWNSFLARHRRWLRVTRRTGVAGLLWACIMLGWSLAVAQEAPIAQP NAMIGEPLFRGLDHPMPPTAVPFALGGQLARIYAADVAHGAGQAPGNDFW IDRLLAREGTGGGFDDHNDWLFTRGRAAYLSYHAPDAPGFVGQVAYWHST DYDALFHIHATLGKRHVQWKERAQQRRQTPSYFTTVFEDAGAGVRMQLVK YITEQNVAVASVVLSSLDGAAHTVSLQAVSPIAPHADGNELTGAFDAYNH ITTVFPRLSGDGFHAEGQRLVRDIDIPASGETAPVKVQLGMLTRELPEAR AEYTRIAAQTPQQAYQQHVASYNRWWVDNLPYLDTPNENISKSLFYRWWV LRFNFLDANVPGNDYQFPVAIEGVLGYDNAIVLTAGMFLDDLKYLRNPLY AYGTWLSAGETAGGGKYTDNPGSPENWSNSYAQYITAAAWRSMQIHGGPA TLAGKLARYGSGDVDGVLAAYDLNHNELIEYDWAAMTGNDADAVSFDWAD QHGQIRMDRTESAYVYANAQAAAQAATLAGDTATAQRMQATARRIRKAVL EVLWQDRSDAPDSVGLYGDLLKHRQADGPRLAVDWKETNNYYPFSVGLMP KQGDADYDPKYVRALRLFADAAQYPLFPFYTANQVDMQARGSGADVGSNN FSTINATVAFRLFGSALRDYPSPYLNAQSYRKLLYWNAWAPFINGDNRYP DQNEFWAKGTAGRGGKIGYRSWIHHTQLGATNFSMIEDAMGFRPRSDDKI ELYPIDIGWDHFAADNLRYRDRNLSIVWDRDGSHYGGRVPKGYSVYLDGR LAFCVDRLAHVIYDPASGQVSAAPDAVNRNGAAQVLQAHPAALASMTQVP FAAGTRVAQILAKAGVDVTLPPAHSRNLAQGARVSASFAAAGLPATAAVD GSTASTPFWGTAGSPSASDWIALDLGGTRTLDQVVLYFYRSSSPGGDQNG FPSGTRPGYAAPWIYAVQYRDGSGVWKNVPGQVRDATMAEGNRNRVRFPA IHAAALRVVVTHAGTARTGIKEIQLFDSGLPAPASVGNTPPQVQAWQLDT PGADGAVVVQGRVGDDGLPNGTLQVRWRVQQAPEGGDAVFADAAALQTSV RFTRAGHYILRLAANDGALMGHADVQVSAPASRPLQSIPLQAMASVSAQL TGMQYRVQALNDGFIPQAGSFPSGSLRWGSYGLDQPATVWLQYQWPRPVR LSSSALYLWNDQPNGGVAAPAGWKLQMLQDGRWQDIVSKSGYPIAAATTG AASIASFAPVVTTALRVVLTTQTTANGHAAIGVDEWQALSELPKQVEAIH LRTAPGQLPTLPQEITAFFADGSVLPVAVQWSELAASRLGREGVVELQGL VEGAIPVKATIWVRATPPGQINTVQPLPTVTAVVGHAPTLPGFVTVQYND GSRERLPVQWPTLQPARYAQPGELQLTGMAQGRAPTGNVSVPLGVQIKAA TP >XCV1809 sugar porter family protein MSSVSIDGAPDAGENTRFIILISCVATIGGFLFGFDSGVINGTVDGLKQT FQSTAAETGFEVASMLLGCAIGAFFAGRLADRWGRRAVLIISAALFLLSA IGAGASHSSGFFIFARVMGGFAVGAASVISPAYIAEVASARYRGRLATMQ QIAIISGLFCAFLSNYLLANAAGASTEPLWAGQAAWRWMFWMQAVPSILF LLLLLVIPESPRYLVVKGRREQALVVLKRLYGNAAAQTKLGEISASMAAD QHKPKFSDLINKATGKIRPIVWIGIGLAVFQQLVGINVVFYYGAVLWQAV GFSEQDALLINVLSGGLSIGACLVTVMLVDKIGRKPLLWIGSAGMAVSLA LVTYAFATASLDPNGKLAMSDAMGMLALVAANVYVVFFNASWGPVMWVML GEMFPNQIRGSGLAIAGAAQWTSNFAITVSFPILLGSIGLAGAYGIYTVA AFISVFFVLKYVYETKGKELEQMEG >XCV0043 putative secreted protein MSILVTGATGTVGSLVTQGLADAGAQVKALVRQQGKRSFPAGVTEVVADL TDVASMRAALASVRTLFLLNAVTPDEVTQALIALNLAKEAGIERIVYLSV IHADTYTNVPHFTGKHTVERMIESLEIPATILRPAYFMQNEGMVQQTITK YGLYPMPIGAQGIAMIDARDIADIAVVELLRRDRADGPLPPVTLDLVGPQ ALTGVDAAKVWSAALGREIAYAGDDVAAFEAQLATYGPSWLAYDMRLMMA GIQRLGMHAAEGTVAQLQALLGRPLRTYEAFVREATAPA >XCV1805 putative alpha-xylosidase MQTTIRSAGAVPANRRTPLAQCLALSLALLANAAHAQEVRKAADGVTVVP SAKGAAPVRLQVVDSGIIRVSADPDGDFARSPSLMRVPVQGDTAFQMAEQ GDSVQLKTGKVTASISTVDGHVSFADANGKPVLSEVAGGRSFAPLKAEGK QYLSVRQRFQSPADEALYGFGQHQQGWMNQKGRNVELQQNNIDMAVPYLV SSRNYGLLWDNNSITRLGDPRGLQPLPKTLKLYDAKGKAGALTARYAING KQILERRESEVNYQYLSDLPKYPKKAITKDKNSRMQVTWEGEIEALTGGE HTFSLYSSEYAKLYVDGKLVIDRWRQNWNPWNHEFKLDLEPGQRHTVKIE WDLIDPSYIALLHRDPLPAAEAKDLSLWSEAGQMIDYYFVSADSYDQAVA GYRELTGKSTMLPKWAYGFWQSRERYKSQDELVGAVAEYRKRKLSLDNIV LDWSYWPEDAWGSHDFDKQHFPDPDGMVKAVHDMHAQIMISIWPKFYPTT ANYKELDAAGFMFRRNVEVGELDWIGKGYKNSFYDPYSEKAQAIYWRQIN EKLNSKGFDAWWMDADEPDVHSNLDIAERKARTTPNALGSSTEYFNSYPL PHTHGVYVGDRAADDKRVFILSRKGYAGTQRNAVAVWSGDIVSRWDDMRD QISGGVNMALSGLPNWTFDIGGFAVEKRYEDQDPAHLPEWRELNTRWFQF GAFVPIFRSHGQFPYREIWNIAPEGTPFYESMAYYNRLRYALLPYIYSLA GDTYQRDGVIMRGMMMDFPNDPKVRDINDQYLFGPAFLVAPVTRFGATSR QVYLPAGSSWLDFATGKRYEGGQSIEAAAPIERMPLLVRAGSIVPTGPVQ EYVDQVPDAPLTVVVYTGADGQFSLYEDDGKGYGYEKGEFSRIPLVWNQA KGELSIGKREGSWTGMQAKRTINVRFVDGPREDAGALAPKTDASIQYDGK PVSVLQRKIASGKARRR >XCV1200 conserved hypothetical protein MGVSEHSAVAGVSAQWPARLWVVRHGQSAGNVARDVAESNGATLIDLEHR DADVPLSALGERQAEALGAWMAGLPEHEGPTLILSSTYVRARQTAAAVAR ALGQPTDAVSVDERLREKEFGVLDRYTTVGILATFPELAEQRKLVGKFYF RPPGGESWCDVIFRLRSIVGDLQRNHVGARVLIVGHQVIVNCFRYLIERM DEATILAIDREGDVPNCGVTEYAAAADGQSLQLVRTKFVPPELADEPVTT ESDRPAGAR >XCV0493 conserved hypothetical protein MPHSLCCRHACIDNCPVTAANPAPSTAASAPRALVFGGSGQIGERLLIRL LSSRWQVTAWSRQPRAARSGLIWRQGDLAVPAAAGEAFEVIFSCGPLDHF ARWYAENPVVAPRIVAFGSTSVEVKEHSIDAAERDVAQRLATAEQALFSA ARARGASATVLRPTLVYGAGRDKTLTQIAGLAQRTGAFVLPANATGLRQP VHVEDLASAALAVVGQPATQQRSYAVGGGEVLAYTQMVERVLEALPRPAR LYQVPPSLFGLALTAAQRLGRLRGLNAAALQRMREDLVFDLEPARRDFGY APRAFRPLPEELGIGA >XCV3597 putative alpha-1,2-mannosidase MESAILQQPPNRRRDSATTPHRACRLSSGAGVYPTGDVNHTGRNIGPAHV PLRAPRRHCPVTLPVVLLHKRGLPRTIAIALFCLAALPAMAATHFASAFE DGDPSPMPVTDTAVQVAVGAGPAAPYAAKPNAGYSAAHALRYASNGAGGR RALFTTDLLIQTQTTLSWMVLPESVGNDHVASTYVSLDLLLDDGTHVSAS AARDQHGVALGAQAQGDSKTLYPQQWARKQVRLGDVPGLRGRRVRAIELD VAPPAGARAAGWIDDIAIAEVPLATPARPSDRVLTTRGTQSNGTFSRGNN FPATAVPHGFNFWTPVTDAGTLTWLYRWNEHNGADNRPRLQALSLSHQPS PWMGDRQTFQVMPSLTAGVPDADRSRRALGFSHDDEQARPYRYAVQLDNG IHAEIAPTDHAALFRFRFPARGDANLLFDNVDARGGLKLDAATQTLSGYT DVRSGLSTGATRMYVYASFDRPWHSSGLLDTGRPTGWIKFAAGSARQVQM RIATSLMSVDQAKHNAELEIAADASFEQVAARAQEAWDALLGRFEVPDAT ADQTTTLYSNLYRLYLYPNSAHENVGTATAPDWRYASQNSWSDDTIDGSA VRSFAPIRDGRVYVNNGLWDTFRTAWPAYALFAPDDAGALVQGFVEQSRA GGWIARWSSPGYADLMVGTSSDVAFADAWRKGVQGFDPAEAYAAALKNAT VVAPDRHVGRKGMARSTFRGYTDTDTHEGMSWSMEGALNDFGIANMAEAL SIQANTAAARERYATEALYFRYRAAGYAALFDPAVGFFQGRKPDGTWRVD AAQYDPRVWGNDYTESSGWTFAFTAPHDGEGLATLYGGRAALAAKLDMFF ATPETAQAQFAGSYGNTIHEMTEARDVRMGMYAHSNQTAHHIPWMYLYAG QPWKTQRITREVLARLYLGSEIGQGYPGDEDNGEMSAWYLFAALGLYPLR MGAPEYVIGSPLFKQARVRLPGGGTLTINAPQNSPENVYVQSLRLNGKPW RKTWLPHAAIAKGATLDFEMGPTPSRWGSAPEDVPPSLTAPGKRPAPLRD LLGASARVTQADGRALTALHDDDAGSASAVSPATVLTLSGLDRGEAMLYT VTSGDAAIASAAWTLEARTAGGTWRVVDTRREERFQWPLQTRPFRIATPG SYAEYRLHWTAPARAQVAEIELLGAVPDGR >XCV3335 putative glycosyl hydrolase MTEPNLDLGVIGNCSFGALVDRQARVVWSCLPAFDGDPAFCTLLSPKTEG GDFAVELEDFASSEQHYLPNTAVLRTVLRDSHGGELEVIDFAPRWRNNGR FYRPVSIIRQIRPLSGNPRIIVRARPLADWGGRTPDTTWGSNHIRWVLPE FTLRLTTDVPVRFVRDGLPFVLSHPVSLVLGVDESLTRSLTGYVQEAQER TEEYWREWVRYLSIPLDWQEAVIRSAITLKLCQYEDSGAIIAAMTTSIPE APNTPRNWDYRYCWLRDAAFVVRALNRLGATRTMEQFIGYIFNIATTDGT MQPLYGIGFESQLEEHEVDTMAGYRGMGPVRRGNLAWIQQQHDVYGSVVL ASTQLFFDLRLKDQGDADTFRRLEPLGERAYALHNVPDAGLWEFRGRAEV HTYTAAMCWAACDRLSKIADRLVLPERSSYWRERADSIRERVLSEAWSEE RGHFTDTLGGHRLDASLLLLADIGIVANDDSRFVRTVEAVGRVLKHGDAL YRYIAPDDFGEPETSFTICTFWYIDALAAIGRKDEARELFERILSRRNHL GLLSEDLSFEDGEAWGNFPQTYSHVGLIIAAMRLSRSWQEAS >XCV3123 putative enzyme II of the phosphotransferase system MACGILLITHPGIGAALLNVATGLLRQLPLKTEAFDVPFDADLDALLPQA SSAMRRVDSGDGVLVMTDLYGASPSNLANRLAKLGTPVRRVSALSLPMLL RVMNYPEQGLQELPATAAAGTRNGAIIDDA >XCV4296 glycoside-pentoside-hexuronide:cation symporter family protein MTSSPATSPASARLRWREKLGYGAGDLGLNLYWANISAFLLIFYTDTMHL PAAAVGTMILLTKIADAIADPAMGALADRTRSRLGKFRPYLLWGALPMAA AGVLAYTTPDLDQHGRMWWATITFLVMMLAYTVVSIPYSALSGVITADSQ QRTGLISLRFIGAFAGTTLVNYFTMDLVRWFGAGNDALGWQRTMLLYGAV ALALFVTVALTTRERVQPPPQQRTPIRRDIADLLQNKPWCVLFVLSLIIM ITITMRGGAGVYYLKYYVQRPDLVGLFLGSYSVALGVGAAITPLLTRRWD KRQLMFWLMVLVGLLSCAMFFVPADAVWAVFVLNMLIGLALGPKSPLAFS MYADSADYTEWRTGRRATAMTFAAATFSQKLGGALASAGIAWVLAAMGYV ANTAQSTGSLTGIVLLLTVIPGAVALLAAWTMRFYPLDDGLLNRIQLELA ARKRDEPEHP >XCV1833 drug/metabolite transporter superfamily protein MTPAQLSRRAALWMLTSTFAFGLMAITIRLASSTIATTEIAFFRNAFGLL ALLPLIVRPGKPLPRTRQLPQYFARTLIGLASMLCGFWAIGHLPLSQAIS LSYSTPLFVTVLAVVWLHEQVRLRRWLAVAAGFIGVLVILRPGSSTFTPG LLIALLAAVISAIVAIQIKQLSRSDDSDTVVFYTYVFWVPMSLIPALFQW NWPQGIGWVWLVATGIFGTAGQLFWTRALKLGEVSALQPISFMQLPLVAL LGWWLFGEAIERHTVIGAAIIIGANVYIAHRETVLARRAATHAPVEGAKP GE >XCV0349 conserved hypothetical protein MTSTSPLILVTGASGQLGALVVEALLGHLPANRIVATARDTASLAEFAKR DIAVRQADYANPQSLDTAFAGVGRVLLVSSNAVGQRVPQHRNVIEAARRA GVELLAYTSILHADTSTLSLAAEHVATEALLRESGVPHALLRNGWYTENY TGSIAAEVAHGAVIGSAGDGKISAATRADYAAAAAAVLASDAPQAGQVYE LAGDAAFTMAEYAAEVAQQSGKPVAYHDLPEADYAAALVQIGLPAGFAQV LAQCSAASRDGALFDESQTLGRLIGRPTTPLRDAVAAALAAR >XCV0326 Acriflavin-sensitivity family protein MSSSDHRPGLLPDPPTRSNPDTDAPAAVRIRLALFLAGFATFSLLYSVQP LLPEFARAFKVDPATASLPLSLATGALALAIFGAGAVSENLGRRGLMFVS IALAAGLNLIAAFLPHWGALVVVRTLSGIALGGVPAVAMVYLGEELPANK MGAATGLYVAGNAFGGMSGRIVMSVLTDHTDWRTALAVLSVFDLLCALAF FWLLPPSRNFVRRHGINLRFHLRAWAGHLRDRNLPFLFALPFLLMGVFVC LYNYAGFRLGGPEFGLSQSQIGMIFSAYVFGIVSSSVAGAASDRFGRGPV VTIGIVLCGLGVALTLAHVLALVVAGIVVVTIGFFIAHSAASAWVSRLGG AHRSHAASLYLLAYYAGSSVIGALGGWFWQHGGWAALVGMCLTLLMLALA SAYVLRQRADDARPYGRFAPHPARGE >XCV0928 putative membrane protein MRERLMVGVACGIGAGALWGLVFLAPQLLGAFTPLQLAVARYLSYGAVAT LLLAPRARQTAARLGAAEWWALVRLSLMGNLMYYVLLGSAVQWAGSAATA LIIGLLPVVVTVIGTRAAGAVQLRRLAAPCVLCVIGVTLVAVDTVQDDSG QQASDRLTRIAGLLCAAGALVSWSAYSIANARWLLRRPDLSGGDWSLLTG VVTGALALLLAPAALIGSAAHAPLEWASFWGVSLLLGILASIIGNALWNR ASRVLPLTLVGQMIVFETVFALLYGFAWEMRLPTPLELAAIACLLVGVLW CAALHAEAK >XCV3120 putative nitrogen regulatory IIA protein (protein-N(pi)-phosphohistidine-sugar phosphotransferase) MPLTDLMAAVRTVVSPAADRDTVLHAAADLLSCRQAGADELYANLCEREA LGSTAIGHGIAIPHGRCPNLTEPRGALLRLDTPVSFGGDEPVDLVFAMAV PAHYTHQHLMLLSELAERFSDADFRRNLRAAPNADALMALLADVPPAQAS AA >XCV4346 putative membrane protein MRSSHPPALSAVAVPASQGLPSGLLIGSIALLILGVQPILLGTLVEQKLI TLSGVGIVAMGEIVALGLGVALGDALLPHRWQRQVAVLAALLAALLDLAT TQAVGDTAFVLVRAAAGLAEGLLLWVATLTIVRAAKPDRVTAVFMLTQAV AQIALANLLALWVLPSTGWKGGFVALGAVTLCAALLTPLLPATLSAVSAT APASRVRWSPTTLLPLLIAFVQMAATGALWAYLEPLGLRAGLDAGAVQAH TSLVLAMQIVGALAAIWWVRRLGHARTLVVGSLVLAAVAAIMARAAPAGT AAFTVACVGFGLVWMFLMPFHVGLAFGADAHGRVAVLVPAVQLLGSAAGP LLASLLLQHDDPAPVPAFSLAAALLAAVLAAAAGRDQRRRAPAGAQQNRG DR >XCV1335 putative alpha-L-arabinofuranosidase precursor MQWISPALQASRRQLLNAVFVAAALASVPASFAAEVKASGTLRVDQPGAQ VSRQLFGQFAEHLGTGIYGGVWVGEESPIPNTRGYRNDVVAALKAIAVPN IRWPGGCFADEYHWRDGVGTPGKRPIRVNTHWGGVEESNRFGTHEFMDFT ELLGTQAYVAGNVGDAAPEEIAQWTEYMTAPTRSSLANERRANGRDAPWQ VPYFGVGNELWGCGGNMRVEYAADVFRRYQTFVKSPANQKIFKIAPGPSD DDYHWTEVMMREATKFMDGLSMHYYTIPGGWPPRASSTTFDETAWIQTLS RTLVMDELITKHSAIMDKYDPARKVSLIVDEWGTWYAPLPGTNPGFLQQQ NSLRDALVASLNFDIFSQHAERVRMANIAQMVNVLQAMILTDGDKMVLTP TYHVFALYKPYQDATHLPLQLQTPAYRHGDTQVPAVHGSAVKAKDGHVYL ALTNLDATAAAAVSVQVEGLPLRAVEGQILTAPAITTYNTYAQPKAVAPA AFKGARVQGKAVNVALPAHSIVMLKLR >XCV2569 putative pectate lyase MTTLAELQAALNVKNHHIIIRGKIHGGPKLTTLNFSSTIWNNITIEGAAG GGAALQNIQLKFSGENLPAGINIQNVVIRNISFAGNIGDLQALPNQVKGT SNNTGINYVGVSLRRISNAWIDHCDFYDMSDDLLSVGMSSDYVTLSYNHF YFSNSWVNMNPDPVWNWVDKNYHDLANERLAILVGHNKNDSYVYGGNKLH VTLHHNWFGPNLAGRPLLRGWVHAYNNYCDNSTSPNGERTAADGRRYEKQ QYNALQVGSGSIVFSESNYFYKTNNSNQIRLESDGDMYNFYEKENFYDAV TGNSASGLTFNNAQVKYSYVPDDAARVPGIVRSTAGPH >XCV0286 putative membrane protein MHFLLFAVVCSVLVSVLLKLAPRHRIDVFQAITWNYATAALLAWLILHPA LDTLRATTTPWLALLLLAVALPSIFLVLARSVAVAGVVRTDVAQRLSLVL SLAAAFTVFGEPVNGWKLAGLALGMVAIVCIVRRPRQHLATDPLPSTTGL PWLIGVWMGFALIDLLLKHIAQAGTPSLTSLTLCFALAFLLMLGVQGVRW ARGARLSTRSMLAGVLLGALNFGNILCYVRAHQLLPHSPATVFASMNLGV VVLGALVGTLGFAERLGLRGWLGLALAAPAIAAIAWGIRLG >XCV2673 major facilitator superfamily protein MSSSVSEAGATPPRYPDYRIISLILACAIFMEQMDATVLATALPTLARDF GVAAPAMSIAMTSYLLALAVLIPASGAIADRFGLRRVFGASIWVFVGGSI LCSLADSLPTMVAARVLQGAGGAMMAPLGRLILLRTVERRHLVSAMAWTL VPAFIGPMLGPPLGGFFVSYLDWRWIFYINVPIGIAGFLLVRRFIPEIPT ESTPARFDLRGFVLCGTALGCLLFGLEMVSQQNGIGEASWLLAIGGSAGL GYLWHARHHPAPLLDLSLLRIASFRLSVIGGALMRITQGAQPFLLPLLFQ IGFGMSAAHSGRLILATALGALLMRSITPQLLRRFGYRNSLIGNGVLASL GYMVCAFFRPDWPPALMFGLLLCCGAFMSFQFAAYNTIAYENVPAARMSR ASSLYTTLQQLMLSVGVCAGAMILNLAMLAGGHATPHQSDFSLAFCIVSL ISLSATWWHVRFDKHAGQEMSGHRA >XCV2493 putative membrane protein MDFLTEWIWFFLFVPLAALGGWIVGRRGGQRHGDTQVSRLSSTYFRGLNY LLNEQPDKAIELFLHIAELDKETFETQVALGHLFRRRGEVDRAIRLHQGL VQRGDLTDQQRVQALLALGEDYMKSGLLDRAETVFTELAQLDQRAPQALR HLIGIYQAERDWEKAIDNATRYEEVTGEPMGKLISQFECELADRYRGLGK TDDALQAIARAYQADGTSVRAGILEGRIEAERGHDEAAVRAFERAARHDP EYLPEIIPALMAAYRRVGDIAGARNFLSEMTEHYRGIAPVLALTQLMEAQ DGVAPALAYLGRQLKDRPSVRGESALIDLTLAEGSDPVGTLQDLKHITDQ LLVRNPSYRCTRCGFGAKTHHWQCPSCKEWGTVKPLLNYAVV >XCV3862 conserved hypothetical protein MHTPTLFESFFMAGFECSTHRRRDGRRLDLIAATRHDRWAAKDYAALAAH GLRTARDGLRWHLIEPRPGHYDWSSFLPMLHAANSVGTQVIWDVCHYGWP DDVDIWTPQFVDRFARFAAAAAQCIKDASDAVPFYAPLNEISFWAWNGGD HARMHPMARGRGFELKHQLVRATIAAIDAIRQVDPRARFLQVDPAIHVVP SNDRPGPRREAERLRLAQFEAWDMICGKQWPGLGGAPEYLDIIGLNYYSD NQWYLGGVPILRDSPDHRPFSTIMLEFWQRYRRPMIVSETGAEADQRAPW LDHVGSEVALALQHGVAMEGVCLYPVLDYPGWDNDRHCPTGVLGYADEHG GRPLHQGLADQLRREHARFGLRAPQFALADIAP >XCV1599 putative glucose/galactose transporter MVSLSTQSSVPSGNKAPVNNGVALSVVTTIFFMWGFLTCLNDILIPHLKA VFELNFAQAMLVQFTFFGAYFLMSLPAGWLVNRLGYKQGIVAGLAVAAVG ALGFWPAAELRVYSAFLGALFVLATGITILQVAANPYVALLGPERSASSR LTLAQALNSLGTAIAPLLGGWLILSNTVMSGDQLKALPEAEQLAYRVQEA QAVQGPYIGLGIVLFLLAIFVFLFRLPALTDASAQKDDSKHSLLDALQHP HVRFGVLAIFFYVGAEVAIGSLMVNYFSLPQIGGFTEREATKYVSAYWTL AMIGRFIGSALLAKLSPRVLLSVFAAINAVLLGLTMASGGMLAVYALVAI GLFNSIMFPTIFTLGIERLGPLTGRASSLLIMAIVGGAIVPYLQGLLADS IGLHESFVLPLLCYLYIVFYGIWGSRLRGALAEARA >XCV0076 conserved hypothetical protein MSRILVIGGHGKVARLLTPLLVQGGHQVTALFRNPAHEDDVMADGATPVV FDIEHAQTDAIAAQLAGHDAVVWSAGAGGGDAARTYAVDRDAAIRSMHAA EQARVRRYVMVSYLGAGLEHGIGPDDAFFAYAQAKAAADAHLRSTTLDWT VLGPGRLTLDPPSGRITRDPGSDAEGGVSRANVAQVIAAALATPGSIGKT IGFIDGQTPIAQALSQLE >XCV0121 putative membrane protein MDKLIAHLVLALLVSGVCAVLLRFIRMHGALKALINLLITTTVVCAVVMQ DGSAPPWQNALLIASFFSIPASVCVVLVSTAMAWIINKRRARRPA >XCV0140 putative trehalose synthase MNAVASLQADAEQSAVVADQRWYKDAIIYQVHVKSFFDSNDDGIGDFPGL ISKLDYIAELGVDTIWLLPFYPSPRRDDGYDIAEYMAVHPDYGSIEDFEQ LVAQAHARGIRIVTELVINHTSDQHPWFQRARNAPAGSPERDFYVWSDTD QEYEGTRIIFCDTEKSNWTWDPVAGQYFWHRFYSHQPDLNFDNPAVLEAV LEVMRFWLDRGVDGLRLDAVPYLIERPGTSNENLPETHAILRKIRATLDA EYPDRMLLAEANMWPEDTQQYFGQNADECHMAFHFPLMPRMYMAIAREDR FPITDIMRQTPEIPESCQWAIFLRNHDELTLEMVTDSERDYLWQTYAADR RARINLGIRRRLAPLLERDRRRIELMTSLLLTMPGTPVLYYGDEIGMGDN IHLGDRDGVRTPMQWSIDRNGGFSRADPAQLVLPPVMDPLYGFQAVNVEA QMRDQHSLLTWTRRVLSVRKRYQAFGRGSLRFLYPGNRRMLAYLRCYQDE TVLCVANLSHTLQAVELDLSEFEGRVPVDIIGGGSFPPIGRLTYLLTVPP FGFYAFQLVSEGTLPDWHVPSPVPLPDYRTLVLRSDADESAALLPHLPTL EGEILPAWLSARRWFSAKDQALRSVRIARRTPLPGDEPMTLLELEVELED GRHERYMLPVGIVWEREQPSTLAEQLALARVRQGREVGYLTDAFALKPMV RGVIDALRSNAALDFCDGDDASQQGQVCFEATPALATLDIPQDPEIRWLS AEQSNSSLVVADKAVFKLLRHVAVGANPEIEIGRRLTEMGYANAAPLLGS VSRIDAQGTVTTIALLQGFIRNQGDAWRWTLDHLARSFDEYATAQTDEAR AEAVAGYDAFAAVVGKRLAELHEALSRATDDADFAPQRIDLPTANDVVAG VGRQVEEMWDTVNARLAGSEDSAEREALEAVLAERPQLDALLAQAPSVLA DSLLTRVHGDFHLGQILVAFDDVVLIDFEGEPAKPLAERRAKASPLRDVA GFLRSLDYASEVSARGEEGTAARAGVGVDTHLDEFLVQFRRRSTQAFLDA YHAVLDASAHPWIAPAAFNAATLLFLVEKACYEVRYEAANRPGWLMVPIE GLRRILQRARAGAGDT >XCV1644 putative membrane protein MRLRAAGLPLACSETGTMLRALIDLKPRDVPLRVALRNTVAVVLPLAIGV ATGQVAAGLAVCSGALNTMFSDQPGPYRARLQRMLMAALAAGLAALLGIW VGHNTPALVLAGLLLGLGGGLLVALGPVAARVGLTSMILLVVSADMRLPV QQAPGVAALIFAGGLLQVVLALAAWPLQRYRPERFALADLMRQLAGIARQ RPDASAAPPATQEVLDAMVMLHGEHRSRAIAVQSFRIIAEL >XCV1130 histidine triad-like protein MTDTIFGKIIRREIPATIVYEDDEVLGFEDIAPQAPVHVLFIPKQHAFPT LDDVPPEQALLVGKLAIAAATYARAQGLAQDGYRIVMNCREHAGQTVFHL HLHLLAGAPLGRFGTP >XCV3213 putative sugar hydrolase MRVRRTHLATSEITHMATRRDFLQGAIAAALFGSVGLPGRARARAGNYAL PADARARADLTRHVDVFIGTGGHGHTFPGATLPFGMVQLSPDTYNAVWDS CSGYHESDGSIMGFSHTHLSGTGIGDMLDVLLVPATGEVKLVPGPLDTPD AGYRSRYDHADEAASPGYYRVRLKDSGVHAELTATARAGLHRYHFPKGKP AHVLLDLCHGMQDKPEIATRVSDAQLRVVDERTLTGGRRVYQWAKGRYIY FAMRLSRPFKHVQLYNEDQPLAAGTRSTDGTHLKAALHYPDAADAPLLIK VGISAVSADNALANLDAELPDFDFARVHAQAVAAWEKELARVRIDSDDDA QRRIFYTGLYHSLLAPTLFSDVDNRYRGMDLQIHTAPKGYNNYSTYSLWD TYRAAHPLLTLAQPERVPDLVQCLVRGANECPDGVGIWPLQGVETGCMIG YHSAVVLAEAHAKGFTGIDYKAAWPAYRKRAMDDTTHGLGEYRRLGYIPA DKVDESVSRTLEYAYDDWACAHLAQAAGASADARTLRERSRNYRNVFNRD SGFVQARLADGSWATPFDPRGMGHIAKWRDFTESNAWQATFLNQHDLYGY MELYGGRDGFVAKLDELFSTSSELPADAPPDIDGMVGQYAHGNEPSHHVA YLFAYAGQPYKTQAMVRRLLREQYHDARNGLSGNEDCGQMSAWFVLSALG LYAVDPVSGNYIVGSPLFKRATLDVGNGRTLRIVAKDNSAQNVYVQSLTF NGKSLTRAWLRHTELAAGGTLEFAMGPKPNPAFGADKKDLPPSFA >XCV2803 aglA, alpha-glucosidase MLQTPWWRGAVIYQIYPRSFLDSNGDGVGDLPGIIAKLDYIAGLGVDAIW ISPFFKSPMADFGYDIADYRAVDPLFGTLDDFDRLLDKAHALGLKVMIDQ VLSHTSIEHAWFQESRQDRTNAKADWYVWADPREDGTPPNNWLSLFGGVA WQWEPRREQYYLHNFLVDQPDLNFHNAEVQQATLDNVRFWLDRGVDGFRL DAINFCFHDAQLRDNPAKPADKRVGRGFSADNPYAYQYHYFNNTQPENLA FLERLRALLDRYPNAVSLGEISSEDSLATTAEYTAKGRLHMGYSFELLVQ DYSAAYIRETVSRLEATMLEGWPCWAISNHDVVRAVTRWGGDDASPAFAR MVVALLCSLRGSVCLYQGEELGLGEADVAFEDLQDPYGITFWPTFKGRDG CRTPMPWTDAPSAGFTSGKPWLPLSEPHRLAAVSVQQDDAQSVLSAVRAF LSWRKSMPALREGAIAFYDTAEPVLMFRREHAGQVMLLAFNLSADITELA VPAGAWRQIDVPGVERGVIDHGRLRLPGHAVVCAMGGE >XCV4333 aguA, alpha-glucuronidase MHGRCCGNADAGCRYDDASHGTGKQAERRYAPACAGDARACRMSRSAMQQ HDRGVGAFTLQAVMWAALLCSGLLIGANAHAEDGYDLWLRYQPLANAAQL RDSASQLVVVGDSPTLHAARDELARGLQGLLARTPPRVDAVTQDGAIVLG AASAPQIAALKLDTGQLGRDGYLIRSAEVHGHRITAIVGGSDLGVLYGTF HLLRLLQTGQSLAALDVRASPRLQLRMLNHWDNLDGLVERGYAGASLWNW QTLPGYLDPRYTDYARANASLGINGTVLNNVNAKAWSLTPQYLDKAAALA KVFRPYGIRVFLSARFSAPIEIGGLKTADPLDPQVRRWWRDTAGAIYARI PDFGGFLVKANSEGQPGPQDYGRSHADGANLLADALAPHGGVVMWRAFVY SHEQPDDRAKQAYSEFVPLDGAFADNVIVQVKNGAIDFQPREPFHPLFGA MGRTPLMPEFQITKEYLGFSTHLAYLGPLFSETLQADTYARGKGSTVAKT VDGSLFAESKRTRLTGIAGVANIGADRNWSGSIFDQANWYAYGRLAWDPQ LSPQAIAQEWTRMTFSNDPAVVEPVVGMMLRSREAVVDYMTPLGLHHLMG RGHHYGPAPWDAGSERPDWDPVYYHRADRNGIGFDRSASGSNAVAQYAPP VAREFGDVRRVPEPLLLWFHHVPWDHRMASGRPLWDELVRRYDHGVAEVA AMRTTWRGLAGRIDAQRYQQVADFLAIQQGEAQWWRDASIAYFQSVSGRP LPAGVSPPAHPLAYYQALTFPYAPGNPK >XCV2233 alkH, phospho-2-dehydro-3-deoxygluconate aldolase MTIAQTQNTAERLLRDAGILPVVTVDTLDQARRVADALLEGGLPAIELTL RTPVAIDALAMLKRELPNIVIGAGTVLSELQLRQSVDAGADFLVTPGTPA PLARLLADAPIPAVPGAATPTELLTLMGLGFRVCKLFPATAVGGLQMLKG LAGPLSELKLCPTGGISESNAAEFLAQPNVLCIGGSWMVPKDWLAQGQWD KVKESSAKAAAIVRQVRAG >XCV2996 araJ, arabinose efflux porter AraJ MPMSNLTSARASRFPPALLALTIGAFGIGTTEFVIMGLLQQVAADLGVSL SAAGLLISGYALGVFVGAPVLTLASARLPRKAVLIGLMLIFTVGNVACAL APDYTSLMLARVLTSLAHGTFFGVGAVVATSLVPAERRASAISLMFAGLT VATLLGVPAGAWLGLQLGWRATFWAVAAIGVLATAAVAVWVPATAGAATP VSWRQEVAVLQRGQVLLALAITVVGYAGVFAVFTYIQPLLLQVTGLAQSA VSPVLLVFGVGMIVGNLLGGRLADRRPTAALLGSLAALVVVLGALGCVLH SKAAMVAFVGLLGVAAFATVAPLQLRVLEHARGAGQNLASSLNIAAFNLG NALGAWLGGVVIATQAGLAATPWVAALLSAIGLGMALWSVQLQRRRATAP LACTQMG >XCV3641 bcsZ, cellulase precursor MSAHAHTGGMTRRRLLHAGALAGVAALLPAAARAAPSQCGPWPLWSAFVD KHIQPDGRVVDFLNPDQRSTSEGQSYALFFALVNNDQVLFDKVLSWTRHN LCGGRPDLHLPAWLWGRDGGSAWRVLDANTASDGELWIAYALLEAGRLWS RPGYLKAGQQMLQLIRTQEVATLPGLGPMLLPGRTGFVDNGRWTLNPSYL PIQVLRRCANADPKGPWAAIAANSARVLRDSAPVGFAPDWTVWDGKTFNA DPKRGNVGSYDAIRVYLWAGMLDAGEPLRARLLKDLSGPADLLAAQQTPA EKIDTARGVGTGALPVGFSAALLPYLSALGKPALLKAQAQRVPAATQPAA AALPYFERTLALFGQGWLENRYRFAADGRLLPAWRTPACAATT >XCV3214 bga1, beta-galactosidase MLFLLPQAGEGARRADEGRTQTPPPAIHPHHRPTYIETSMLRTTLAPLVL ALALALPAAATTPKPWPAFGMQGTQFVRDGKPYQLLSGAIHFQRIPRAYW KDRLQKARALGLNTVETYVFWNLVEPQQGQFDFSGNNDVAAFVREAAAQG LNVILRPGPYACAEWEAGGYPAWLFGKGNIRVRSRDPRFLAASQSYLDAL AKQVQPLLNHNGGPIIAVQVENEYGSYADDHAYMADNRAMYVKAGFDKAL LFTSDGADMLANGTLPDTLAVVNFAPGEAKSAFDKLIKFRPDQPRMVGEY WAGWFDHWGKPHAATDARQQAEEFEWILRQGHSANLYMFIGGTSFGFMNG ANFQNNPSDHYAPQTTSYDYDAILDEAGHPTPKFALMRDAIARVTGVQPP ALPAPIATATLPATPLRESASLWDNLPAPIAIDTPQPMEQFGQDYGYILY RTTVTGPRKGPLYLGDVRDVARVYVDQRPVGSVERRLQQVSLEVEIPAGQ HTLDVLVENSGRINYGTRMADGRAGLVDPVLLDNQQLTGWQAFPLPMRTP DSIRGWTRKAVQGPAFHRGALRIGTPTDTYLDMRAFGKGFAWANGVNLGR HWNIGPQTALYFPAPFQRKGDNTVVVFDLDDVATPSVRGLKQQVWLTPKE >XCV4356 bga2, beta-galactosidase MRAHAKHNVTRALRAGYAVRACTGLFWLCSAWPIIAAPHAASDASRERIS LDAQWRFHRGDPPANQEILDYDVRPQVVRSSDGRVADAQPEQAQLIDAPA VRVLKPWILPTANGLIADPAQRHIRPPGNPGSTVAYVQPHFDDSAWETVD LPHDWAIAGPFLADGPYGGMGRLPSWGIGWYRKSLDIPASDRGRAMFLDL DGAMSYATVWLNGKLVGGWPYGYSSWRVDLTPYAIAGKRNQLVIRLDNPP ESARWYPGGGLYRNVWLTKAAPLHIAHWGTQLTTPYVSADAAQVQLTVTL DNAARSATQAQVRTAIYLLDDASDRPSGEAVARIPAQPISVPAGGTAQVQ GSTRIDAPRLWGPPPTQHPHRYVAVTEVDQQGRVVDRYETRFGIRSIVFD ADKGLLVNGEHVPIRGVNNHHDLGALGAAFNRRAAERQLQLLQQMGANAI RMSHNPPAPELLDLTDRMGLLVVDEVFDSWEMKKTPLDFHLVFPQWHAAD LRAMLRRDRNHPSVMLWSVGNEVGEQYTGQQGAAIARTLRAIVHAEDPTR PATVAMNYASPEMPLPAALDVVSLNYQGEGIRDAAEFEGTERIRKPPQYP AFHARFPHKAIVSSETASALSSRGVYLFPVTADNSAPVRDGRGGDSVAHQ VSAYELHAVDFGSSADKVFAALDQHPYVAGEFVWTGFDYLGEPTPYYSSR SSYSGIFDLAGFPKDRYWLYQSRWRPELPVAHLLPHWSWPGREGQVTPVH VFTSGDEAELFVNGVSQGRKRKAPRQYRLRWDAVVYQPGELRVQAYKDGK PWASERVQTAGRAARMQLTPDRCSIRGDGQDLSFITVRLLDRDGRPAPTA GDRLRFRIEGPGELVATDNGDPTNLETFAASQRHAFNGLCLAIVRAKAGA RGTITVHVESDTLQAAQTQVAVQ >XCV1505 bglS, beta-glucosidase precursor MPQLDMKPFTSRHHRPRPLVLAVVMGLGIALAAPLAVAQGAPASQPWMDT ALTPDQRADRLLAQMTEDEKFQMLRSYFGLGTDKIPKPEGALGSAGYVPG IARLGIPAQQLADAGVGVTNPGGIRKGDYATAMPSGPSTASSWNRQLAYT GGKIMGRESWQQGFNVLLAGSVNLQRDPRNGRNFEYAGEDPLLAGTMVGE SIRGVQSEHVLSTMKHFALNDMETRRNFHSAQIGEQAMHESDLLAFEIAL KIGDPASVMCSYNKINGTYGCEHDYLLNQVLKQEWKYPGYVMSDWGGVHS GSKAALAGLDQQSAGEVFDAAVFFDTPLRMAVSAGVVPRARFDDMVRRVL RSLFAHGAFDYPTQRQPIDGKAGLLAAQHVAEEGSVLLRNEQATLPLSQE VRRIAVIGGYADKGVMSGGGSSRVDYTINGGNAVPGITPTTWPGPVIIHP SSPLQALRAALPNAQIDYVDGTDRAAAARAAKAADVAIVFATQWAAESVD LPDMRLPDNQDALIEAVAKANPKTTVVLETNGPVRMPWAERVPAVLQAWY PGIGGGEAIANLLTGAVNPSGHLPVTWPVDESQLPRPSIPGLGFKPAKPG EDTIDYAIEGANVGYKWFAARKLTPRYPFGHGLSYTQFRMGGLQVEASGS QLTASFEVENTGSREGAAVPQLYVTLPDGHATPLRLIGWQKLTLKPGEKR SVQVVAEPRTLADFDAQARRWTIAAGTYRVQLARSASEPVQTAQVTLQAA QLP >XCV3988 bglX, beta-glucosidase MAADRIETLIARMTVEEKVGQLGVFADMVRPFAPDVNPEANVLNADEVLQ QVRLGRVGSLFNGVGAALGVQIQKVAVEESRLGIPVILAADVIHGMRTVF PIPLGEAASFEPALAERTARATAIEATAAGLHWTYAPAVDIARDQRWGRG AEGAGEDVMLGAAFAAARVRGFQGSDLTAHDCLLATPKHFAAYGAVAAGM EYNTVDIAPQTLRDVHLPPFKAAFEAGALTVMSSFNDINGVPASANHELL TEILRGEWQFPGVVISDYTADMELIAHGYAADERDATKKAFLAGLDLSMQ SGFYAAHLPALVESGEVPMATLDASVRRILQLKDAIGLFDNPYRSLDPAR EADTTHLPAHDALSRDAARRSIVLLKNEGGVLPLKKSGQRIALIGPFVQD RENIEGCWTLFGDKERYVTLEQGVRAVVGTEDLSVVAGCGLEEALPGGIS AAIDAAQAADVVVLALGEPQRFSGEAQSRTEITLPPAQQALAEAIAATGT PMVVLLRNGRALALSGAVRDADAIAVTWYLGTQTGTGVADVLFGDYNPSA RLPISFPQVTGQQPYFYNHLRTGRPELPALSEYKARWREMPNEPLYPFGH GLSYTTFAYAQPQLSAAQLGWDETLTITTRVTNTGKVAGEEVVQLYVHDR VASRVRPVRELKGFRKVLLQPGESQEVVFTLERDALAFTNHKGIFGAEPG LFDLWVCASAKSGEAVSFELLER >XCV0098 cbbFC, fructose-1,6-bisphosphatase MATMAAHFLHRLPVPMSRPSLTRFLIEEQHAGRIDAELRQLITIVSRACK RISIAVSKGTLGGVLGDAGTGNVQGEAQKKLDVLSNDILLEANAWGGHLA ACASEEMDHSQPVPDQYPSGDFLLLFDPLDGSSNIDVNVSVGTIFSVLRA PKGTEKPGDEHFLQPGTQQVAAGYCIYGPSTMLVLTLGHGTHAFTLEREE GSFLLTQANMRVPEDTAEYAINMSNQRHWEPAMQAYVGDLLAGKDGARGK DFNMRWIASMVADVHRILTRGGIFIYPWDKKDPSKPGKLRLMYEANPMSM LVEQAGGAATTGRERILDIQPTQLHQRVPVFLGSKNEVAEATRYHLDADK A >XCV0244 cdh1, NAD(P)H steroid dehydrogenase MKVLVTGGGGFLGQALCRGLRARGHEVVSFQRGDYPVLQRLGVGQIRGDL ADPQAVRHAFAGIDAVFHNAAKAGAWGSYDSYHQANVVGTQNVIEACRAN GVPRLIYTSTPSVTHRATNPVEGLGADEVPYGENLRAAYAATKAIAERAV LAANDAQLATVALRPRLIWGPGDNHLLPRLAARARAGRLRMVGDGSNLVD STYIDNAAQAHFDAFEHLAVGAACAGKAYFISNGEPLPMRELLNRLLAAV DAPAVTRSLSFNTAYRIGAVCETLWPLLRLPGEVPLTRFLVEQLCTPHWY SMEPARRDFGYVPRISIEEGLQRLRSSSSNDIAITG >XCV2768 cdh2, NAD(P)H steroid dehydrogenase MSLRILVTGASGFVGGAFLRRFQGQPGVEIHGIGRRASDLPNYHRIDLSQ AFSLDWQPDVVIHAAALASPWGTRAQFQRHNVQATANLIDFCKRNGCPRL LYVSSSSVFYREAHQYGLDEDSPIGPAFVNTYAQTKYLGETLLDDYPGEK SVLRPRAVFGPGDTVLFPRVIAAARKGALPRFVGQTQPVIGDLIYIDTLC DYLYRAATAPQLQAAYNLTNAHPVDLQQLLLEVLARLQLPLPRREVRIGT ALRMASVVEAVYRGLRLRGEPPITRFGVGVFAYSKTFDPRRTLADLGPPS VGLDEGVDAFVHWQAAQWT >XCV1823 celD, glucan 1,4-beta-glucosidase precursor MACGATRRRGRTTLEKRILDKLLRRTAAPVARRALCLATAAAVLMLAACQ GKDTAAEASKTAPAAAPAEASTAIHPDQWPSPKWPFPQDAALEQRITDVM AKMSVEEKVAQTIQGDIASMTPDDVRKYRIGSVLAGGNSDPGGKYNASPA EWLKLADAFYEASMDTSKGGNAIPIIFGIDAVHGQSNIVGATLFPHNIGL GATRNPDLIKKIGEVTAAETRVTGMEWTFAPTVAVPQDDRWGRTYEGYSE SPDVVASFAGKMVEGVQGVPGTPQFLDGSHVISSVKHFVGDGGTTDGKDQ GDTKVSEATMRDIHAAGYPPAIAAGAQSVMASFNSFNGEKMHGNKVMLTD VLKGRMNFGGFVVGDWNGHGQVKGCTNQNCPASFIAGVDMAMAADSWKGI YETELAAVKSGQISAERLDDAVRRILRVKMRLGLFEAGKPSKRPLGGKYE LLGAPEHRAIARQAVRESLVLLKNQAGILPLNPTKRVLVVGDGANDMGKQ SGGWTLNWQGTGTKRSDYPNGTTIWEGLDKQIKAAGGSAELAVDGAYKTK PDVAVVVFGENPYAEFQGDIATLLYKPGDESELALIKKLKADGIPVVAVF LSGRPLWMNQYINASDAFVAAWLPGSEGEGIADVLLRKADGSVQNDFKGK LSFSWPKTAVQFANNVGQKDYDPQFKFGFGLTYADKGDLAALPEESGVSG EQSVGGMYFVRGKPALGIAMQLSNAGQANMPATTLPVGLSDGSLKMSAVD HKAQEDARRLVWSGSTASSVLLVSAKPVDVSRESNGDVQLQLTLRRDSAV TASVWLGVGCGDKCGGRVDVRKTLAALPQGQWKVVGVPLKCFAVAGADVS KLTQVASIESAAALDLSVSKVALGALNEAEVTVDCPVK >XCV2797 cgt, cyclomaltodextrin glucanotransferase precursor MRSAMYVALTMYAGAAMAAPAAKDYYGTLEPFAAEAVYFVVTDRFVNGDT GNDHRDQGGAHRTFDVPTPCADGSEDNIGYLGGDFKGIVEHADYIRDLGF GAVWITPIVDNPDEAFTGGKPITCGSTLSDHGKTGYHGYWGVNFYKLDEH LPSPGLDFAGFTRAMHASKLKVVLDIVGNHGSPAYTMPQAQPGFGKLYDA QGRLVADHQNLAPAQLDPQHNPLHAFYNTGGGLAELSDLNENNPAVLDYL AGAYLQWMEQGADAFRIDTIGWMPDRFWHAFVARIREKRPGFFMFGEAFD YDTNKIAGHTWTRNAGVSVLDFPLKQQLAAVFGHEQAGFEKLAVPLFLRQ GPYANPYELMSFYDNHDMARLDASDAGFIDAHNWLFTARGIPVIYYGSEI GFMRGRAEHAGNRNYFGVERIRTAQQSPIFGPLQRIAQVRRNTPALQRGV QVDVRLHGDQAAFLRVYQHAGTTQTALVLLNKADTAATIQVTRFLQPGAW RDAVSGEQLQVQRGFATAVPAHGVRVLLSDAPITDPALRKQLDLQMVEQA ARDARNR >XCV3602 cit, Citrate:H+ symporter MHSSSGEATQQSKLGMVLRVTSGNFLEQFDFFLFGFYATQIAAAFFPASN EFASLMMTFAVFGAGFLMRPLGAVILGAYIDDVGRRKGLIVTLAIMASGT VLIVLVPGYASIGLWAPALVLLGRLLQGFSAGAEMGGVSVYLAEMATPGR RGFYASWQSASQQLAIVAAAAIGFALNQLMAPQDLAQWGWRIPFGIGCVI IPFIFLLRRSLEETAEFAQRRQPVTMKQVMRGLANNAGIVIAGGLMVALT TTAFYLITVYAPTFGKTVLKLSTGDALIVTLLVGVSNFIWLPIGGALSDR FGRKPLLVTMAVVCIATAYPVLALLAAAPSFTHMLQALLWLSFIYGLYNG AMIPALTERMPAHVRVAGFSLAYSLATAVFGGFTPVISTWLIHVTGDKAA PGYWLVFASACALGATLFLYRRQGNPATATGLDAAAGATK >XCV0149 dctM, C4-dicarboxylate transport protein MGIAMLLGTFVVLLLIGVPVAYALGAAALATLLYLDLPTVVLVQQISAGS GSASLIAIPLFIFAGELMLRGGISERLIALASSLVGRVRGGLGQVSVLSS LFFGGVSGSAIADVSAVGGTMIPQMIKRGYDRDYAVNVSMTAALVALLVP PSHNLILFSAAAGGGLSIADLFAAGIFPALLMTAAMMVTGYAVARHRGYG TEAFPGWRALALRLIGALPGLGLVGLIFIGIRAGIFTAVESAAIAVVYAL IVTALLYRQLRWAEFFAAVTHAARTTGVILFVIATAAVFGWLLAYLQVPA AAVKFLQAIADSKNMVLLMIVVMLLLLGMFMDLAPKILICTPIFLPVVKA YGIDPIHFGLVMVLAGGIGLITPPIGSVLFIGTSIGQITIAQSMRTIWPF WLAALCVLLIVAFFPELSLWLPRALRA >XCV0147 dctP, C4-dicarboxylate transport system protein MITRRHFLGAGLGAAAAAPWLGAGATTPIPGGQLLTATDVHVGDYPTVEA VRWFGKQLEERTHGRLKLRQYHSGQLGRESEAIDMARFGAIDITRVYSGA LNNTFPLTQALCLPYVFDSVPHLRRAIDGHVGDSVLRSFEQRDLVGLAIY DSGARCFYNTKHPLHRPEDLKGLKLRVASSDIFLKLMRMLGANPTPMSLG ETFSAMETHMIDGAENNMRSFQSSRHFEAAHYWSQSEHSYAPDILVMSRQ SFQSLSAADRGLVVELARASVPVMRNLWDASETVARKQVIDYGVKLNQVD MPAFRAAAAPLLAEYRKQPEIEALYRRIRDFA >XCV0148 dctQ, C4-dicarboxylate membrane transport protein MTEPETVAVPVAPLQRALDRVSDIAVGVASLALLGLVVVQGWQVFTRYVL NDSPSWTEPVTLLLLSTALSLGAAAGVHTNRHFGFYLLGEHVPPLVRKMF EVIRPLMIMSIGAVLAWWSAALLLDGLDIKMAGAQMPQSINYLPLSIGGA LMVLFAVFKLWRVLRPVHAGGVR >XCV1797 dgoA, 2-dehydro-3-deoxyphosphogalactonate aldolase MTSDTTASPFVLPLVAILRGITPEETLDHVGALIDAGFDAIEIPLNSPRW EQSIALAQQAYGKRAWIGAGTVLRNDDVDTLVEIGARFIVTPNTRPSLIR HAVSRGLTVVAGFATASEAFDAIDAGATILKLFPAATYGAAHVRALRSVL PTHIPVYVVGGVSPQTLAGFIAQGAAGAGIGGELYKPGQSLQTTQTHARA FVQAYQELQG >XCV2234 edd, 6-phosphogluconate dehydratase MSLHPNIQAVTDRIRKRSAPSRAAYLAGLDAALREGPFRSRLSCGNLAHG FAASEPGDKSRLRGAATPNLGIITAYNDMLSAHQPFEHYPQLIRETARAL GATAQVAGGVPAMCDGVTQGRAGMELSLFSRDNIAQATAIGLSHDMFDSV VYLGVCDKIVPGLLIGALAFGHLPAIFMPAGPMTPGIPNKQKAEVRERYA AGEATRAELLEAEASSYHSPGTCTFYGTANSNQVLLEAMGVQLPGASFVN PELPLRDALTREGTARALAISALGEDFRPFGRLIDERAIVNAVVALMATG GSTNHTIHWIAVARAAGIVLTWDDMDLISQTVPLLTRIYPNGEADVNRFQ AAGGTAFVFRELMDAGYMHDDLPTVVEGGMRAYINEPRLQDGKVTYVPGT PTTADDSVARPVGDAFESQGGLRLLRGNLGRSLIKLSAVKPQHRSIQAPA VVIDTPQVLNKLHAAGVLPHDFVVVLRYQGPRANGMPELHSMAPLLGLLQ NQGRRVALVTDGRLSGASGKFPAAIHLTPEAARGGPIGRVREGDIVRLDG EAGTLEVLVSAEEWASREVAPNTSVAGNDLGRNLFAINRQVVGPADQGAI SISCGPTHPDGALWSYDAEYELGADAAAAAAPHESKDA >XCV0029 egl1, cellulase precursor MSAVCFSLRALLRSTLLFIVFGSLSLAHAQTRALTYAGVNLSGAEYASSK KPGVLNKDYMYPATNDYTYFAGVGMNTIRLPILWERLQPTANGELDPAQL ALLQQAVARAKAAGMYLLIDIHNYAKYYGYKIGGPEVPVATFTDLWRRLA LAFNSDNAVMFGLMNEPNNISASEWAGAAQAAIDAIRRTGANNLILVPGA LWTGAHSWYSPTNDGYSNATALTAIYDPLNRYAFEVHQYLDADSSGTSST CVSSTIGAERLRNFTQWLRTNRKRGFLGEFGTANNAVCNQALQGMLAHME TNADVWLGWTWWAAGSWWNLSYAYNVHPNKDGTDKPQMAILSPQAALATR APVATAVARSSAASTSATSTSAARTTR >XCV0031 egl2, cellulase precursor MKSLTTRTRRPRCRALSLLLLALMPLAQAQSTSGLKYAGINLSGAEIKSS QKPGVLNIGYHYPAADEYAYFAGKHMNTVRLPILWERLQPKAGGELDPAQ LALIRQAVANAKAANMYVIVDVHNYAKYYGHTIGSTKVPISTFNDLWRRL AIAFKSDNAVIFGLMNEPYDIDPQAWARAAQASIDTIRKTGANNLILVPG ALWTGAHSWYSTVAGQSNAVAMASIRDPLNRYAIEAHQYLDADSSGTSGG CVSATIGVERLRSFTEWLRLNKKRGFLAEFGTGNTATCNLALNGMLGYME SNSDVWMGWSWWAAGAWWSRAYPFNVQPDAQGRDKPQMSILGPRARRITD >XCV0033 egl3, cellulase precursor MFRTPPHFPRLRIAALALTLLAATPLVQAKEPPGPKKDTAGLKYVGVNLS GAEFNSRKKPGTLFKDYTYPAASDFSYFAGKGMNTIRLPFLWERVQPELN GQLDQAQLGLIKKSLEAAKANKQYLILDLHNYATYNGKRIGTSDVPAGAL ADLWRRLALEFKDDKAVIFGLMNEPNGISAPDWANAAQGTINAIRKTGAK NLILVPGTAYTGAHSWRSTSYGVSNAKALEILKDSGNNLAFEAHQYLDKD YSGTKPVCTSDSVGQEKLQGFTSWLRENKQKGFLGEFATANNPVCDKALE GMLTYMEKNSDVWLGWTWWAAGAWWKPDYPFNVQPGKDGSDKPQMAILSK YARRAGK >XCV0670 engXCA, extracellular endoglucanase precursor MPIFRTASTLALATMLALTAAPAFSYSVSNNKIVDDNGNVVQLKGVNVFG FETGNHVMHGLWARNWKEMINQMQGLGFNAVRLPFCPATLRSGQMPSSID YSRNADLQGLTSLQILDKVINEFNARGMYVLLDHHTPDCAAISELWYTSS YSEAQWLDDLRFVANRYKNVPRVIGVDLKNEPHGAATWGTGNAATDWNKA AERGSAAVLAVAPKWIIAVEGITDNPVCSTNGGIFWGGSLQPLACTPLNI PANRLLLAPHVYGPDVFVQSYFNDSNFPNNMPAIWDRHFGQFAGNHALLL GEFGGKYGEGDARDKVWQDALVKYLRGKGINEGFYWSWNPNSGDTGGILR DDWISVREDKMTLLRTLWGTVSNSTPTPTPTPTPTPTPTPTPSAGFSTKV IPDSRWNGGYCNRVQVTNTGTASGNWSISLTVTGTVNNAWNVTWSQSGTT LQASGVDFNRTLAPGATAEFGFCAAG >XCV1752 eno, Enolase MTTIAKILAREILDSRGNPTLEAEVTLDDGSFGRAAVPSGASTGTKEAVE LRDGDKTRYLGKGVRHAVDNVNGTIAETLKNFDAADQQGLDRRLIDLDGT ENKGRLGANALLGVSLAAAHAVAASRKQPLWQYLSTITESDVALPVPMMN IINGGAHADNNVDFQEFMVLPVGCSSFSEALRAGTEIFHSLKSVLKGHGL STAVGDEGGFAPDFRSNVEALDTILEAIGKAGYTAGEDILLGLDVASSEF YDNGKYNLVGENKRLTSEQFVDFLADWVAQYPIISIEDGLAEDDWAGWKL LTERVGKKVQLVGDDLFVTNPKIFKQGIDSGTANAILIKVNQIGTLTETL EAIAMAHAAHYASIVSHRSGETEDTTIADIAVATTATQIKTGSLCRSDRV AKYNQLLRIEQALGSGARYAGRDAFVSLKR >XCV3462 fbaB, fructose-bisphosphate aldolase MSIEQLAETAQAMVAPGKGIIAIDESTSTIAKRFASVGIENIEENRRAYR ELLLTTPKLSDYISGAILFDETIRQKTKDGVPFAEYMTAHGIIPGIKVDK GAQPLAGMPGELVTEGLDGLRTRLEEYYTLGARFAKWRAVINIGEDIPSG TCIEANSHALARYAALCQEQGLVPMVEPEVIMDGSHDIETCYEVTEATLR SLFGALYEQNVVLEGTILKASMVISGKSCEEQASIEEVAESTVMCLKSTV PAILPGIVFLSGGQTDEQSTAHLNEMHQLGNLPWPLSFSYGRAMQQAALK LWAKDMTGNFAKAQQVIYERAKENGLAALGKWKG >XCV2681 fruA, PTS system, fructose-specific IIBC component (protein-N(pi)-phosphohistidine-sugar phosphotransferase) MSSSIVVIAAGERSTEAVLAAEALRRAATAAGRRVTIEIRSDQGVLGALP GELASNAAQVLVVGDAEADTTRFGDAQLVRLSLGAVLDDPAAAIGKLAAH ADPAVAGNPGGTASGNKRIVAITSCPTGIAHTFMAAEGLQQAAKKLGYQM RVETQGSVGAQDALTDDEIRAADVVIIAADREVDLARFGGKRVFKSGTKP AINDGPALINKALADASVQGGATPATGTAASGTANKGTGRTGAYKHLMTG VSFMLPFVTAGGLLIALAFALGGIYAGDDAHQGTLAWSLFQIGAKAGFTL MVPALAGYIAYSIADRPGIAPGMIGGLVAANLNAGFLGGIIAGFIAGYGV AALNRYIKLPRNLEGLKPVLILPVLGTLLVGLAMMYVFGQPVADLLAWLT AWLRGMQGSSALLLGLLLGGMMAFDMGGPVNKAAYAFSTGLIASQVYTPM AAAMVAGMTPPLGIALATWVFRNRFTVEERGSATAAGVLGLAFVTEGAIP YAARDPLRTIPALVIGSAVAGAISMTAGAELKAPHGGIFVLLIPNAVTHL LNYVLALVVGVVVTAIALRLLKKPVTDVVA >XCV2679 fruB, Multiphosphoryl transfer protein FruB MLTRKHYSVFVHRTLTWIVGTFPLYFPARPHPEPALSSPSPAPVTPDLVC LRASARDKDDAIAQAAQLLVAAGCVAPGYDASMRRREGLANTFLGHGLAI PHGVGEDRHLVRRDGIAVLQLTDGVEWNPGQITRLVVGIAAQSDTHITLL RRLTRLIQDPAQLETLFSTDDPGVIVAALTGDRAPETNAAPATDLAETFE WTIAYPSGLHARPATRWAETARGFSARAQVRAGDQAADAKSLVGLLQLGL RAGDSITVSAEGSDAAELLRRLRAVMDSLTAQEKADAERAAQRRAAPVAG WTPPQAQPAIVGIGASPGVAIGIVHRLRAAQTEVADQPVGLGDGGALLHD ALTRTRQQLAAIQDDTQRRLGASDAAIFKAQAELLNDTDLITRTCQLMVE GHGVAWSWHQAVEQIASGLAALGNPVLAGRAADLRDVGRRVLAQLDPAAA GAGLTDLPEQPCILLAGDLSPSDTANLDTARVLGLATAQGGPTSHTAILS RTLGLPALVAAGGQLLEIEDGVTAIIDGSSGRLYIDPSEQDLDAARTHIA EQQAIREREAAQRALPAETTDGHHIDIGANVNLPDQVAMALTQGAEGVGL MRTEFLFLESGRTPSEDEQHATYLAMAQALDGRPLIVRALDIGGDKQVAH LELPHEENPFLGVRGARLLLRRPDLLEPQLRALYRAAKDGARLSIMFPMI TSVPELVALRAICARLRADLDAPEVPIGIMIEVPAAAAQADVLARHADFF SIGTNDLTQYVLAIDRQNPELAAEADSLHPAVLRMIRSTIDGARKHDRWV GVCGGLAGDAFGASLLAGLGVQELSMTPNDIPAVKARLRGAALSQLQHLA EQALACETAEQVRALEAKREDKA >XCV2680 fruK, 1-phosphofructokinase MSLQAITVTLNPAIDQTIQLEHLQPGAVHRASSVRNDAGGKGINVAACLA DWGSQVAALGVLGVGNAGVFEALFRERGIADHCQRVAGETRTNLKLVDAR SNDTTDINLPGLRLGPAHLQGVADHLAPLLRPGLPVVLSGSLPAGLPDDS WAQLQAQASAAGARVLLDTSGMPLVRALEAARQALPYAVKPNRDELAAWT GRPLNDRGALSAAAHELIARGIQLVVISMGTEGALFVQRDQRLIARPPRL AHGSSVGAGDAMVAGLAAASLDAATTLEQCARLATAFSMCRLESGDARRI TPEGVRRAATEVVIEMLS >XCV3207 fucA1, alpha-L-fucosidase MTTDSRQFAAPSRRHAGAAPRSRMLAFALLLALPALQVNAAQSPTAPTAT TLSPEAIDQQWLDATAAYAPERERLVREAEAGARKGPFRPDWAALKAYQS PAWYDNAKFGIFIHWGVFSVPAFGSEWYSRNMYLQGSKEFTHHVATYGPQ ASSGYKDLIPKFTAPKFDPNGWAKLFRASGARYVVPVAEHHDGFALYDSK LSDWTAMKMGPKRDLLGELSKAIRAQGLHFGLSSHRAEHNWFFDGGRTFD SDVNDPRYAALYGPAQVRLPGKDDADVANDWTPVSQAWLDDWLARTTELI DTYQPDLIYFDWWIAHPTFRRSLPTMLAYYYNQGAARTEADRGVVVNYKL GAFPEGAGTLDIERGQLTGIHPTHWQTDTSVSNASWGYIENDTYKSPTFI IHMLADVVAKNGNLMLNIGPRADGSIPDTERGILLSIGRWLKTNGSAIYD SKPWRVYGEGPTEVVGGTFQDVKTKPYTAEDFRFTTRDGALYAIELGWPA GGKAVIRSLTAADGVRGVTLLANGKKVPFEQQADGLHLRLPAKPVGEHAY VLRIDLSSSSTP >XCV4289 fucP, L-fucose:H+ symporter MHHSDIAASPRGNLARTAMVPLLLIVSLFFLWGMANNLNDILIKQFKKAF ELTDLQAGLVQSAFYMGYFVFAMPAAMFMRRYSYKAAVVLGLLLYACGAF LFYPAAQVHTYWLFLLALFVIASGLAFLETTANPLVTVLGPADGAARRLN LAQAFNPLGSITGVLVGQHFIFSGVEHTPAELAAMAPAAREAFFATESAA VQMPYLIIGAVVVLWAILIALVRFPSGAPEADTGVAPRRARFSELLRNRL FVFAVVAQFFYVGAQVGIWSYLIRYLQDAVPGTPEKTAATYLTISLVLFM AGRFIGTALLRYLAPAKLLASFAVINLVLCAVAIALPGWTGLYALVAASV FMSVMFPTIFALGLDGMHDDARKLGSSMLVMSIIGGALLTAVMGAVSDMA GIHWAMVVPGACFAVILSFALRARRAAPVVAGA >XCV0610 ganA, arabinogalactan endo-1,4-beta-galactosidase precursor MTIFCRHYHRVWLIVLLCLCSAGVSAQGIAKGADVSWLNQQAANNPPQVF RDAAGNTTDFIKLFKDVGGNAIRLRVWVNPSGGWNDGRDTLDKAKRAAAQ GMRIMIDFHYSDSWADPGKQTKPAAWAGHSVAQLNTDVYSHTQGILKYLK DNGITVSWVQVGNEINSGMLWNEGKTPNFATLGQFINSGYTATKAVYPNA KVVLHLANGYDNANFRWFFDNLRSAGGKWDVIGMSHYPPVGSWQDYNSRL DTNMRDMIARYGSDVVISEVGMDWQQAATTRAMLSNLLSRSSSIGARPRR VLLGAQRLPGLAGLHHGRSQQQRPTDRSAASILTSTLPRGGARRGAMSWQ TQRPRHRVGAPPGATGFTDKAARAQVRSCNRWRPPLGCAGDGTQLHPQTR HRVGAHLGARASPRASRAQVRSYGRACTAAHSMRQRPAIACRCPSSFGRT PAAPAAPHRRFNRHPGSTQRTTASHSIRTRSEEWQQVRAVHLGVHEFTMS THPRGVSPRER >XCV3469 gapA, glyceraldehyde-3-phosphate dehydrogenase MAIKVGINGFGRIGRNVLRSAAQNFANDIEIVAINDLLEPDYLAYMLQYD SVHGRFKADVSVDGNTLIVNGKKIRLTQERDPANLKWDAVGADVVIESTG LFLTKETAQKHIDAGAKKVILSAPSKDDTPMFVYGVNDKTYKGEAIISNA SCTTNCLAPLAKVINDKWGIKRGLMTTVHAATATQKTVDSPSNKDWRGGR GILENIIPSSTGAAKAVGVVIPELNKKLTGMSFRVPTSDVSVVDLTVELE KPATYAEICAEVKAQSEGALKGVLGYTEDKVVATDFRGETCTSVFDADAG IALDSTFVKLVSWYDNEWGYSNKCLEMVRVVAK >XCV1673 gcd1, glucose dehydrogenase MTILDRPSGRGHWALATLGGVIALLGAVLLAGGVWLAALGGSWYYAPAGA AMLIAGVLLFRGRNAGAWWFAGVVAVSLLWTWWESGSDYWRWVPRLGLIV GLAFVLALLLPKLHRPVSRTVSRSLAGALAMVFVVAFALAFMPHGVTEAD GALAHAAGMLGGLVNRDTSAPVEASGVQPANAPADGDWAAYGRSQAGQRY SPLQQINRDNVTQLQQAWLFHTGDLPDKRWGAETTPLKVGDSLYLCTARN QVIALDAASGKQRWRYDPKVKDEAIPYTAACRGVSYYEVPAAATAADAGA TAQLCGTRVIEGTLDGRLIALDARSGTPCPDFGSNGQVDITVGMGQTPPG YVSINSPPAIVRGVVVTGHQVLDGQKRYEPSGVIEGFDAVTGQLRWAWDM THPEWNGAPPPGQSWTRGTPNMWTTAAADEQLGYVYLPMGNSTADYWSSS RTPQENRYATSLVALDVATGKPAWNFQTTHIDAWDYDLGSQPSLIDFPKD GVNVPAVLLPSKQGELYVLDRRTGKPLVGVEERAVPGGGVEPQMRARTQP FSLYHTLRKPDLTERDMWGMTPIDQLVCRIQFRKASYKGIYTPPEADRHS IEYPGYNGGSDWGSVAVDPHRGVIVANYNDMPNYNLLVPRAKADKLGWAP RDEVRGDAGGAEGAGDPQTGTPYAVNVNAGWRLPFTKLLCKEPPYGGIRA IDLASGKTLWDRPFGSARGNGPFGIRSGLPIEIGTPNNGGAVVTASGLIF IAAATDDLIRAIDLATGKELWHAKLPAGGQANPMVYEYCGREYLVIMAGG HHFMETPAGDALIAYALPQKAQ >XCV3337 gcd2, glucose dehydrogenase MTDQSSKRGLGTWLLVAYAVVIAVLGAVLAYQGGRLVAVGGSWYYLIAGI ALFLAGVLLALGKRAGLWLFGATLAGTIAWALWEVGLDGWGLVPRLAMMS VLGLVLLPFWGVARRRMQPVSGLGYALVTGVLPILGAALILWPLLMPRNV ELADASKLPADSATAFSRGTVPSPDGNVAANHDASNWTSYAGSNLSNHYT PGAQITPDNVKNLKVAWEFHTGDLKPKDSKLGYAFQNTPLKVGDLLYICT PTQKVIAVEAANGKERWRFDPQTNPKAMAGVAATTCRGVSYYQAPEGTAE CPTRIFWPMVDGRLGALDAQTGKLCTSFGSNGYVDLNAGTGNTKPGFVGP TSPPVVMRGVVIQPTGQVRDGQEGDAPSGVVRGFDALTGQLRWAWDLGNP AITAEPPAGQTYTRSTPNVWSLMAADDELGLVYLPTGNASGDFFGKGRTP QDEEYTASLVAVDAATGKERWHFRTVNHDLWDYDIGPQPNLVDWPVAGGG TRAAVIQATKSGQVFVLDRATGEPIMPVKQIPVPQGTDHGDWTAATQPIS PGMPNTVGAPSREFEKIIESDAWGMTPFDQLVCRIQFKQLRYEGMFTPPT LQGSLAFTGNHGGINWGGVSVDLQRGIMVMNSNRLPYTLQVYTREKMNEL GVVSVFDGKSKTPGYMAQKGLAYGARKEPWMSPLNTPCVAPPWGYIAGVD LRTQQVIWRRPLGTGYDQGPMGIPSKTKFEIGTPNNSGSLATAGGVTFIG ATLDDFMRGFDTRTGKQVWETRVPAGPQAAPMSYTINGKQYIVAAVGGHD RMETKSGDSVIAWALPDDAQAAPAK >XCV0451 glgA, glycogen synthase MVAMMPLHATTARLERSTLLPTLKKSGRPRDARGRFIRHHERLPVSLADT RGALFVASEMADFIKAGGLGDVAAALPRALRHRYDVRVLIPGYRAVLERA GKVEIVGRVLAHAALPACDIGRIVQSDGLPIYILLSKELFERDGSPYVST SGSEFEDNAIRFATLSHAAAQIAAGHAGLGWKPRLLHLNDWPCALAAGYV RWSGGTTPCLLTIHNLAYQGLVPYSMAAALGIPAERVAELEFYGQMSFLR GGIVNADHVNTVSVSYAKQITGPAQGCGLDRLLAGRAAKGALTGIVNGID ASWDPRTDEYLDSHFSVNQWQGRQANAAQVRKAFGLRESTGPLFAVVSRL VHQKGLDLICEVAPQIVAAGGQIAVIGGGEPEIERQVAELTRRYPGQVGA FIGFEEGLARRMFAGADFLLMPSRFEPCGLSQMYAQRFGCLPIAHATGGL IDTVDDGVTGFLFQHASVEALRRCLERAFRTFRLPSLLSAMRRAAMLRPS GWDVAGKKYLSLYEHTAATAPALATVS >XCV0141 glgB1, 1,4-alpha-glucan branching enzyme MMSGVMTAVSNRWDPGAVRALAEARHGDAFAVLGAHPSDNGRFLRTYLPG ADRVSAVLDDGQVVALDAGPEPGLFAGELPAHGGYRLRIGWPGGEQETAD PYAFGPQLSDFDLHLISEGHHLQLADALGANVVEVDGVRGTRFAVWAPNA SRVAVVGDFNSWDARRHPMRLRHQAGVWELFVPDVGPGAHYKYQLRGPHG HELPAKADPVARRAELAPGTASIVADPTPHQWSDDGWMATRARRQAHDAP MSIYEIHAGSWLREAGLDLDWDGLADRLIPYVADMGFTHVELMPVSEHPF GGSWGYQPLGLFAPTARFGTPDGFARFVDRCHREGIGVIVDWVPAHFPTD AHGLAHFDGTALYEHADPREGFHRDWNTLIYNHGRREVSGFLIASAMEFL QRYHVDGLRVDAVASMLYRDYSRNAGEWIPNIHGGRENYETIAFLRRLNE VVREHTPGAVMIAEESTAFPGVTADVAHGGLGFHYKWNMGWMHDTLHYAG LDPIYRRYHHGELTFSMVYAYSERFVLPISHDEVVHGKGSLLGRMPGDDW QRFANLRAYLGFMFTHPGRKLLFMGCEFGQPTEWNHDAGLPWHLLDDPRH RGVQTLVRDLNRLYVQYPALHAHDDDPSGFAWVVGDDAGNSVVAFLRKGK RGDAPVLVVINFTPVVQHGYRIGVPQGGQWREVFNSDAGIYGGSNLGNGG SVTAEQQSMHGHAQSLPLLLPPLGAIVLTPYG >XCV0452 glgB2, 1,4-alpha-glucan branching enzyme MSERQGGQEQRTEADGMTTEGISETSQTLQALANGLPADAFAVLGPKPLA EGRRQVRVLAPGAEAMGLIDPRGKLLARMQASAIDGVFEGILAADGPYRL RIVWPDRVQEVEDPYAFAATLDESLLLQIAAGDGQAVRRALGAQHVHCGD VPGVRFAVWAPHAQRVAVVGDFNGWDVRRHPMRQRIGGFWELFLPRVEAG ARYKYAVTAADGRVLLKADPVARQTELPPATASVVPSAAAFAWTDAAWMA NRDPGAVPAPLSIYEVHAASWRRDGHNQPLDWPTLAEQLIPYVQQLGFTH IELLPITEHPFGGSWGYQPLGLYAPTARHGSPDGFAQFVDACHRAGIGVI LDWVSAHFPDDAHGLAQFDGAALYEHADPREGMHRDWNTLIYNYGRPEVT AYLLGSALEWIEHYHLDGLRVDAVASMLYRDYGRAEGEWVPNAHGGRENL EAVAFLRQLNREIATQFPGVLTIAEESTAWPGVTAAISDGGLGFTHKWNM GWMHDTLGYMQRDPAERAQHHSQLTFGLVYAFDERFVLPLSHDEVVHGTG GLLGQMPGDDWRRFANLRAYLALMWAHPGDKLLFMGAEFGQWADWNHDQS LDWHLLDGARHRGMQQLVGDLNAALRRTPALYRGSHRADGFDWSVADDAR NSVLAFVRHDPAGGAPLLAVSNLTPQPHHDYHVGVPRAGLWREILNTDSA HYGGSNLGNSGRLATEPVGMHGHAQRLRLTLPPLATIYLQAEK >XCV0457 glgX1, glycogen debranching enzyme MATRKFTQRSRIREGRPNPLGATWDGLGVNFALYSRNATRVELCLFDERG REQERIALPEYTDEVWHGYLPDARPGQLYGYRVHGPYAPDAGHRFNHNKL LLDPYAKQIVGELKWAPHLFGYIIGHRDKDLSFDRRDSAAFMPKSAVIDP AFTWGQDRPPQTPWNRTVIYEAHVRGLSMLHPAVPPEERGTFSALKTDEL IDHISSLGVTAVELLPVHAFVDDQYLLEKGLRNYWGYNTLGFFAPQARYM STRTVAEFKQMVARLHHAGLEVLLDVVYNHTAEGNELGPTLSFKGIDNAS YYRLADDRRFYINDTGTGNTFDLTNVGALRMVMDSLRYWVQEMHVDGFRF DLASILGRERYGFDPSGSFLDAVRQDPVLSQTKLIAEPWDIGPGGYQVGN FPPGWVEWNDKFRDNVRAFWRGDSGQLAELATRLTGSADLFNHSGRRPTA SVNFVTAHDGFTLRDLVSYETKHNLANGEDGRDGSDHNISSNYGVEGETN DPAIKQLRRQQMRNLLATLLLSQGTPMLLAGDEFGHSQNGNNNAYCQDNE LTWIDWTAATKAAAADQAAFVRRLIRIRQRYPLLHRARFFDGKFDEALGL KDLTWLAPNGTEMDEAAWHDPEARALMLRLDGRSPTTGLREIAANVTLLM LINAASTAVSFTLPAMHDEHWRVLVDTARHGGRVVAGGSEWKAPAHSLTL LAVERDRIVSSARIVSEGAR >XCV3368 glgX2, glycogen debranching enzyme MRRPASAAYANPSRIRQGRPFPRGAVFDGKGTNFALFSAHATRVELCLFD EQGNETRVDLPEYTNEIWHGYLPDAKPGQRYGYRVHGPYAPTEGHRFNHN KLLLDPYARELDGDLIWSDELYGYTVGHPDGDLSFDERDSAPFMPKCVVV EDTYDWGDDTRLLKPWNETVIYETHVRGYTMRNPQVPEAVRGTFAGLAQP QVLQYIKDLGITAVELLPVLAYLDDQHLLDKGLRNYWGYNTIGFFALKSR YLSSGHRDEFRDMVKAMHKQGLEVILDVVYNHTAEGSELGPTLSFKGIDN ASYYRLADDKRYYINDTGTGNTLNLSNSRVIQFVNDSLRYWAGEMHVDGF RFDLATILGREPSGFDQRGGFLDACNQDPLLSEVKLIAEPWDCGPGGYQV GHFPPGWSEWNDKFRDNAREFWKGEDGKLAEFATRFTGSADLFDRRGRRP WASVNFITAHDGFTLRDLVSYNEKHNIDNGEDNRDGSSNDGSCNYGEEGD TDNAEVLQIRERQMKNLLATLLLSQGTPMMLSGDERAQTQGGNNNTYCQD NEITWLDWENDPTDGRLTEFVKSLTRLRKRYPILSRGRFLNGQYNEEAGL RDLTWLNPGGIEMDDAHWTDPAARSVGLLLEGKAQTSGVKELANDDTLLI VINAYHEGVTFTLPSSDEPVHWKLVLSTDEALEVDMMPAGASEFLAPPRS VSVFECKSDQ >XCV0455 glgY, Maltooligosyltrehalose synthase MIDLRATARLQLHAGFTLHDALAQVPYYAGLGISHLYLSPIGMAVPGSAH GYDNIDPTVVNPELGGEDALMALSQAAREHGMGLIADIVPNHMATHAQNA WWWDVLRNGRSARHADWFDIDWRAPGRDGKLWLAVLDRPYATALAEGLIT LVIENDGSAALAHYDQRYPIRPQTLDIPEKAARAQWLRDYNDGAKRGDGR LHKLIERQPYRLNWWRVGNDMLNYRRFFDITSLVALRVELPAVFDAVHAL PLRLVAEGHLDGLRIDHVDGLTDPTGYVRKLRSRLDAAGRTRGLKPGTLG LYLEKILAPGEHLPADWPCDGTTGYDFMDQVGGLLHDAAGFRPLVRAWQK VSGRSGDFAQEERTARDEILRGPLQSEFNRAVGALSALARLDPPTREFSP QMLARGLCVLLRWFPVYRTYAGAKGVTGSEAERLRATAAKAREGMPESIV AAVDAIERWLLDDAGADRAQIALRRILRRRVEQLSAPLNAKSVEDTAFYR HGVLLSRNEVGSHPTHFANESAEFHAQNLERAKHYPRALLATATHDHKRG EDLRMRLAVLSEQPRWWVEQSAQFDALVDALESPALSGGDQQMLWQTLVA AWPIGLGADQTEPLAGYAERIAQWLLKAVREAKLHTSWTDGSPAYEHAVQ ATVEQVLCSRAGLPLRRALLRASNYIAAAGARNSLVQTTLRLTVPGVPDL YQGTEGWDLSLVDPDNRRPVDYVQRQQWLQQARDFSGLLRSWRDGAVKAR LTALLLQLRREFPALFAKGDYQPLNVAVGGDAQALAFRRQYRGQSLVVAV TRLGAGVEGDGDLPLLVAPATWGQASLALGEGTYRNVLDGSTLQSQRGRV ALSTLFARAPVAVLLSQEN >XCV2236 glk1, glucokinase MTAPSKPVLVADIGGTNARFALADVDASVPLLDDTSREFAVVDFGSLGEA ARYYLDQIGVQATQGVFAVAGRVDGDEARITNHPWVISRSRTATMLGFST LHLINDFAAQAMAISLLRPQDVVQVGGASWRPAPIDQARNYGVIGPGTGL GVGGLIIRNGRCFPLETEGGHVSFPPGTPEEIRILEILSEQFGRVSNERL ICGPGLVNIHRALSEIAGVDPGPLQPKDITARAAAGDPRSSRTIDLFCAI FGAIAGDMVLMQGAWDGVFLTGGLVPKVLDSLQHSGFRQRFEHKGRFSAI MSKVPSLAVMHPHAGLLGAAAYAVDAQRQHPGEQR >XCV3204 glk2, glucokinase MSASSPMEAVAFPRHETFVAADVGGTHVRLALVCESDDASKPVTVLDYRK YRCAEYPGLADIMTTFFAELGCAPVRRGVIASAGYALEDGSVITTNLPWV LAPEQIRRQLGMQALHLVNDFEAVAYAANYMIGNQVMQLSGPAQGAAGPA LVLGPGTGLGAALWIPNGAHPVVLPTEAGHAALAPASDLEMALLQELRRT RTHVGTETLLSGPGLLNLYTVLAALRGDSVVHATPADITAAAMAGNDGLA HDALQAFCGFMGSVVGDLMLLYGVRSGVYLAGGFLPQIASFIAESDFVAR LLDKGALRPALEQVPVSIVEHGQLGVIGAASWFLQHGR >XCV3251 glk3, glucokinase MAAISRSAYASASPDVPVATSFVAADVGGTHVRVGHMLQTRDAAIELSHY RTYRCAEHASLQAILEDFLQQRRRVDAVVIASAGVALDDGSFISNNLPWT ISPSRIGTALAVRDVHLVNDFEAVAYAAPQMEQRAVLQLSGPTPRHARAN GPILVVGPGTGLGAALWIDAKPRAIVLATEAGQVALASTHPHEYALLQRL LRGRHYLPLEHVLSGPGLLHLYHAVCELHGATPLHRLPAAVTHAALHEND ALARECLQIFCGLLGSAVGDMALAYGAAGGIYLAGGFLPTIGQFLAGSTF AERFLDKGNMRAVLERIPVKLVEHGQLGVLGAANWYLQHHTELS >XCV0373 glpF, glycerol uptake facilitator protein MSRQLVGELISEAVAMFIIIALGDSVAAMYILYDPSPYQNAYWGVCIAWG LAVTLAIYVTGSVSGTHANPAVTLALALFRGFSWKKVLPYWFAQVVGAFL GAAIVYQLYGPVIDHFNQVQQLTREAGGAAGVFFTAPGLAVTPMHALVDQ IIITAFLIFGIFAITEQFNEAAPTANSGALMIGLLVATLGASMGYLEAWA MNPARDFGPRLLAYFAGWGEAALPAKDNYWWIPIVGPLIGGPIGALAYQW LILPFLPARVRHLQGGSKPLDPL >XCV0375 glpR, transcriptional regulator, DeoR family MPPEPCSLSAARPACRHACTASGRCSPASPCRAQRAPRRVCILTRMRDHL RMESTHYRTVPAPALNPRQEQLVALVRQQGFAEVEGLATRFEVTPQTIRR DLTLLCDAGVLRRYHGGVSMPSSVENLAYTARKALQAREKQHIAARVARF IPDDASLFINLGTTNEEVARALLQHRGLRVITNNLNVAVMLSANPSFEVI VAGGVVRGRDQGVTGEATVELIRQFKVDFGVIGISGIDLDGTLLDFDYQE VRVAQAIIEHSRHVLLAADHSKFGRNAMVRLGALAQVHDWFTDRPPPQEL ASVLAEAGTRVHLADADGTA >XCV0768 gluP, glucose/galactose transporter MTTARPANPVVSIAIVGVLFFIIGFFTWINGPLITFVRLAFDLNEVNAFL VLMVFYLSYFFLALPSSWILKRTGMKKGLALSLVVMAVGAAGFGQFATQR WYPGALGGLFVIGSGLALLQTAINPYISILGPIESAARRIALMGICNKIA GILAPILIGSLVLHGIGDLSAQVASADAATKEALLTAFAAKIHAPYLVMS GVLLLLAIGVLFSPLPELKPSEANATPGATGGVQKSSIFQFPHLWLGVLC LFVYVGVEVMAGDAIGTYGHGFNLPLDSTKIFTSYTLGAMLLGYIAGLVL IPRVISQARYLSVSAVLGVLFSLGALFTHNYVSVGFVAALGFANAMMWPA IFPLAIRGLGRFTEIGSALLVMGIAGGAIIPQLFAILKQHYDFQVVFAAL MVPCYLYILFYSLRGHRVGLPAQAK >XCV4472 glxK, glycerate kinase MKIVIAPDSYKESLPALEVATQIEAGFREVFPDWQYHKVPVADGGEGTVD ALVAATGGRVIACTVSGPLGTPVQAFFGLTGDGRTAVIEMAAASGLALLP PAARAPLRTSTAGVGELILAALDAGARRFIIGIGGSATNDGGSGLAQALG VRLLDGQGEAIGPGGGALATLARIDTEGMDVRLQDCQFEVACDVDNPLIG PTGASAVFGPQKGATPGMVRQLDRNLQHYADLLQRDLGVRLHALPGGGAA GGLGAALVAYLGAQLRPGVEIVAQALGLDALVAQADLVITGEGRLDSQSL HGKTPVGVARVAQRHSKPVIAIAGCLGNGAALLHGHGIDAMFAVVHRACT VEQALAEAASNVRIAARNVAAALQLGGALAQVGSGRERG >XCV0741 gndA, 6-phosphogluconate dehydrogenase MELGMVGLGRMGANMAERLVNGGHRVHGYDPGANARTSAQAKGIVTADAL AALVSALPSPRVVWLMVPAGKIVDDTLAQLLPLLQAGDIVIDGGNSYYKD SQRRAALLQDSGIAFVDCGTSGGIWGLQEGYSLMVGGDEAAVTALHPILA TLAPAPDKGWGRVGPSGAGHFTKMVHNGIEYGMMQAYAEGFALMQHKADF ALDLHQVAEIWRDGSVVRSWLLDLTADALTHNPTMAGIAPFVADSGEGRW TVAEAIDLEVSAPVITLSLMERLRSRDKDSFTDKLLAAMRNQFGGHAVMT TTPAAPTIGSKDA >XCV0577 gnl, gluconolactonase MDRHCRVRAPGAARPAECPPPATRHAGLAARLGNARLLTLYDQATWSEGP AWWEAQRTLVWSDVVGRRVLGWREDGAVDVLLDATAFTNGNAVDAQQRLV HCEHGRRAITRSDVDGRAHLLVGRFEGKRLNSPNDLIVAHDGAIWFTDPP FGLLKPSQGCPGPQELDHHGVYRLPPDGGALQCMVGLDHPNGLAFSPDER VLYVSQTPEGGPTSPEITAFDWRDGALHNRRRFAVVPDGLPDGFCVDRQG WLWSSSGAGVCVFDTDGQYLGLVPTPATASNCTFDLEQRRLFITGGSTLW LLELQQ >XCV4353 gnl1, gluconolactonase precursor MRLPSYLLLAVPLLAVLAACTKQTPPTPRFAAIGQLQTFDRRFGDVVASD ARIEKLTEGFTWSEGPAWVRKGGYLLFTDVPENKLYRWSEQAGLSVLLSP SGYTGPELPTLREAGANGLYAEPDGTVLLADSGTRILARLDPVTRKKTPL ATAFEGHRFNSPNDVVRRSDGVVFFTDPPYGLKDLDKSPVKELRFNGVYR LDTDGSVHLLDDSLSFPNGIALSPDARTLYVSNSDPQRPIWMAYALDAQG AVTGKRVFADASDLIAKDVPGLPDGMAVAADGTLFATGPGGVIVFDPAGQ RLGRIATGEAVSNCAFGNDGHTLYMTSHAMLARVRVKSLGLQFVR >XCV3029 gpmA, phosphoglycerate mutase MTRKLVLLRHGQSQWNLDNRFTGWVDVELTDQGRQEAVAAGKLMKDEGLQ FDVAHTSVLKRAIHTLQGALKELDQDWLPVSKSWRLNERHYGGLQGLDKA ETAAKHGEEQVKIWRRSYDIPPPAMDVNDPGHPCHDRRYATLDRNALPGT ESLATTLVRVLPYWHDAIAPQLKAGQTVLVTAHGNSLRALYKYLNDVSNE QILELNIPTGIPLLFELDDNLQVRSFRYLGDPEAAKRAAEAVANQGKAK >XCV2784 gumE, xanthan biosynthesis exopolysaccharide polymerase GumE MLIRMSEETRVRWHNLLIELTLLVGVGYNLVLAFINANVFTVRPVITYAV EFMVYAACFLLGMGSLSRKRIALIVSGLGLIVTLMFVRFLVNWQIDPKFF RDALVVFAFVVLGSAYTGSVPKLFIRMTIIVSLVAAFELAMPVKYGDLIN PKSFFVNARGMSAEGFWNEDSNLFVSATRPGERNFLPGSNLPRASSMFIE PVTMGNYICFFTAIVLVFWRWMRPAALILSVGLIGFMIVASDGRLAAGTC VLMVLLTPLLKRLDQRLAFLVFLLVIMSAWLLVWVTGITAYQDTTMGRVF FTVYSMNNLSFESWMGLDFAQAYRYFDSGISYFIASQSIVGVLAFLLAYS FLLLMPSKEGQLFKNLAIFAFALSLLVSNGYFSIKTSALWWFVCGCMWHM LPTWSASGAQTALIKDDPTADGAQLPLPAGAAR >XCV2783 gumF, xanthan biosynthesis acetyltransferase GumF MSVSAMPASRSALPAADAQVATGGRVRDPRIDATKAIAILLVVFCHAKGV PHGMTLFAYSFHVPLFFLVSGWLAAGYASTTTGLDRRSVGRHVRSLLLPY VTFYLLGYAYWLLTRNIGEKAARWGSHPWWEPIVAMFTGIGPDLYVQPPL WFLPVMLVTVVSYMVLRRLLAPILIAGLALIVAWFWMNWFPTQHVRIFFG LDVLPVSLCFYALGALLIHVSARLPTSLAGSALATVVLGLAVAWLAVANG RIDVNMLEFGSNHALFLVSALLGSLMVICAARLVQSWAWLQWIGRNTLLI LCTHMLVFFVLSGVAALAGGFGGARPGLGWAVFVTLFALAASVPLRWILM RFAPWALGAGRAPGGGMSGALA >XCV2782 gumG, xanthan biosynthesis acetyltransferase GumG MGGLCHAVRIGRQRAAALDPDALRSVGAGRWARAGWRHERRLGMTSTSSS PHAARAHHLADARTARAPTRDWQIDAAKALAIALVVLGHASGMPAAYKLF AYSFHVPLFFVLSGWVGERFGHRALTGASVAKLARTLLVPYLAFFMVAYA LWLLTAAIDGHAGHPQTRPWWHPLTGLLWANGSRLYVLPALWFLPALFVT TLAYIGLRARLSAAAVAAISLPIALAWAGWFPSLQQRLPLALDVLPVALF FIAVGGWLSRFADALRSLRAQVWALALLPLAALWWWLAGWNGQVDVNNLQ FGQSAAVFLLASLLGTAMTFCVAYFIRRLRWVQWIGSNTLLILCTHTLVF LVATSVVARTGLIARSAIGTPAWALGLSAFAIAVSVPMRAVLVPIAPWML GLKRK >XCV4297 idnK, gluconokinase MDTATHATPASASPLAIVVMGVSGSGKTTIAHALAAHYRFRFLDADDYHS VAARAQMAAGQPLTDAMRLPWVELLSAKLRDCVQAGESVVLAFSGLRSAH RQLLRNSGVPMRFVFLHAAPHVIAARLSNRAGHFMPPTLLDSQLQTLELP LDEADVVSVDVDASVPAVVQDAIAQLAAIDPAAVQHASRASERV >XCV0357 ilvD, dihydroxy-acid dehydratase MPEYRSKTSTHGRNMAGARALWRATGMRDGDFHKPIIAIANSFTQFVPGH VHLKDLGQLVAREIERVGGVAKEFDTIAVDDGIAMGHDGMLYSLPSREII ADSVEYMVNAHCADALVCISNCDKITPGMLMAALRLNIPTVFVSGGPMEA GKTKLAEHKLDLIDAMVIAADDSASDEKVAEFERSACPTCGSCSGMFTAN SMNCLTEALGLSLPGNGTVVATHADREQLFLRAGRVAVELCHRWYGGEDP TALPRGIATFEAFENAMTLDIAMGGSTNTILHLLAAAQEGEVAFGMHDID RLSKRVPQLCKVAPNTPKYHIEDVHRAGGIMAILGELARGGLLHTNAATV HARTLAEAIAQWDVTQTDDETVHTFYKAGPAGIPTQIAFSQATRWDSLDT DRSEGCIRDIAHAFSQEGGLAVLYGNIARDGCVVKTAGVDESIHVFEGTA RVFESQDAAVKGILADEVVAGDVVVIRYEGPKGGPGMQEMLYPTSYLKSK GLGKQCALLTDGRFSGGTSGLSIGHASPEAAAGGAIGLVRDGDRILIDIP KRSINLLISDEELALRRAEQDAKGWKPVEVRPRKVTTALKAYALLATSAD KGAVRDKALLDG >XCV0122 kdgK, 2-keto-3-deoxygluconate kinase MSRARILCFGELLLRLGAPGHELLLQQPRLDVHCGGAEANVGVSLAHFGH EVAMVSTVADNPLGAAVLGELRRHDVDTRHVRRVDGRMGLYFLTTGAIHR PSEVIYDRADSAFALAPADAYDWPRLLEGAQWLHLSGVSPALGAEVAQAT LAAARAARAAGVKVSFDGNYRPKLWQRWQGDARGVLHQLFACADVVFADY RDIGVVLGGEFAQDTLEARVEAAAQQAFAAFPQLQLMACTQRVAHNVDHH SLGAMLLPRDGAVARAPSEELTPIIDRIGGGDAFAAGVLHGLIEGWSLED TARFGLAAGCLKHSIPGDFNPLSVADVQACVGDARFDVKR >XCV0152 kduI, 4-deoxy-L-threo-5-hexosulose-uronateketol-isomer ase MSLYCKTHYATHPDAIKGASNDALRELYLLDGLFVDDAVTLKYTHYERFV LGGAAPLGKTLELPRQTEPASAAGHPFLERRELGVLNVGAGTGTVTVDGT AYTLGPKDGLYVAMGSTDVSFASADAANPAKFYLASTPAHARFETKQLSI KDAVALERGALETSNERTIYQYIVPATCQSSQLLLGLTVLKPGSVWNTMP PHLHDRRSEVYFYFDLGANDRVYHFMGEPDAQRHIVIQNNEAVVSPPWSI HMGAGTSNYAFIWAMGGENLDYTDMHVLDICQLK >XCV0454 malQ, 4-alpha-glucanotransferase MSTRDPGGDDLNTLAAAAGVMVDWVDASDQPRQVSEQSVHAVLSALEFPA ATAAQRADSLRRCQAQADEPAPLLTVQVGQPLPLRVAAHASGRWSDDSGA SEDVRADAQGRLRAPQRFGYWTLQIGAITQQVAVAPPRCFSVADACGQPS PRAWGMALQVYSARSLDDGGIGDAAGTVEWLRHAALAGADALALSPVHAA RPVSGGYSPYSPSDRRFLDPLHAAPVRILGELALDAINAVPGLRERFDGL HNAALIDWQASAHAKWELLRQLYTRVSPDHADLVAFRNAGGAALEGFARF AAQDFGDNDPQLHVFTQWLAARSWSDAQREAHERGMKIGLIADLAVGFDP NGAEAAAAADTVLRGLVLGAPPDAFNADGQHWGIGAYSPTALRRSGYAPY IALLRAVLRDRGGIRIDHILGLMRLWVVPDGASSNEGAYLAYPLHDLLNL LALESWRHRAIVIGEDLGVVPPGIREELSQRGVMGIDVLMFTRDDDGAFV SPALWRPDAIATTTTHDLPTLTGWRTGRDIEWRRKLELIQPAQASDDAAA RNKDVARLDAAVELAGLSSARDPLLGALRFTATNVSPLALLPVEDALALD EQPNLPGTVEVHPNWRRRLPDPLPHARLNSALHGFAEARRVAAVSEPHP >XCV4025 manB, phosphomannomutase MSKANERRQGMSSVRTSGPVLGGMLLLLAAWFGWNSYAQWRQDAVAQGLE QARDRAVQDVGQAMATQASQLDAVLKQPPVIAALAGGDALAAASAIRERF KGAEDVQVLPGDLAAAYANPKDFGYARLSLLESAQVADRAQVRVVREAKQ VRLGVAAAVRLGGQPAVAYARLPLLRLTGPLDAIAAPDSAYLAVRQGSYN VAQQGDMALADAAETLARPLGTSGLRVAAAVPQGDSGPLGLGAVGCAIVA ALLLIIAVLLVLASRGQVALPRRRVADQSGADEPTFSQSLQHDASVASEA RALDAEAPPAPPALVPAVQVATEMFRAYDIRGVVGKDLNPGVAALVGQAI GSVMQAQGLRDVVVGRDGRLSGPELSNGLIEGLRRAGCNVTDIGLAPTPV VYFGAYELRAGSCVAVTGSHNPPDYNGFKIVIGGETLSGAAIAELHQRIN EGRLHTAATPGELEQRDISDAYIQRIADDVQLDRPIKVVVDAGNGVAGEI APRLLEAIGAEVVPLYCDIDGTFPNHHPDPSEPHNLNDLVKMVQRFDADI GVAFDGDADRLGVVTKEGAMVFPDRLLMLFAADVLQRNPGALVIYDVKCT GKLSDYVLRNGGSPLMWKTGHSLIKSKMRETDAELAGEMSGHFFFKERWY GFDDGIYAAARLLEILAQREETPSDVLDALPESVSTPEIKVPVEGDAHAL VARFVARAQTGEESPFESARLSTIDGLRADFIDGWGLVRASNTTPILVLR FEADSEAALQRIRTLFRNELQTLLPEHPLAF >XCV3210 manB, beta-mannosidase precursor MPLSRHRFVPAPARLGLALAFAISQAWAAPPTAVNLDSGWQVRLVPGQEQ GKTYPKAAAWLPAQVPGAVQTDLIAAKIVPDPFYRDNEGKIQWAGLSDWQ YQTRFNVDAATLKREHVELVFDGLDTFAEVTLNGKQLLSADNMFRQWRVD AKSLLKRGDNVLEVKLYSPIKKIQPWLAKQPYALPGAYDSAFGDEPEARH SSTYVRKAPYNFGWDWGPRMVNAGIWKDVRVEAWDAVRVNGLHIAQQRVD ADSAQLQAQLELQAGRSGPVQVTLDVLGPDGQKVGQFTQDAVVDPGQNRI DLAVRIAKPKRWFPAGYGAQDRYTFVANVRDADGDSQQIKRVTGLRSVEL RREKDQYGKSMEIVINGIPIFAKGANLIPLDAFPARVTHARMRSTLQDAR DANMNMLRMWGGGHYQDDYFYDVADELGIMIWQDFMFGGAVPPYDVEFRE NTRQEAIEQVKRLRDHPSIVLWCGNNEVQTGWENWGDRVKFKQSVDAEER ARIERGMTTLFGTVFREVVATYDSDVPYWATSPGTDFDGAADQTDDGDMH YWKVWGGPALPVTEYLNVTPRFMSEYGLQSFPDMRTVRAFAEPGDMDPES PVMRVHQKFDKGNGNKRLMLYIRREFGEPKDFDSFVYLSQLMQAEGINIA ASHLRASRPQSMGSLYWQLNDVWPGASWSSVDYYGRWKALHYHARRFYAP EMIAALRNDKGQTEVSLVSDRTTPLAARWRMRVMGMDGKVLSKREEKASV KPLSSLQVGNFSDKQLLGSADPKRTYAVFELLDGDTLLSREVVFFAPAKQ LALPAAKIDSQWRTDGDGYALTLTSNTLAREVWLSFGDVDATLSDNAFDL LPGEPLTVRVSSKAALAQLQSTLQVRDLAATLAGAPPEPAEAK >XCV2863 mrsA, phosphoglucosamine mutase MSARKYFGTDGIRGRVGQGVISADFVLRLGNALGRVLTQGRSKRPLVLIG KDTRISGYMFEAALEAGLVAAGADVQLIGPMPTPAIAFLTSTLRADAGVV ISASHNPHYDNGIKFFSAEGEKLDDATEAAIEAALDEPFHTVESERLGKA IRTRDAIGRYIEFCKASVARGFTLHGLKMVLDCAHGATYHIAPMLFRELG AEVVVIGAAPDGLNINAGVGSTHIDNLAAKVRECGAHLGIAFDGDGDRVL MADDQGNPVDGDDLLYVLARSWQASGRLTGTVVGTLMTNYGLEQALAALH IPFQRAKVGDRYVHQALVEGGGTLGGETSGHLLCLDRASTGDGIVSALQV LEALGRDGQSLREALASLSKVPQKTVNVRLDGGTAKAIVEAVNVQQALQQ AQAAVQGRGRAFLRPSGTEPVVRVTVEADDAGLMQDTLDRLSGAVRDAA >XCV4338 mtlD, mannitol dehydrogenase MRVRRSPSSKHSYLTGDTMQAPRLSRDTLATLPPVVSRPSYDPASPTIGI VHLGAGAFHRAHQAVYIDDLLAEDPSWAISAVSLHRPQVRDALRPQHGLY TLALLDEHPHLRVIGAIREVLCAADEHAAVLARLADPAVRLVTLTITEKG YCLAGDTLDLSHPDIVHDIAHPARPRSAIGYLVAGLQQRRHDGTAPFTAL SCDNLTDNGMLLQRAVVRLAEQTDPALAQWITQHAAFPRSMVDSITPATD DALRTRVHDQLGVHDAWPIQRERYSQWVIEDRFCNGRPAFERVGVTLSED IAGYARAKLRLLNAPHSALAYLGSLLDLETVAEAMRHRELAAYVETLMRA EIAPTLQAMQGFDAQRYSDAILARFRNPAIGHLLAQIAWDGSQKLPVRLL GTIGDALATGRPIQRLCLAVAAWLHFVRRQAHNGVPLTDPLNDVLSALGR NATGDAGHDVADFLTLEAVFGSLPADARFRASLQAAYAALGMATPAEVTH ALGSMGDV >XCV0709 mxaF, methanol dehydrogenase heavy chain (fragment) MWSGTLVTDGGLVFYGTLDGWFRAVDKDTGKKLWETKLPSGIIGNPIAYK ANGHQYVAVFSGIGGWIGLPVTAGLDPSDPYGALGAAGLAFGAGFDKIPL GGMVHSFRIDGAGKTVTATGTATAAAGGGTANAAAKTAR >XCV0708 mxaF, methanol dehydrogenase heavy chain (fragment) MHQSSCRSVCSTALLMLALSAVLSGCKKDTPTETAAPATAATPAAAPAAA PAAAVDTDSEFTANASNADNWGGVGRDFALTRHSPLAEINRDNVKNLKMS WEMKTDATRGHEGQPLVIGSIMYMVSAYPNNVFAIDLAAQDDGGKVLWKY TPQQDERSVAVACCDTVNRGASYADGKLVFGSLSGDVIALDAKTGKEVWK QKLAHPDKGETITMAPIIADGKVVAGISGNEFGVLGRVAAYNLADGKQAW SCDAAGTDKAICLGPDFNKANPQHGQLGDLGVKTFPNEEWKRGGGAAWGW YSYDPKLKLVYYGTGNPGLWSPSYRCGKTSQEECNNGEHDNKWSMTLFAR KIDTGEAVWGYQKTPFDQWDYDGINEPILVDLTIDGKQVPSVVQFDRNGF AYVLDRRDGTLLRAHKFVPANWAERIDMKTGRPVKVAAHSPLERGKKVQA FPSAMGGKDQQPCSVDPANAAVFFCGTNNWHMELEPQERGNTMMGLPYVF ANVMMKPNEPGALGIVKAFDVVEGKSKWEIKGEVPGVERHPGH >XCV0771 nagA, N-acetylglucosamine-6-phosphate deacetylase MHALATQALCNARVLTDNGLQDGLVVVLAGTQIQAIVPADDARVAQAHTR VDLGGATLLPGFIDIQVNGGGGVLFNNARDPQALATIAAAHRRFGTTGML PTLISDTAQVMAEAIDATRQAIAQGVPGVLGIHLEGPYLSPARKGTHDAG KFRVPDAHEIAVDTSLDNGVTLITLAPERVPLDDIRAFVAGGAIVFAGHT AATYEQACEGIAAGVSGFTHVYNAMSQLAGREPNAVGAALEDPNVWCGVI VDGVHVHPASLRVALAAKPRGKLLLVTDAMPMVGSDSASFDLYGETITAV DGVVRNADGALAGSALDMATAVRNSVRWLGVDLAEAARMASTYPAQCIGL GERLGRIAPGYQADLVLVDDDVQVLSTWVAGQRD >XCV3209 nahA, beta-hexosaminidase MTTRCPRCAAGPSVRQSLRLPIRLCYCAWLPCTAAIPGCDCMTSNSAPTA RLTAVAPFSSRLLALAFAAVSLAGCGQRAPGTSPAAATAGAPAAATADTA GTPLPLIPAAVEVKRGSGSFTVGAGTVISIVPGDADARRSAEHLADLLQR TRGLRLEVRAEASASPGSIRLERSAQAPVAHKEGYSLEADARGVRIAARD GAGLLYGAISAWQLMTPDARKGEVQLPAVAIRDWPRFSWRGQHLDVARHF HDVDTVKHVLDTMALHKLNVLHWHLTDDQGWRIEIKRYPKLTEVGAWRTP PGAGQHGTPQRYGGFYTQEQISEIVAYAARLHITVLPELDMPGHAQAAVA AYPEDVGVPGARTQVGVDWGVNPYLFNTSERSLTFITNVLDEVLTLFPST YIHIGGDEAVKDQWEASPAVRAQMRKLGVKDAHAMQGWFNEQLAAYLTQH GRRMIGWDEILEGGVPASASVMSWRGIEGAVIAAQQGHDVVLAPGDWLYL DNLQTTRSDEPNGRLTVLPLSKVYAFGPVPAELSAEQARHVLGAQGALWS EYIPSQWHVDHALFPRLSAIAEVTWSPPAARNWNSFLARMPAQLQRYKAL GIDYSDGAFAADIALEGGPNPVLAGGPAKVTLSTQAGAGTLHYTIDGSEP TPASPRYSAPLTIRLPTTVKATAFDANGTPLAATRSRTFDRASLLRVDTQ GLQHCVETGALGLRLPLLPEMTGADTPVYNVDLFHACRLYPQARLDGIGA IRIDAARLPNNFGLAHEQSKVVQYPAKTRGGELEVRLGCDGDLIASVQLP RSDTLGEQFTLETALPARTGIHDLCLRFTAPIRGPLYAIGAVQLIETTAQ APPAATR >XCV4295 ndvB, NdvB protein MSATPPATSDALSSLMAPSADGARYALYSPTAMPNAGGFLWNRRMMVQLT CRGYATGQFMQPEPSKYAHAPMLEARNFMMPEQPYYAHHPGRFFYLKDED TGALYSVPHEPVRAQPQAFEFSAGKHDVRWRVRHDDIVVELCVSLPTDDA VELWECRVHNLSGRARRLSLYAYFPVGYMSWMHQSGGYEPALGAIVCRSV APYQKVDDYFRQRDFKDCTFLLHEQTPVAWDAQQMAFEGEGGLHAPSAVQ AEQLGNHDAHYETPAAALQYRLTLDADAASVYRFAFGPAKDDAEIAALRA RYLSEAGFAQAAREYAEYLQAGRGCVQIATPDAALDNLVNHWLPRQVFYH GDVNRLTTDPQTRNYLQDHMGMAYLQPATARAALLHALSQQEPSGAMPDG ILLVEGAELKYINQVPHTDHCVWLPIFLSAYLAETGDTSILDTLVETHDG QRLSVAERLDAAMQWLLDARDARGLSFIAQGDWCDPMNMVGWRGKGVSGW LTVATAYAVRLWSEICTAQGRSAQAQAFGEAVAVINADANRELWDGNWYA RGITDDGVRFGIADDVEGRIYLNPQSFALLAGTADAQQRAALLEAVREQL HTPYGPVMLAPAYTHMRDDVGRLTQKWPGAAENGAVYNHAAAFYLYSLYQ IGEADRAWEILRALLPGPTREDVLQRGHLPVSLPNYYRGAWHQYPRTAGR SSQLFNTGTVAWVYRCVLDGLFGLVGQGDTLAIRPQLPSHWPHARARRQF RGADFDVTLTREPGRTAMEVLVDGALCPEQRIGNIARGQVYRVEVRLPG >XCV3336 ostA2, Trehalose-6-phosphate synthase MSRLVVVSNRVAVPGETRAGGLAVGLLAALKERGGMWFGWSGKTVRGDSG GMHEQTEGDITFVTMDLNKRDIDSYYNGFANRTLWPLLHFRLDLVDYDRA TREGYMRVNRLFAEKLAPLLKDSDTLWIHDYHMIPLGAMLRELGVGCKMG FFLHVPMPSADLVQAMPDHARLFSTFYAYDLVGFQTQRDAERFKAYVRLF GGGRILEGDLVEGPGGRRFTASSFPIGIDTDLIAHQAKASAGKQAVRDLR ESLRGRQLAIGVDRLDYSKGLPERFQGFERYLERYPDQSGSLTYLQIAPV SRGDVTEYRQLRSQLEQIAGHINGGHAEPDWTPLRYVNQNFSHATLTGFY RAASVCLVTPLRDGMNLVAKEFVAAQDPADPGVLVLSLFAGAADEMKEAL LVNPHDLDGVADAIATAASMPLASRIERWHAMMDHLRKNNINHWRQRYLQ ALSEV >XCV3334 ostB, Trehalose-phosphatase MADAHSPLPSPPLLDDACALFLDVDGTLIDFADRPEAVQLLPEVREAIGL LSERLNGAVALVSGRPLAQLDALFAPLLLPAAGLHGHELRSDVAARAAMP QDTSEWLHGLHQRAAALTHQHPGVLVEDKGASVALHWRARPQAGPEVLAF AQQEIAQLSGYRLQPGDHVVEFVPEGSNKGLAVEQLMQHGTFAGRTPVFV GDDLTDEFGFDAANRLGGWSVLVGDRAQTSARFRVGGTAHVHAWLQRNAR SR >XCV3132 pel1, Pectate lyase precursor MIIKTLHGALALALSACAAGAIAGPVGYGAATTGGGGKTPVNVATFEAVQ AAIDNYSGSGGLVLNYTGQFDFGTIKDVCAQWKLPAKTVQIKNKSDVTIK GANGSSANFGVRVVGNAHNVIIQNMTIGLLQGGEDADSISLEGNSSGEPS KIWIDHNTIFASLTKCSGAGDASFDGGIDMKKGVHHVTVSYNYVYNYQKV ALNGYSDSDTKNSAARTTYHHNRFENVESRLPLQRRGLSHIYNNYFSNVF TSGINVRMGGVAKIESNYFENIKNPVTSRDSSEIGYWDLINNYVGSGITW STPDGSKPYAMPPTG >XCV3687 pel2, Pectate lyase precursor MKPKFSTAAAASLFVGSLLLTGVAYADAALEVATTGWATQNGGTKGGSKA AAANIYTVKNAAELKAALSASVGSNGRIIKVSGIIDVSEGKPYTKTSDMK SRARLDIPTKTTLIGITSNAEIREGYMYVKANDVIIRNLTIENPWDPEPV WDPDDGSAGNWNAEYDGLTVEGASNVWVDHVTFTDGRRTDDQNGTANGRP KQHHDGAMDIKKGANFVTVSYSAFKSHEKNNLIGSSDSASSTDSGKLKVT IHNTLFENISARAPRVRFGQVHLYNNYHVGSTSNKVYPFSYAHGVGKESK IFSERNVFEISGVSSCDKIAADYGGSVYRDQGSLLNGKALSCSWNTNIGW TPPYTYNPL >XCV3554 pfkA, 6-phosphofructokinase MTTGNLLYAQSGGVTAVINATAAGVIAEARARKIKVLAARNGILGALREE LIDTSKESAAAIAALAQTPGGAFGSCRYKLKSLEEDSAKYERLLDVLRAH DVRWFLYNGGNDSADTAWKVSQLAKAYGYPLHCIGVPKTIDNDLAVTDTC PGFGSAAKYTAVSVREAALDVAAMADTSTKVFIYEAMGRHAGWLAAAAGL AGQDPDDAPQIILLPERAYDQAAFLAKVKQVVDKVGWCVVVASEGIQDAH GKFVADAGGATDSFGHAQLGGVASFLAAQVKQELGYKVHWTLPDYLQRSA RHLASKTDWEQAQAVGKAAVQYAIKGMNAVIPVIERVSDAPYRWKIVPAP LHKVANHEKKMPPSFLRKDGFGITERARRYFAPLIKGEAPLAYGSDGLPK YVSLKNVAVAKKLPAWEG >XCV1819 pgi, glucose-6-phosphate isomerase MTQTNGFDALHAHAQRLRGAAIPALLAAEPQRPTQYARQVGPLYFNFARQ KYDRAALDALFAIARERDLAGAFQRLFRGEQVNVTEQRAALHTALRGDLT DAPVASEAYATAAEVRQRMGALIQQLEATEVTDIVSVGIGGSDLGPRLVA DALRPVSGARFRVHFVSNVDGAAMQRTLATLDPARTAGILISKTFGTQET LLNGSILHAWLGGSERLYAVSANPERAAKAFDIAPGRVLPMWDWVGGRYS LWSAVGFPIALAIGFERFEQLLEGAAQFDAHVLNTPLEENVAVLHGLTAV WNRNLLGSATHAVMTYDQRLALLPSYLQQLVMESLGKRVKLDGSAVDSDT VSVWWGGAGTDVQHSFFQALHQGTSVVPADFIGTVHNDDPYAENHVALMA NVLAQTEALANGQDSSDPHRSYPGGRPSTVILLDALTPQALGGLISMYEH SVYVQSVMWGINAFDQFGVELGKQLASQLLPALKGEAADVADPVTRELLS KLRG >XCV3465 pgk, phosphoglycerate kinase MSIVRMTDLDLSGKRVLIRQDLNVPIDNGQITSEQRITASVPTIKLALEK GAAVMVTSHLGRPKEGSWTEEDSLAPVATRLAALLGVDVPLVRDWVDGVD VAPGQVVLLENCRMNVGEGKDDETLARKYAALCDVFVMDAFGTAHRAQAS THGVIRFAPVAAGGPLLMAELDALAKALDNPAKPLLAIVAGSKVSTKLEL LSNLVNKVDQLIVGGGIANTFIAAAGHAVGKSLNEPDLIPTANQIVADAK ARGAEIPLPTDVVVAKQFLPDAQASVKSLDAVDADDLILDIGPHTAQRYA ELIASAGTVVWNGPVGVFEFESFSHGTETLARAIASSKAFSIAGGGDTLA AVDKYDIAQEVTYISTGGGAFLEFLEGKTLPAVAALQARGQ >XCV2235 pgl, 6-phosphogluconolactonase MNLQDNPRIALVRYDDPAEWTEAVASEMADLLEQEISRRGQARMLLSGGT TPAPVYESLAHRPLDWSRVEVGLVDERWLSPQDQDSNAWLVNHSFLTHAP AATFIPLVRPGKQLPECVHTANLQAKHAEPACLAVLGMGGDGHTASLFPG ATDLPKALASPQPYASLDATGCPGSNQWPLRITLTPAGLASIPTRLLLLR GKQKLDVLQAALAGDDVNEYPIRVALQQPGPRLRVHWCA >XCV1636 ppnk, inorganic polyphosphate/ATP-NAD kinase MTAPPRIAFLASPAEPAVAARARLTQRYGDHALDSADIVCALGGDGFMLQ TLHRHGAADKPVFGMKLGSVGFLMNQYRDNEDDLLERLQRAEPAYLRPLE MQVQTESGASAGSLAYNEVSLLRQTRQAAHLSVDLNGQTRIAELIGDGVM VATPAGSTAYNYSAHGPILPLGSHTLALTPIAPYRPRRWRGAILKADTEV RFRVLDPYKRPVSVTADSHEIRDVVEVTIRESTQRQVTLLFDPEHNLEER IFSEQFAV >XCV2202 ppsA, phosphoenolpyruvate synthase MNENILWLHELRLADLARVGGKNSSLGEMIGNLAGLGVSVPGGYATTAEA FKDFIAHNDLSKRIFDKLATLDVEDVNALTLAGKEIRGWVIDAPLQPELD RDIRTAYAQLCAENGGGDVAVAVRSSATAEDLPDASFAGQQETFLNVTGA DDVVHKVKEVFASLYNDRAIAYRVHHGFKHEDVFLSAGVQLMVRSGVGAA GVLFTLDTESGFRDVVFVTSSFGLGEMVVQGAVNPDEFYVYKPTLTAGKP AILRRSLGSKAIRMVYSDVPGERVRTEDTPVELRNTFSISDEDVHELSKQ ALVIEKHYGRPMDIEWAKDGVSGKLFIVQARPETVKSRSHATQIERFALE AKDAKILAEGRAVGAKIGSGVARVVRSLDDMNRVQAGDVLIADMTDPDWE PVMKRASAIVTNRGGRTCHAAIIARELGVPAVVGSGNATAVIKDGQEVTV SCAEGDTGFIYEGKLAFERTTTDLGNMPPAPLKIMMNVANPERAFDFGQL PNAGIGLARLEMIIASHIGVHPNALLEYDKQDADVRKKIDAKIAGYGDPV SFYVNRLAEGIATLTASVAPNTVIVRLSDFKSNEYANLIGGSRYEPHEEN PMIGFRGASRYVDPSFTKAFALECKAVLKVRNEMGLDNLWVMIPFVRTLE EGRKVIEVLEQNGLKQGENGLKIIMMCELPSNALLADEFLEIFDGFSIGS NDLTQLTLGLDRDSSIVAHLFDERNPAVKKLLSMAIKSARAKGKYVGICG QGPSDHPELAEWLMQEGIESVSLNPDTVVDTWLRLAKLKSEG >XCV0081 proP, metabolite:H+ symporter family protein MHDARAMRSHFGWFKRRRQLQLDDVTVVDRSMLRKAVGAAALGNAMEWFD FGVYGYLAVTLGQVFFPASNPTAQLIATFATFTVAFLVRPIGGMVFGPLG DRYGRQKVLAATMILMALGTFSIGLIPAYERIGLWAPALLLLARLLQGFS TGGEYGGAATFIAEYATDRNRGLMGSWLEFGTLGGYIAGAATVTALHMSV TPAQMLDWGWRVPFLIAGPLGLLGLYMRMKLEETPAFRAYTEQSEQRERQ TAAQGLTTLLRLHWPQLLKCVGLVLVFNVTDYMLLTYMPSYLSVTMGYAE SKGLLLIILVMLVMMPLNIVGGMFSDKLGRRPMIIGACITLFALAIPCLL LVGSGNDGLIFAGLMLLGLALVCFTSSMPSTLPALFYTPVRYSALSIAFN VSVSLFGGTTPLVTAWLVERTGDPLVPAYYLMGAAAIGLLTMLFVRETAG LPLRGSPPAVASDAEARALLQADSPVTVDAQLPVTTTASMGQPRTA >XCV1156 prpB, methylisocitrate lyase MTSSSTPSAGTRFRAALAAESPLQVIGAINANHALLAQRAGYRAIYLSGG GVAAGSLGLPDLGINTLEDVLIDVRRITDVCELPLLVDVDTGFGPSAFNI ERTIKSLIKAGAGGCHIEDQVGAKRCGHRPGKEIVSQGEMVDRVKAAADA KTDAAFFLIARTDAIQMEGVDAAIERAIACVEAGADGIFAEAAYDLDTYK RFVDAVGVPVLANITEFGKTPLFTRDQLAQAGVAIQLFPLSAFRAANKAA EAVYTAIRHDGHQQGVLDSMQTREELYERIGYHDYEQRLDALFARKGA >XCV3124 ptsH, phosphotransferase system HPr enzyme MLERELIVSNRLGLHARATAKLVQTLSSYRSNATLAAKGREVNAKSIMGV MLLAAGQGTSVVVRLDGEDEAEALQALVDLFERRFDEDS >XCV3125 ptsI, Enzyme I of the phosphotransferase system MSLRLRGHGAARGNALGRARVRQSHTLEVAEQRVPANQVETQLQRLHAAI ASARVEMQQLRDRLHGALAREVGEFLELHALLLDDPELLQGLDELIRTHR YSADYALRVQRDRLAAVFDGMEDAYLKSRMDDLDHVIGRIHAFLHKRAPD LKGVAGEILVCDNVAPSELAQLQAQGVVGIVTTAGSTLSHSAILARSLHL PLVVGVSDALQRIEDGDVLIVDAGSGQVIVDPKPEHLRDYRERLRALAKE QRELGRLRSKPTRTRDNVDITLLANAESLEDVANAHALGASGLGLYRTEF LFLQRNELPDEDEQFHTYRDTVLGMSGHPVTIRTLDLGADKADRTGLTLS DEDNPALGLRGVRLSLARPAVAQAQLRAILRASGYGPVRILVPMVSGREE ILQLRKQLKKLTAQLRAEGHEIAEHIPLGAMIEVPAAALALDCFIDDIDF LSIGTNDLVQYLLAVDRNNEALGELYSPLHPAVLRLIAQVIATGRTYGKP VAVCGEIAGDPRFVPMLLALGLTEFSLHPATLLEVRRAVRDTHLGELRVH GEKLLRARDRKGIEKWLAGHAQGLLR >XCV3463 pykA, pyruvate kinase type II MKERQRRTKILATLGPATDAPGVLDTLFKAGVNVVRLNFSHGDPSGQAKR AAEVRAAAARVGAEVGILADLPGPKIRIERFAEGKIKLTMGDRFDLVADA NAPAGDQTQVGVSYLGLPQDVTAGDVLLLDDGLMQLQVTDVQGERIVTKV LNDGVLSDRKGLNKQGGGLSLGALTERDKELIGIVAKIGVDFIAVSFCRN AQDMHDARQIAQQHGCDAQLVSKIERTEAIENLVEIVEASDVVMVARGDL GVEIGDAELPGLQKKIIRESLAQNKVVITATQMLQSMVESPIPTRAEVLD VANAVIDGTDAVMLSAETAAGAYPVRAVEAMARICLGAEHQFEFDTDFEA AQRNLQRADQAIAMATMFLSEHIGLGGVVALTESGGTPRFLSRFRSNMPI YAFTRHDGARRQMAMMRGVFPISFDSRGLTPREAARAAIRLLVENERMGP GDRVVFTSGEHMETHGATNTLRLLEVGEDGRATGLGEL >XCV0870 rbsK, ribokinase MSSVVVVGSFNVDHVWRCDALPVPGATIAGRYSTGPGGKGFNQAVAAARA GAKTHFLCALGDDAGGALARSLAAQDGFSLIAEPSNEPTGTGGIYVDGHG RNTIVIGAGANAVLSPAFIENQRPLVAAAKVLLAQLESPAETIESALALA HECGVLTVLNAAPANAPTSIGLLKLSDVLTPNETEFAALLGRHVGERINA DDVAALDGNTLHSLCRKLLPGGTVVVTLGAVGAFISHAEEQLRGDSQAHY RVGAESAQTIDTTGAGDAFNGALVASLAQVPAASFATHVRFATRYAARST EVEGAAVSMPRLRADD >XCV3717 rmd, NDP-hexose oxidoreductase MASHSDLTGKRVLISGASGFTGRYMAQQLKEQGCTVIGVGTRSDGTGTAG TDEFWPMDLRDAADVARIVAHAQADYVVHLAAVAFVGHGDADDFYRVNLL GTRNLLQALAASRHRPERVLIASSANVYGNATEGVIDEAVTPAPANDYAV SKLAMEYVASLWRERLSLVIARPFNYTGVGQATNFLIPKIVSHFASHASS IELGNTEVWRDFGDVRSVVLAYRKLLQAPAAEGQIVNVCSGVASSLGDII GICSKITGHDIDVQVNPAFVRENEVKKLLGSNARLQELIGDWQSLALEDT LRWMLEASCQH >XCV0502 rpe, D-ribulose-5-phosphate 3-epimerase MALLHFSELPMQPTAIAPSILSADFARLGEEVNNVLKAGADWVHFDVMDN HYVPNLTIGPMVCQALRKHGITAPIDVHLMVEPVDRIVPDFADAGATTIS FHPEASRHVHRTIQLIKSHGCQAGLVLNPATPVDILDWVLPELDLVLVMS VNPGFGGQAFIPSALDKLRAIRRKIDATGKPIRLEIDGGVKADNIGAIAA AGADTFVAGSAIFNAPDYAQVIAQMRAAVDAVR >XCV1918 rpfH, putative membrane protein RpfH MRAALAQLRRRLARRPDSEHGQALVRIVMLWLILAYTLVCAPHWQLSDDH LQRLLCLVAIGHGGALLLFAWIVAKPRPSHLRRTLGMLADYGLLSLAMTW FAAPMACLYVVVMWVTIGNGLRFGRHALHSAVAMAMLSFGATLANSPYWQ QRIELGIALLAALVVIPLSLLRLMQDSADAAARIAAYAHGADAAGPRGPL SSPSKRPQV >XCV3528 rpiA, ribose-5-phosphate isomerase A MSEAKRLAAEKAIDYVEDGMIVGVGTGSTVAYFIDALGRIGHRIKGAVSS SEQSTARLRQHGVEVLDLNHTGNLSLYVDGADECDPNRCLIKGGGAALTR EKIIAEASERFICIVDPSKQVPVLGKFPLPVEVIPMARSLVARQILALTG GQPVWRDGVVTDNGNVVLDVHHLQITDPVGLERSLNQIPGVVCVGLFARR PADVVIVGGEPPQVI >XCV0154 rpiB, ribose 5-phosphate isomerase MKIALMNEFSQAAKNPVILQQLNEVASEQGHSVFNVGMDGDNDHRLTYIH LGIVASLLLNSKAVDFVVAGCGTGQGAMMSLNAHPGVFCGYCIEPTDAYL FAQVNNGNALSLAFAKGYGWGAEINVRYIFEKAFSGERGMGYPAERRESQ QANAGILTQLKQATAKSYLDGLRAIDPELIKQAIGGERFQQCFFDNAQDA EIRNFVAGLLGKTEAAAAAA >XCV2115 sndH1, L-sorbosone dehydrogenase MKRQTTSLITVSILAAALAACGKAPEVSQRGATPELPEPDRGLLPDMKIA EPTAWNERKPTVPAGYRITPIAKDLGIPRQTLVLPNGDILVAEGRGGGAP NLKPKDVIAGAIKAKGTSKAKSGNRLTLLRDADGDGTYELKTVFADKLNA PYGLALIGEALYVANQDALVRFEYRQGQTRASGAPTKVTDLPSAINHHWT KALTASADGRYLYVAIGSNSNITERGMAVELDRAQIWQVDAATGAHKPYA TGIRNPTALAIQPGSGALWAVVNERDEIGPNLVPDYLTSVREGGFYGWPY SYWGKNVDARVMPQDPQKVASAIVPDYALGSHVAALGVAFSSSAMGAKFA DGVFVGEHGSWNRNPPVGYKVVFVPFRDGRPAGDPIDFVSGFHGEDGKTR GRPVGVTVDPRGALIVADDLANIVWRVTPDAAAAAPQ >XCV3802 sndH2, L-sorbosone dehydrogenase MNASRLKFARWPLSLMALAVLAACGDTATLAIEQGTGPDPQLPEPVKRLI PTVKVAPVKRWAANAKPIAADDLQVAAFARDLDHPRWVYVLPNGDVLVAE TAEPPKPEDAEAGGGLRKKVQGAMMKKAGAAVASANRITLLREADGDGVA EVRTQFVSGLFSPFGMALIGDRFYVANADALVSFPYKPGDTHLTAKPTFV ANLPGGINHHWTKSLLASPDGSKLYVGVGSNSNVAENGMEAELNRAAILE IDPATGSSRVFAGGLRNPVGTAWEPQSKSLWVVVNERDEIGSDLVPDYLT SVRDGGFYGWPYSYYGQHVDERVKPQNAELVAKAIKPDYALGPHTASLGL SFASGTLLPERFRQGAFIGQHGSWNRDPPSGYKVLFVPFADGKPNGPPIT VLDGFLDAEGNAQGRPVGVASDSRGALLVADDVGNVIWQVTPKAR >XCV3618 suh, sucrose hydrolase MASSARARLPAVPPASACVTTFKDPAPGPARRPLMSTSPIDSTALRAAFA APLDPQRADVLLSRYDQHASRLLDALHALYGQRADYASWLAQWLGEIGTI ARQRPQALQALDSTRHAGWFGEQHMLGYSAYADRFAGTLQGVAERVPYLQ ELGVRYLHLLPFLRARAGDNDGGFAVSDYGQVAPSLGTNDDLIALTTRLR EAGISLCADFVLNHTADDHAWAQAARAGDARYLDYYHHFADRSLPDRYEA TLGQVFPHTAPGNFTWVDDTAQWMWTTFYPYQWDLNWSNPAVFGDMALAM LRLANLGVEAFRLDSTAYLWKRIGTDCMNQPEAHTLLVALRAVTDIVAPA VVMKAEAIVPMTQLPPYFGSGTDQGHECHLAYHSSLMAAGWSALALQRGD ILHNVIAHSPPLPRHCAWLSYVRCHDDIGWNVLQHEASGNAAQPPFSLRD VARFYANAVPGSYARGESFQSSGDGVHGTNGMAAALAGIQAAQEAGDAAA LAVAVDRLVLLYAIALAMPGVPLIYMGDELAMVNDPGYRDDPLRQHEGRW LHRPAMDWQLAAQRHDANSLSGKVYRRLRGLIRKRTALTALAADQALGSI ALNDARVFALTRGESFIALHNFSDQPLDVELAAVGVDGWTLLAIDDAVDA AAVSDDVSIVLPPYGVRWLQRKG >XCV2582 suhB, Myo-inositol-1(or 4)-monophosphatase MQKPAVTVMVKAARLAGNVLLRGINKLDALNVVQKGRMDYASEVDADAEK VIIKELKRGYPEYAVFGEEGGVQGGKSGRYTWVIDPLDGTSNYLRGFPHY CVSIALVENGEPTDAVIFDPLRNELFTASRGAGAVLNDRRIRIAERKDLE GAMVHTGFPPRERARASAQLKCVDALLVQAEDVRRTGSAALDLAYVACGR ADAYFEAGVKAWDIAAGVLLVREAGGRVCDYKGATPPRMDNMGPETQQIV AGNIKISDALQKVIVNTGYAREFDAKF >XCV0939 talB, transaldolase B MTASPSKLAQLRELSVVVADTGDYDAIKRLKPVDCTTNPTLVKKALDLPV YADLIERELAWGREHGGDDRTATVNEVADRLTIGVGVKLAELVPGRVSTE VDADLAHDTQATIAKARKFVAMYAERGVSKDKILIKIAATWEGIEAARQL QKEGIDCNLTLIFNRSQALACAEAGVFLISPFVGRILDYYVAQGQTPASI DEDPGVVFVRTVYNEFKQRGSSTVVMGASFRSTAQIEALAGCDRLTISPD LLEKLDAEHGELPRKLSPAKADNAQFTPIDSDSFASGLAADPMATEKLAG GIDTFAKDLHALRKTIADKLAG >XCV3490 tktA, Transketolase MTQPTRRQLANAIRFLAADAVEAAKSGHPGMPMGMADIAEVLWNDFYRHN PNNPQWFNRDRFVLSNGHGSMLQYALLHLSGYDLPIEQLKQFRQLHSKTA GHPERSETPGVETTTGPLGQGFANAVGFALAEKLLAQRYNRPELEIVDHR TWVFMGDGCLMEGISHEAASLAGTWGLGKLVAFWDNNQISIDGNTAGWFS DDTPARFEAYGWHVIRDVDGHDADKIKAAIEAALENTDKPTLICCRTKIG FGAPTKAGKESSHGAPLGKDELEGARKALEWPYGPFEIPEEIYAGWRAGG TGTLRQAEWEQLFDKYAKQYASEADELTRRSHGELPADFIAKADAYIAKA QEEGQTIASRKASQLAIEAFAPLLPELIGGSADLAHSNLTLWKASKSVAT DDPDANYVYYGVREFGMTAIANGLALHGGFIPFDATFLVFSDYARNGVRM SALNPAHAIHVYTHDSIGLGEDGPTHQPVEHLASLRYIPNNDVWRPGDAV ESAVSWKAAITRKDGPSCLIFSRQNLQHQPRSAEQIKLIERGGYVLADAQ GGTPDVILIATGSEVGLAVEAKQTLDAAGLKTRVVSMPSTDVFDRQDAAY RDSVLPNAVRKRVAVEAGVTGFWRKYVGLDGDVVGMDTFGASAPADQLYA YFKITAEHVVAAAKAL >XCV2855 tpiA, triosephosphate isomerase MRRKIVAGNWKLHGSRAFATELVAKVAAHMPLEGVEVVILPPLPYLGDLI EDFEAHHLSFGAQDVSSNEKGAYTGEVSASMLVDVGAGYGLVGHSERRQY HHESSELVARKFAAAIHAGLIPVLCVGESLEQREAGQTEAILRAQLDPVL ALVGSAGFAGAVLAYEPIWAIGTGRTATPEQAQAVHAFLRGEVAKADARI ADSLPILYGGSVKPDNAGELFAQPDVDGGLVGGASLVAEDFLAIARAAAA C >XCV0660 treA, Periplasmatic alpha,alpha-trehalase precursor MSSAAPPCCTSLLGLSLSMFVAPGTLTAAPLDPPVVNAPAPTPPTPDLAY PELFQAVQRGELFDDQKHFVDFLPLRDPALINADYLAQHDHPGFDLRKFV DANFEESPPVQTDAIRQDTALREHIDLLWPKLVRSQNHVPPHSSLLALPH PYVVPGGRFREVYYWDSYFTMLGLVKSGETTLSRQMLDNFAYLIDTYGHI PNGNRTYYLSRSQPPFFSYMVELQAGVEGEAVYQRYLPQLQKEYAYWMQG SDDLQPGQAARHVVRLADGSVLNRYWDERDTPRPEAWLHDTRTAAEVKDR PAAEVYRDLRAGAESGWDYTSRWLADGQNLRTIRTTAILPIDLNSLLYHL ERTLAQACAQAGAECTRDYAALAQQRKQAIDAHLWNAAGYYADYDWQTRT LSNQVTAAALYPLFAGLASDDHAKRTASTVRKTLLRPGGLATTAVKTGQQ WDEPNGWAPLQWVAVDGLRRYGEDALARTIGERFLAQVQALFAREHKLVE KYGLETDAAGGGGGEYALQDGFGWTNGVTLMLLNLYPGKDAKAAPAKRVR KPEAAAR >XCV2238 ugpC, sugar ABC transporter ATP-binding protein MAKVQLEGVRKVYDNGQVAVQGASFEVADGELMVLVGPSGCGKSTLLRMI AGLEDISAGTLKIGERVVNDVAPKDRDIAMVFQSYALYPHMTVAENLAFG LKLRGHPKQVIAERVNNAAELLGLTPMLDKLPKAMSGGQRQRVALGRAMV RESSVFLLDEPLSNLDAKLRHSVRTEIAQLHRKLGTTMIYVTHDQVEAMT LGQRIVVLKDGVIQQIDSPMALYDRPANLFVAGFLGSPAMNVLQGRLDAQ DGLHLVMADGWRVPLGAARVDAAWFGQDVIVGVRPEHLQPSDDAVLGFDA RVDVIEPVGNEIFLNLDRGGQPLVIRVPPQSLPAVGQPLRLALRSEALHF FDPATGQRLEAA >XCV4357 uxaC, glucuronate isomerase MRSSVLSLHPDRLLPADPGTRAIARRLYAQVATLPIISPHGHTDPAWFAT NAPFANATELLLVPDHYVFRMLYSQGIDLDALGIPRADGTRAAVDPRAAW RVFAEHYTLLRGTPSALWLNHVFHDVFDLRIRLDAGTADHYYDHITAALQ TPAFLPRALFERFNIEVIATTESPLDRLQHHAAIAASGWQGRVVTAYRPD PVVDPEHEQFAGALQQFGALTGEDVLSWDGYLRAHRQRRAFFAAHGATST DHGHPSAATADLSPVQAQRLFDTVVRGEATPEQAELFRAQVLTEMAAMSL DDGLVMQLHPGCFRNHNRQLFEQYGRDKGADIPMRTDYVHALKPLLDRHG NDPRLRLIVFTLDETSYSRELAPLAGHYPSLLLGPAWWFHDAPEGMWRFR EQTLASAGFYNTVGFNDDTRAFLSIPARHDVARRVDSAFLAKLVAEHRLE EDEATEVAIDLAYRLPKQAYNL >XCV4021 wbnF, nucleotide sugar epimerase MTILVTGAAGFIGAYTCRALAARGETVVGLDNYNSYYDPQLKHDRVAALC PGIDIRTLDLTDREGLAALFDEIQPTRVVHLAAQAGVRYSLENPHAYVDS NLVGFVNMLELCRHRGVQHLVYASSSSVYGDSATPPFSEDQRVDQPRSLY AATKAANELMGYTYAQLYGLRATGLRFFTVYGPWGRPDMAPLIFSRAVLA GRPIEVFNHGKMQRDFTFVDDIVAGVLGALDTPSTAPVPHRVFNLGNHTP VELETFIDVIAQAAGRAAEKVYRPMQPGDMIRTMADTQRAQAAFGFDPAT PVERGLPQVVEWCRQYFGERT >XCV3722 wzm, O-antigen ABC transporter permease MKDLLRPLWVYRYFIFSSIKNELRMRFIQSKLGALWMIIHPLMQVLIFAT ILSEVLAAKLPGIDNKYAYALYLMSGTLCWSLFNETINKCVSLFVENGNL MKKMAFPRICLPFIAAGAMLVNNLLLLLAIFIVFAVLGHYPGLQVLWLPF LLVLTLTFAMSLGLLLGVFNVFMRDIAQVVPVVLQALFWLTPIVYNISIL PEDVAKVFKLNPLFPLVTAYQQVLLYGTTPDWRSLMPLCAATAILGLMSL VVFRRASQEMVDAL >XCV3721 wzt, O-antigen ABC transporter ATP-binding protein MSDVVMRVEDVGKAYRVWSSQWLRAASWFGAPVQAREEHWILRNVSFSIK TGESVGVVGRNGAGKSTLLKLITGTVQPTEGVIARSGRIAAILELGMGFN PDLTGRQNAYHSAGLMGYSQQQIDAAMPGIERFAEVGEYFDTPVRTYSSG MQVRVAFAVATAFRPDVLIVDEALSVGDAYFQAKCFKRVQEFKELGTTLI LVSHAVGDIVKHCERVLFIKDGGVYADGPAREVSNLYLDELFGRKSSPDS ARADVPIKAIPGESIDDVFHTRPLYNRNEHRWGQGGAKIVDYAVTSSGER FPARIDSGAVTKFHMKIFFERDFDNVVPGLLLKTLEGLFLYGTNSFLASD GRKMLSPRAGDVITCHFALPLSVNEGHYMVSLGVSSGDPLGELVPLDRRY DSILLDVSRPMQFWGIVDLNAEFSADVS >XCV3703 xanA, phosphoglucomutase / phosphomannomutase MTLPAFKAYDIRGRVPDELNEDLARRIGVALAAQLDQGPVVLGHDVRLAS PALQEALSAGLRASGREVIDIGLCGTEEVYFQTDYLKAAGGVMVTASHNP MDYNGMKLVREQARPISSDTGLFAIRDTVAADTAAPGEPTASEQSRTDKT AYLEHLLSYVDRSTLKPLKLVVNAGNGGAGLIVDLLAPHLPFEFVRVFHE PDGNFPNGIPNPLLPENRDATAKAVRDNGADFGIAWDGDFDRCFFFDHTG RFIEGYYLVGLLAQAILAKQPGGKVVHDPRLTWNTVEQVEEAGGIPVLCK SGHAFIKEKMRSENAVYGGEMSAHHYFREFAYADSGMIPWLLIAELVSQS GRSLADLVEARMQKFPCSGEINFKVADAKASVARVMEHYASLSPELDYTD GISADFGQWRFNLRSSNTEPLLRLNVETRGDAALLETRTQEISALLRG >XCV3704 xanB, phosphomannose isomerase / GDPmannose dehydrogenase MSDVLPIILSGGSGTRLWPLSRESYPKQFLPLVGDKSMLQSTWLRAAPVA GHAPIVVANEEHRFMAAEQLQQLGVKPSAILLEPKGRNTAPAIAVAALEA TRDGADPLLLVLPSDHVIQNEAAFQAAVTLAATAAEQGKLVTFGIKPTAP ETGYGYIKAGAGTGASAVERFVEKPDLATAQSYLASGEYYWNSGMFLFRA SRYLEELRKFHPAIADACQKAWENGKRDADFTRLDKDAFAASPSDSIDYA VMEKTADAVVVPLDAGWNDVGSWSSLRDVSKQDAQGNAHHGDVIQLDCQN TYAYGSRLIAMVGLEDVVVVETPDAVLVGHRDRIQEVKDIVSQIKTAGRS EATWHRKVYRPWGAYDSIDMGQRHQVKRITVKPGAVLSLQMHHHRAEHWI VVSGTAEVTRGEEVLLLTENQSTYIPLGVTHRLRNPGKLPLELIEVQSGS YLGEDDIVRFEDTYGRA >XCV4330 xylA, xylose isomerase MSNTVYIGAKEYFPGIGKIGFEGRDSDNPLAFKVYDANKTIGDKTMAEHL RFAVAYWHSFCGNGADPFGPGTRAYPWDAGTTALNRAEAKADAAFEFFTK LGVPYYCFHDIDLAPDADDIGEYEKNLKHMVGIAKQRQADTGIKLLWGTA NLFSHPRYMNGASTNPDFNVVARAAVQVKAAIDATVELGGENYVFWGGRE GYACLHNTQMKREQDNMARFLTLARDYGRAIGFKGNFLIEPKPMEPMKHQ YDFDSATVIGFLRQHGLDQDFKLNIEANHATLSGHSFEHDLQVASDAGLL GSIDANRGNPQNGWDTDQFPTDLYDTVGAMLVVLRQGGLAPGGLNFDAKV RRESSDPQDLFLAHIGGMDAFARGLEVANALLTASPLEQWRAERYASFDS GAGADFAAGKTTLADLAKHAASNAPQQLSGRQEAYENLINQYLTR >XCV0150 xylB1, xylosidase precursor MRVRPISSRWRWPMAGGLLLCAGLSAAADWKRGIEHQRIADQGDGSFLNP VLAGDHPDPSVLKDGDDYYLTLSSFDAYPGLPIWHSRDLVNWQPLGHAIT QNVGAIWAPDLIKHGKRYYIYFPARRGDQGERSNFVVWADDIKGPWSAPI DIGLGKYIDPGHAVGEDGKRYLFLSGGDYVQLSDDGLKVVGTPKHVYDGW KYPESWDVEGYAQEGPKITRHNGWYYMTTAVGGTAGPPTGHMVITARSRS IHGPWQNAPNNPITRTRSAQEPWWSRGHATLVEGTDKRWWMLYHGYENGY WTLGRQALLDPIEWTPDGWFVAKGGDLGTPLKKPSGQALPHGLALSDDFR ASTLGPQWAFFNPAADEAKRLQVGNGVLRLQGKGSAPRDASPLTVIATDP AYQFEVQMTVSPGGQGGALLFYSDKLYAGVGSNGQQFVMHRYGEERPATL APSTNGGTLWLRVTNNRHIVTIHSSTDGKAWTKYPVQMEVSGYHHNVAGK FLALKPALYAAGPGQVEFRNFRYRALD >XCV4281 xylB2, xylosidase precursor MADTTRRDLFKGLAAGALVAPLAAAAQASTPQCAGTPPWARGVEGQRKAD LGNGTYLNPIVAGDHPDPTILKDGDDYYMTFSSFFSYPGIVLWHSTDLVN WTPIGPALHQGLGTIWALDLCKHNGRYYIYIPANPDDTGWSIFVIWADDI RGRWSAPIDLKIAGCIDPGHVVGEDGKRYLFVNGIRKVRLRDDGLATDGQ LEPAYAPWRYPDHWVVENFAPEGPKLTWHDGWLYLVTAVGGTAGPVTGHM VIAARSRSVHGPWEHCPRNPLVRTQSDQEPWWSRGHATLVEGPRGDWWMV YHGYENGFRTLGRQTLLEPIEWTADGWFRATGGDLSKPLRTPARVPAAGM APATGLALSDDFSSDRFGTQWSLHAPKPGEQARVRRANKALTLACAGSSP IDSTPLTCGVPDRAYMAEVTLELVGNAEGGIVLFYNHKAFVGIGFTADSM KTYEYSEELVWARAPNTHRRIRVRLTNDHQVVGFEYSVDEGRQWTRHPTR MEVSGFHHNVFGGFLSLQLGVYAAQQGEVVLRDFRYRALS >XCV4336 xylB3, xylosidase precursor MRAFSATCVALLMALAVPANAQAQAAADVAFDWFEYRGDDAVFATPLPAG HYRNPVLAGFYPDPSITRVGERYYLVNSTFTYFPAIPVLESTDLVHWTQI GNVVERREQLDYDGLRMSRGMYAASIRHHDGRFYVVGTSVDSGGNFIASA SNAAGPWSALTWLPSIDGIDPSLFFDTDGSAYLLNNGPPEGTPLYDGHRA IWMQRFDIAKNAPVGPRKVLLNGGVDLASKPIWIEGPHLYQRDGWYYLSC AEGGTGPQHSQVVLRSRNVWGPYAPAPNNPILTQRDLPAGRAHPVSNAGH VDLVDTPDGQWWAVFLASRPYRGDHYNTGRETFLLPVQWRDGWPSILPAG QPIPYIAKAPAGMKAVATQAPLSGNFVWHDDFDQATLQREWLTVRVPKHD VADLRTRAGWLTLHASSQGLDGTGTPAFLARRQQHLRFTASTALEVPTQA GISAGLAAFQNSTAWYALGARRDGDAVQVFLDKREGAATTTLAQTRIPAT AQLRLQISGDGGAYSFAFDADGRGWQWLRRNDDASFLSTEKAGGFVGSVI GPFAQSHPDRPSQD >XCV4350 xylB4, Xylulose kinase MRTQTLADDTGGNAPLVLAVDLGTSGCKCALVTLDGKVLAWAFEPVQLHV QGVAAEQDPHAWWDAFSATAAAVVQGDAALRRRVVAVCCSTQGEGTVCVD HNGQALGRAMLWLDMRGQAAIARRLQGRWLNVRGYDPLRLWRWLRLSGGA PARSGKDCAGHIAYLRDHQPVRYQRTHKFLNVLDYMNLRLTGRFCATPDS MLTTWVTDNRDPHHIRYDAGLLDMVGVERDKLPDLVPSTAVLGPLLPQVA QALGLSPQTVVVAGAIDTSAVAVAAAVEDHAAHLYLGTSSWLGAHVPRMK TDVRSTIAAVPCAVEGRYLAIALQTTAGANLSFLRDRILFHADELLSDEQ RPDVYEVLNRIAARVPAGSNGLIYMPWLFGERTPVEDPSLRAGLINLSLM HSREDMIRAVMEGVAFNTRWMMEPFARLLGCDPGTIAAVGGGAQSDLWCQ IIADVSGRPIRQLHNPIQANAVGAAFIAGVGLGRLGFGDLAALQRPRRVY EPDAGTRALYDDRYAVFKDLQRTLAPIYRRLNPSTPAPAPEVATHVCP >XCV4363 xylP, glycoside-pentoside-hexuronide:cation symporter family protein MAQCAPRRFPQHSSSPPHLMNDRSQQLSLREKIGYSLGDLAANLIFQTLV TFLAFFYTDVFRIPASVAATLIFVVGMLGAFVFTPVIGILADRTRTRWGK FRPWILWTALPFGALSLAAFNTPTLGEQGKIAYAFATYTLLMLVYVANNL PYSALSGVLTGSMEQRNSLSAYRFLAVTFAQFIIQVLLLPLVLILGNGDK AQGFRNTMALFAAIGTLCFLITFFTTRERVLPISEQRNSVRQDLTDLVRN KPWLVMLALTILVFINLAMKGGMYIYYFKYYLDANALTQFLDHAGFNRFI AGINSVLTGAGMSALQWPQDAPTSAFSVFSAGGILAMIVGIGFSKRLADR FGKRNVFGGALLISTLFLLAFYLYPPNAIGWVFASYVLHGYFYGITIPLL WAMIADVADYSEWKNHRRATAIIFSAMLCGLKIGLSVGGALVAGILAFYG YDAALPQQGAAVTNGIRLSISVYASLPFLLGTALLALYEIDKALETRIEH ELGMRRQAAPFATV >XCV4355 xynA, endo-1,4-beta-xylanase A MRSSAIETCDLSTDLLMHINRANLTKRLGLLIAGLSAVCTLQALAACGTP GTSLKQAYAQGFLLGTAVNADIVSGKDAASAALAACHFNAVTAENVMKAE VVAPRRGVQDFSAADAFVAYAQRNRQFVVGHTLVWHNQTPEWFFTTADGR PNTPAQQLERMRAHIAAVAGRYTGKVQAWDVVNEIIDEDGSYRSTNWVQR VGDGDTVVRNAFTFAQRYAPDAQLYYNDFNAWRPAKRDGIVRMVKMLQQA GVRIDGVGMQGHWGLNYPSLRDIEDAIDAYAALGVKVMITELDIDVLPLT KEGQIIGTGMAHKQFQLPEFKRFLDPYRDGLPADVQAQLRDRYAELFALF WRKRDKIARVSVWGVSDDMSWKNDYPVPGRTNYPLLFDRNHQPKPALDAV LAVPTATAAR >XCV4358 xynB2, Xylanase precursor MLKLRYPLTLVLLLGAYASAVAGPIAAGKQRVLGSAYSPQQAQGFTNYWN ADVPENAGKWGSVEPVRGQMNWGPLDEAYQLAKRNHMQFQFHVGLWGAQQ PTWVRNLPPNEQLAAIEHWFAAIAQRYPDIDLMQVANETLPGHNQPDNRR SDTGNYLRALGGTGATGVDWVLEAFRLARKYFPHTKLMINDYNVTEYNDQ ARQYLHTIQLLQQEHLIDAIGIQGHLSSNGPSVSVQRANLDLLASTGLPI YITEFDLDGRTDAQQLAAWQRFFPMFWEHPAVRGVNVWGFRHGLWRENEG AYLINYDGSERPALTWLRSYVASRP >XCV4360 xynB3, Xylanase precursor MHKRAVALGLLMVAGMAAPTHAAPLAAAASKFLGSAYGAQQAPGFAQYWN KLTPENGGKWGSVEAVRDQMDWSTLDAAYRFAQANQMPFQMHVMVWGNQQ PEWIKTLRPAEQRREIEQWFAAVAQRYPEIALLEVVNEPLNDPPSKADTG GGNYLQALGGNGDSGWEWVLQSFRLARQHFPNTKLMINDYSITNSAQATQ KYLQIVRLLQRENLVDAIGVQEHAFETTPEVAMSVHRDNLDALAATGLPI YITEFDLDGPTDAQQLADYKRVFPVFWEHPAVHGLTLWGFRPGLWRDKEA AYLIRADRTERPALAWLRDYVAAHPGAPAP >XCV2237 zwf1, glucose-6-phosphate 1-dehydrogenase MSASIPRCAHASVAQEQTYRPPDDRRLSDKLLITMSPESETRSMHNTLIL FGATGDLAQRYLFPSLLRLFIDGLLPEDFRIRALALSPHDTDAFREVLRP RLTEALPIATAEQIDTLLQRIDYRSVDLRDAESVANAVRELASRRCVSYL AIPPGLYISTCQGLALGGALEAPHRLMLEKPIGHDSDSARDILQSIGALI DEDRVFRLDHYLGKAAVQNLIALRFGNTLLEAVWNRAYIESVQILVAESE GVDGRDAYYARSGALRDMVQSHILQLLCLVAMEPPASLEADRIRDEKVKV LRALRPMTAEHAAHDCVRGRYTAGSINGQPAQAYHPPEGSDVETFVAVTA HIDNWRWAGVPFHLCTGKRLAERSTRIVVTLKPVTHWLFERPDRQNAVPN RLTFQLQPQENIELGLMSSLAGPEWGAIELQPLELELSVPTGLHRRIAYE RLFVDAFNGNPALFVRDDEVKAAWSWIDSVSDAWKDAALPLQPYPAGSWG PESAAHFLPPATDAQGNNA >XCV4168 zwf2, glucose-6-phosphate 1-dehydrogenase MSEQATTPPCIIVVFGARGDLTKRLVMPALYNLRRSGALGDEFAIVGMDH GDISERAWRTNMGQSMTQLLSSRDAEFQTDEFDTATWDWLRERMHYLRGD FTDQGAYRSLGGVLDKLHKRYGTQGNVLFYLATAARFFEPVLLNLGEAGL VRQREGEGWRRVIVEKPFGHDLPSAQHLNATVAKVLHEDQVFRIDHFLGK ETVQNILAFRFANGLFEPVWNRDRIDHVQITAAETIGVEGRGRFYDPTGC LRDMVPNHLFQLLAMIAMEPPAAFTTEAMHRRRAEVIEAVRPIRPEDVVR GQYASGAVNRNAVPGYREEDTVPEDSDTETYVAMKLQVDTWRWAGVPFYL RTGKRLRERTTEIAIRFKPAPLAPFRSTEVGGYGPDWLVLHIQPDEGISL QFDVKRPGAQVALAPVRMDFRYRDWFPKEYTVGYERLLQDCMNGEAGLFQ DAAMVEGAWRIVQPILDAWKQPPSDFPNYAAGSAGPSAADALLAMNGGHA WRALTPGRKPPPRRPPEARAGAATPVKKATKKIAKKASKATSKRAGKPAA KSAETGADSSSKPTKKSGVKRATKEVAKKTAKTVRKTAAGKVVATKLVSK SVAARKARR
|
Beutenbergstraße 11 D-07745 Jena • Germany |
Phone: +49 3641 65-6000 Fax: +49 3641 65-6351 |
E-mail: info@leibniz-fli.de www.leibniz-fli.de |
Data Privacy Imprint |
|